
<html lang="en"     class="pb-page"  data-request-id="2443c8bc-fa59-401f-9f6b-285edef7aeef"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2012.55.issue-21;article:article:10.1021/jm300119p;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design and Preparation of a Potent Series of Hydroxyethylamine Containing β-Secretase Inhibitors That Demonstrate Robust Reduction of Central β-Amyloid" /></meta><meta name="dc.Creator" content="Matthew M.  Weiss" /></meta><meta name="dc.Creator" content="Toni  Williamson" /></meta><meta name="dc.Creator" content="Safura  Babu-Khan" /></meta><meta name="dc.Creator" content="Michael D.  Bartberger" /></meta><meta name="dc.Creator" content="James  Brown" /></meta><meta name="dc.Creator" content="Kui  Chen" /></meta><meta name="dc.Creator" content="Yuan  Cheng" /></meta><meta name="dc.Creator" content="Martin  Citron" /></meta><meta name="dc.Creator" content="Michael D.  Croghan" /></meta><meta name="dc.Creator" content="Thomas A.  Dineen" /></meta><meta name="dc.Creator" content="Joel  Esmay" /></meta><meta name="dc.Creator" content="Russell F.  Graceffa" /></meta><meta name="dc.Creator" content="Scott S.  Harried" /></meta><meta name="dc.Creator" content="Dean  Hickman" /></meta><meta name="dc.Creator" content="Stephen A.  Hitchcock" /></meta><meta name="dc.Creator" content="Daniel B.  Horne" /></meta><meta name="dc.Creator" content="Hongbing  Huang" /></meta><meta name="dc.Creator" content="Ronke  Imbeah-Ampiah" /></meta><meta name="dc.Creator" content="Ted  Judd" /></meta><meta name="dc.Creator" content="Matthew R.  Kaller" /></meta><meta name="dc.Creator" content="Charles R.  Kreiman" /></meta><meta name="dc.Creator" content="Daniel S.  La" /></meta><meta name="dc.Creator" content="Vivian  Li" /></meta><meta name="dc.Creator" content="Patricia  Lopez" /></meta><meta name="dc.Creator" content="Steven  Louie" /></meta><meta name="dc.Creator" content="Holger  Monenschein" /></meta><meta name="dc.Creator" content="Thomas T.  Nguyen" /></meta><meta name="dc.Creator" content="Lewis D.  Pennington" /></meta><meta name="dc.Creator" content="Claire  Rattan" /></meta><meta name="dc.Creator" content="Tisha  San Miguel" /></meta><meta name="dc.Creator" content="E.Allen   Sickmier" /></meta><meta name="dc.Creator" content="Robert C.  Wahl" /></meta><meta name="dc.Creator" content="Paul H.  Wen" /></meta><meta name="dc.Creator" content="Stephen  Wood" /></meta><meta name="dc.Creator" content="Qiufen  Xue" /></meta><meta name="dc.Creator" content="Bryant H.  Yang" /></meta><meta name="dc.Creator" content="Vinod F.  Patel" /></meta><meta name="dc.Creator" content="Wenge  Zhong" /></meta><meta name="dc.Description" content="A series of potent hydroxyethyl amine (HEA) derived inhibitors of β-site APP cleaving enzyme (BACE1) was optimized to address suboptimal pharmacokinetics and poor CNS partitioning. This work identi..." /></meta><meta name="Description" content="A series of potent hydroxyethyl amine (HEA) derived inhibitors of β-site APP cleaving enzyme (BACE1) was optimized to address suboptimal pharmacokinetics and poor CNS partitioning. This work identi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 18, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300119p" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300119p" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300119p" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300119p" /></link>
        
    
    

<title>Design and Preparation of a Potent Series of Hydroxyethylamine Containing β-Secretase Inhibitors That Demonstrate Robust Reduction of Central β-Amyloid | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300119p" /></meta><meta property="og:title" content="Design and Preparation of a Potent Series of Hydroxyethylamine Containing β-Secretase Inhibitors That Demonstrate Robust Reduction of Central β-Amyloid" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0007.jpeg" /></meta><meta property="og:description" content="A series of potent hydroxyethyl amine (HEA) derived inhibitors of β-site APP cleaving enzyme (BACE1) was optimized to address suboptimal pharmacokinetics and poor CNS partitioning. This work identified a series of benzodioxolane analogues that possessed improved metabolic stability and increased oral bioavailability. Subsequent efforts focused on improving CNS exposure by limiting susceptibility to Pgp-mediated efflux and identified an inhibitor which demonstrated robust and sustained reduction of CNS β-amyloid (Aβ) in Sprague–Dawley rats following oral administration." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300119p"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300119p">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300119p&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300119p&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300119p&amp;href=/doi/10.1021/jm300119p" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9009-9024</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm3008618" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300118s" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Preparation of a Potent Series of Hydroxyethylamine Containing β-Secretase Inhibitors That Demonstrate Robust Reduction of Central β-Amyloid</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+M.++Weiss">Matthew M. Weiss</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Toni++Williamson">Toni Williamson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Safura++Babu-Khan">Safura Babu-Khan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+D.++Bartberger">Michael D. Bartberger</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James++Brown">James Brown</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kui++Chen">Kui Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuan++Cheng">Yuan Cheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Citron">Martin Citron</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+D.++Croghan">Michael D. Croghan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+A.++Dineen">Thomas A. Dineen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joel++Esmay">Joel Esmay</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Russell+F.++Graceffa">Russell F. Graceffa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott+S.++Harried">Scott S. Harried</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dean++Hickman">Dean Hickman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+A.++Hitchcock">Stephen A. Hitchcock</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+B.++Horne">Daniel B. Horne</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hongbing++Huang">Hongbing Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ronke++Imbeah-Ampiah">Ronke Imbeah-Ampiah</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ted++Judd">Ted Judd</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+R.++Kaller">Matthew R. Kaller</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles+R.++Kreiman">Charles R. Kreiman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+S.++La">Daniel S. La</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vivian++Li">Vivian Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patricia++Lopez">Patricia Lopez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Louie">Steven Louie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Holger++Monenschein">Holger Monenschein</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+T.++Nguyen">Thomas T. Nguyen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lewis+D.++Pennington">Lewis D. Pennington</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claire++Rattan">Claire Rattan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tisha++San+Miguel">Tisha San Miguel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=E.Allen+++Sickmier">E.Allen Sickmier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+C.++Wahl">Robert C. Wahl</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+H.++Wen">Paul H. Wen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Wood">Stephen Wood</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qiufen++Xue">Qiufen Xue</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bryant+H.++Yang">Bryant H. Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vinod+F.++Patel">Vinod F. Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wenge++Zhong">Wenge Zhong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Departments of Chemistry Research and Discovery, <sup>‡</sup>Neuroscience, <sup>§</sup>HTS Molecular Pharmacology, <sup>∥</sup>Molecular Structure, <sup>⊥</sup>Pharmacokinetics and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States, and One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 617-444-5188. Fax: 617-621-3908. E-mail: <a href="/cdn-cgi/l/email-protection#4d20203a28243e3e0d2c202a2823632e2220"><span class="__cf_email__" data-cfemail="44292933212d373704252923212a6a272b29">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300119p&amp;href=/doi/10.1021%2Fjm300119p" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9009–9024</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 2, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 January 2012</li><li><span class="item_label"><b>Published</b> online</span>18 April 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 November 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300119p" title="DOI URL">https://doi.org/10.1021/jm300119p</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9009%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMatthew%2BM.%2BWeiss%252C%2BToni%2BWilliamson%252C%2BSafura%2BBabu-Khan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D21%26contentID%3Djm300119p%26title%3DDesign%2Band%2BPreparation%2Bof%2Ba%2BPotent%2BSeries%2Bof%2BHydroxyethylamine%2BContaining%2B%25CE%25B2-Secretase%2BInhibitors%2BThat%2BDemonstrate%2BRobust%2BReduction%2Bof%2BCentral%2B%25CE%25B2-Amyloid%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9024%26publicationDate%3DNovember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300119p"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3318</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">46</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300119p" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Preparation of a Potent Series of Hydroxyethylamine Containing β-Secretase Inhibitors That Demonstrate Robust Reduction of Central β-Amyloid&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;M. Weiss&quot;},{&quot;first_name&quot;:&quot;Toni&quot;,&quot;last_name&quot;:&quot;Williamson&quot;},{&quot;first_name&quot;:&quot;Safura&quot;,&quot;last_name&quot;:&quot;Babu-Khan&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;D. Bartberger&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Brown&quot;},{&quot;first_name&quot;:&quot;Kui&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Yuan&quot;,&quot;last_name&quot;:&quot;Cheng&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Citron&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;D. Croghan&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;A. Dineen&quot;},{&quot;first_name&quot;:&quot;Joel&quot;,&quot;last_name&quot;:&quot;Esmay&quot;},{&quot;first_name&quot;:&quot;Russell&quot;,&quot;last_name&quot;:&quot;F. Graceffa&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;S. Harried&quot;},{&quot;first_name&quot;:&quot;Dean&quot;,&quot;last_name&quot;:&quot;Hickman&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;A. Hitchcock&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;B. Horne&quot;},{&quot;first_name&quot;:&quot;Hongbing&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Ronke&quot;,&quot;last_name&quot;:&quot;Imbeah-Ampiah&quot;},{&quot;first_name&quot;:&quot;Ted&quot;,&quot;last_name&quot;:&quot;Judd&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;R. Kaller&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;R. Kreiman&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;S. La&quot;},{&quot;first_name&quot;:&quot;Vivian&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Patricia&quot;,&quot;last_name&quot;:&quot;Lopez&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Louie&quot;},{&quot;first_name&quot;:&quot;Holger&quot;,&quot;last_name&quot;:&quot;Monenschein&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;T. Nguyen&quot;},{&quot;first_name&quot;:&quot;Lewis&quot;,&quot;last_name&quot;:&quot;D. Pennington&quot;},{&quot;first_name&quot;:&quot;Claire&quot;,&quot;last_name&quot;:&quot;Rattan&quot;},{&quot;first_name&quot;:&quot;Tisha&quot;,&quot;last_name&quot;:&quot;San Miguel&quot;},{&quot;first_name&quot;:&quot;E.Allen&quot;,&quot;last_name&quot;:&quot; Sickmier&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;C. Wahl&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;H. Wen&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Wood&quot;},{&quot;first_name&quot;:&quot;Qiufen&quot;,&quot;last_name&quot;:&quot;Xue&quot;},{&quot;first_name&quot;:&quot;Bryant&quot;,&quot;last_name&quot;:&quot;H. Yang&quot;},{&quot;first_name&quot;:&quot;Vinod&quot;,&quot;last_name&quot;:&quot;F. Patel&quot;},{&quot;first_name&quot;:&quot;Wenge&quot;,&quot;last_name&quot;:&quot;Zhong&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;9009-9024&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300119p&quot;},&quot;abstract&quot;:&quot;A series of potent hydroxyethyl amine (HEA) derived inhibitors of β-site APP cleaving enzyme (BACE1) was optimized to address suboptimal pharmacokinetics and poor CNS partitioning. This work identified a series of benzodioxolane analogues that possessed improved metabolic stability and increased oral bioavailability. Subsequent efforts focused on improving CNS exposure by limiting susceptibility to Pgp-mediated efflux and identified an inhibitor which demonstrated robust and sustained reduction of CNS β-amyloid (Aβ) in Sprague–Dawley rats following oral administration.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300119p&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300119p" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300119p&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300119p" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300119p&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300119p" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300119p&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300119p&amp;href=/doi/10.1021/jm300119p" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300119p" /></input><a href="/doi/pdf/10.1021/jm300119p" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300119p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300119p%26sid%3Dliteratum%253Aachs%26pmid%3D22468639%26genre%3Darticle%26aulast%3DWeiss%26date%3D2012%26atitle%3DDesign%2Band%2BPreparation%2Bof%2Ba%2BPotent%2BSeries%2Bof%2BHydroxyethylamine%2BContaining%2B%25CE%25B2-Secretase%2BInhibitors%2BThat%2BDemonstrate%2BRobust%2BReduction%2Bof%2BCentral%2B%25CE%25B2-Amyloid%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D21%26spage%3D9009%26epage%3D9024%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291719" title="Redox reactions">Redox reactions</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292610" title="Antibiotic resistance">Antibiotic resistance</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jmcmar.2012.55.issue-21/production/jmcmar.2012.55.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/medium/jm-2012-00119p_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300119p&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of potent hydroxyethyl amine (HEA) derived inhibitors of β-site APP cleaving enzyme (BACE1) was optimized to address suboptimal pharmacokinetics and poor CNS partitioning. This work identified a series of benzodioxolane analogues that possessed improved metabolic stability and increased oral bioavailability. Subsequent efforts focused on improving CNS exposure by limiting susceptibility to Pgp-mediated efflux and identified an inhibitor which demonstrated robust and sustained reduction of CNS β-amyloid (Aβ) in Sprague–Dawley rats following oral administration.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/55/21"><issue-title>Alzheimer's Disease</issue-title></a> special issue.</p></div><div class="extra-info-sec articleNote"><h4><span>#</span> Author Present Address</h4><p class="last">Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, United States.</p></div><div class="extra-info-sec articleNote"><h4><span>▽</span> Author Present Address</h4><p class="last">Envoy Therapeutics, 555 Heritage Drive, Jupiter, Florida 33458, United States.</p></div><div class="extra-info-sec articleNote"><h4><span>○</span> Author Present Address</h4><p class="last">Sanofi-Aventis, 270 Albany Street, Cambridge, Massachusetts 02139, United States.</p></div><div class="extra-info-sec articleNote withdrawn"><h4><span></span> Accession Codes</h4><p class="last">The PDB accession code for the X-ray cocrystal of BACE1 + compound <b>21</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DH6">4DH6</a>.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60815" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60815" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that is currently the leading cause of dementia in the elderly and as such represents a major unmet medical need.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Despite the devastating effects of this disease, therapeutic options for treating AD remain limited. Current treatments have no disease modifying effect and are approved only for the management of the symptoms associated with the disease.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">There is a compelling amount of data, both histopathological and genetic, suggesting that the mis-metabolism of amyloid precursor protein (APP) and the formation of β-amyloid (Aβ) peptides play an early and critical event in the pathogenesis of AD.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> These Aβ peptides, particularly Aβ<sub>40–42</sub>, subsequently aggregate and lead to one of the key hallmarks of AD, β-amyloid plaques. While the specific role of these plaques in the progression of the disease is unclear, one of the key therapeutic approaches to treat AD relies on the ability to inhibit the formation of Aβ peptides. To this end, it is generally recognized that the formation of these Aβ peptides is achieved by the sequential proteolytic activity of β- and γ-secretases, the former being rate-limiting.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Thus, inhibition of β-site amyloid precursor protein cleaving enzyme (BACE1) is seen as an attractive therapeutic target for the treatment and prevention of AD.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Herein we report the identification of a series of hydroxyethyl amine (HEA)-containing BACE1 inhibitors that demonstrate robust reduction of central Aβ in a rodent pharmacodynamic model following oral dosing.</div><div class="NLM_p">Previous work from our laboratories led to the identification of a potent and highly efficient class of HEA BACE1 inhibitors.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> This series, exemplified by <b>1</b>, utilized a highly substituted azachroman amine to access the lipophilic S1′ and S2′ pockets of the BACE1 enzyme while leaving the S2 and S3 pockets largely unoccupied (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). While this series exhibited potent cellular inhibition of the BACE1 enzyme, the majority of compounds within this series demonstrated poor metabolic stability and suboptimal pharmacokinetics (i.e., high CL, low bioavailability). In the course of SAR studies, it was found that the inclusion of a <i>para</i>-fluoro phenyl P1 moiety gave rise to an inhibitor (<b>2</b>) with a uniquely improved pharmacokinetic profile relative to its congeners. This compound, which demonstrated reduced turnover in both rat and human liver microsomes, also exhibited reduced in vivo clearance. Oral administration of <b>2</b> to Sprague–Dawley rats at 100 mg/kg resulted in modest reduction of both CSF and brain Aβ levels (35% and 32%, respectively). These pharmacodynamice effects were measured 4 h post dose and occurred with drug exposures of: [plasma]<sub>unbound</sub> = 64 nM and [CSF] = 6 nM. Given the potent nature of this compound in our functional BACE1 assay, the modest pharmacodynamic effect observed was attributed to suboptimal pharmacokinetics and poor CNS penetration. Indeed, systemic exposure was limited by moderate to high clearance and low oral bioavailability. In addition, brain exposure was restricted by Pgp-mediated efflux, even while the passive permeability was shown to be excellent. Efforts to further improve the metabolic stability of related compounds were met with little success, as this series was predisposed to high metabolic turnover. In this communication, we describe the development of a related series of potent BACE1 inhibitors which demonstrate robust reduction of central Aβ following oral dosing in naïve rats. This series addresses the two dominant barriers that have limited the utility of the HEA scaffold as a template for the development of BACE1 inhibitors: poor metabolic stability and a high susceptibility to Pgp-mediated efflux.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/medium/jm-2012-00119p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Previously reported BACE1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300119p&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. BACE1 SAR, in Vitro Metabolic Stability, Rat Pharmacokinetics, and Pgp Transport Properties</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/medium/jm-2012-00119p_0003.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/medium/jm-2012-00119p_0004.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Compounds were >95% pure by <sup>1</sup>H NMR and HPLC.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Values represent the mean of at least two experiments.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Biochemical IC<sub>50</sub>.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Compounds are incubated with microsomes for 30 min at a concentration of 1 μM.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">2 mg/kg iv dose (solution in 100% DMSO).</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">5 mg/kg oral dose (solution in 1% Tween/2%HPMC).</p></div><div class="footnote" id="t1fn7"><sup>Table g</sup><p class="last">2 mg/kg oral dose (solution in 1% Tween/2%HPMC).</p></div><div class="footnote" id="t1fn8"><sup>Table h</sup><p class="last">10 mg/kg oral dose (solution in 1% Tween/2%HPMC).</p></div><div class="footnote" id="t1fn9"><sup>Table i</sup><p class="last">Parental LLC-PK1 cell line.</p></div><div class="footnote" id="t1fn10"><sup>Table j</sup><p class="last">B/A–A/B ratio.</p></div></div><div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05187" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05187" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds <b>15</b>–<b>26</b> were prepared using the routes illustrated in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. The key aldehyde building blocks (<b>7a</b>,<b>b</b> and <b>11a</b>,<b>b</b>) were constructed using the procotols shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The coupling of either 3,4-dimethoxybenzyl magnesium chloride (<b>4a</b>) or (benzo[<i>d</i>][1,3]dioxol-4-ylmethyl)magnesium chloride (<b>4b</b>) with sulfinimine <b>3</b> proceeded with a moderate level of diastereoselectivity (84–91% de) to provide adducts <b>5a</b>–<b>b</b> in good overall yield.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Simultaneous unmasking of the amine and primary alcohol was achieved by exposure to HCl in cold ethanol. Protection of the derived amines provided carbamates <b>6a</b>–<b>b</b> which were subsequently oxidized to furnish aldehydes <b>7a</b>–<b>b</b>. Aldehydes <b>11a</b>–<b>b</b> were accessed via an alternative route that commenced with the homologation of <b>8a</b>–<b>b</b> with methyl 2-(<i>tert</i>-butoxycarbonylamino)-2-(dimethoxyphosphoryl)acetate. The derived enone products underwent an enantioselective 1,4-reduction mediated by (1<i>R</i>,1<i>R</i>′,2S,2<i>S</i>′)-Rh(DuanPhos) to furnish esters that were subsequently saponified to provide amino acids <b>9a</b>–<b>b</b> in high yield and enantiopurity. A one carbon homologation with diazomethane followed by sequential treatment with HBr in acetic acid and sodium acetate provided acetoxy ketones <b>10a</b>–<b>b</b>. A substrate directed reduction with lithium <i>tert</i>-butoxyhydride followed by protection of the resulting vicinal amino alcohol provided the corresponding <i>N</i>,<i>O</i>-acetonides. Finally, deprotection of the acetate and oxidation of the primary alcohol with Dess–Martin periodinane furnished aldehydes <b>11a</b>–<b>b</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/medium/jm-2012-00119p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300119p&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) THF, −65 °C, 42–76%; (b) HCl, ethanol 15 °C then Boc<sub>2</sub>O, TEA, 73–78%; (c) Dess–Martin periodinane, NaHCO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 72–91%; (d) methyl 2-(<i>tert</i>-butoxycarbonylamino)-2-(dimethoxyphosphoryl)acetate, DBU, DCM, 65–94%; (e) (1<i>R</i>,1<i>R</i>′,2<i>S</i>,2<i>S</i>′)-(COD)Rh(DuanPhos)BF<sub>4</sub>, CH<sub>3</sub>OH, H<sub>2</sub>, 50 psi, 94–96%, >95% ee; (f) LiOH, THF, H<sub>2</sub>O, 100%; (g) isobutyl chloroformate, TEA, CH<sub>2</sub>N<sub>2</sub>, THF;HBr, AcOH, THF; K<sub>2</sub>CO<sub>3</sub>, NaOAc, DMF, 42–99%; (h) LiH(OtBu)<sub>3</sub>, THF, −78 °C, 82–98%; (i) dimethoxypropane, CSA, DMF, 95–96%; (j) K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>OH, 50–74%; (k) Dess–Martin periodinane, NaHCO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 84–93%.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/medium/jm-2012-00119p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300119p&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <b>12</b>, (CH<sub>3</sub>O)<sub>3</sub>CH, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (b) HCl, dioxane, CH<sub>3</sub>OH, 97–100%, 2 steps; (c) <i>N</i>-acetylimidazole, DIPEA, DMF, 39–72%, or carbonyldiimidazole, DIPEA, Y-CO<sub>2</sub>H, CH<sub>2</sub>Cl<sub>2</sub>, 77–91%, or HATU, Y-CO<sub>2</sub>H, DIPEA, DMF, 35–53%.</p></p></figure><div class="NLM_p last">Aldehydes <b>7a</b>–<b>b</b> and <b>11a</b>–<b>b</b> were advanced by the route illustrated in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Reductive amination with azachromanyl amine <b>12</b> followed by global deprotection provided hydroxyethyl amines <b>13a</b>–<b>d</b>.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> Finally, acylation furnished inhibitors of type <b>14a</b>–<b>d</b>.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21202" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21202" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In an effort to identify BACE1 inhibitors with improved pharmacokinetic parameters, a series of inhibitors related to <b>2</b> but with alternatively substituted aryl P1 fragments were prepared and examined. Compounds were initially surveyed based on potency against the BACE1 enzyme in an enzymatic and cellular format, turnover in rat and human liver microsomes, passive permeability, and the potential for human (MDR1) and rat (mdr1a) Pgp-mediated efflux. Compounds that demonstrated low to moderate turnover upon incubation with microsomes were further evaluated in vivo.</div><div class="NLM_p">Upon confirmation that the metabolic fate of compound <b>1</b> (and related compounds) was largely oxidative in nature, attention shifted to improving the intrinsic stability of this series of inhibitors. Efforts to improve metabolic stability by blocking the primary sites of metabolism proved unsuccessful, so attention turned to reducing the overall lipophilicity of the inhibitors, a well-known strategy to reduce the affinity of any given molecule toward members of the cytochrome P-450 (Cyp) family.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> This work led to the identification of compound <b>15</b>, an inhibitor containing a dimethoxyphenyl group in P1. In relation to <b>1</b>, <b>15</b> exhibited a slight loss in potency against the BACE1 enzyme but lacked a shift between enzyme and cell IC<sub>50</sub>s and maintained an IC<sub>50</sub> of less than 10 nM in the functional cell-based assay. More importantly, the increased polarity of <b>15</b> did indeed translate to improved stability in the presence of human and rat liver microsomes; however, following iv administration, <b>15</b> exhibited high in vivo clearance. Intrigued by the favorable profile of <b>15</b> in the presence of microsomes, a number of related analogues that contained a high degree of oxygenation in P1 were prepared and surveyed. Related analogues containing a bis(difluoromethoxy)benzyl unit (<b>16</b>) or a dihydrobenzo[<i>b</i>][1,4]dioxine moiety (<b>18</b>) in P1 showed a moderate loss in inhibitory activity and exhibited high intrinsic clearance in human and/or rat liver microsomes, however, <b>17</b>, containing a benzo[<i>d</i>][1,3]dioxole, exhibited an overall improved profile. Compound <b>17</b> maintained BACE1 potency, exhibited low to moderate turnover in microsomes, and was subsequently found to demonstrate moderate in vivo clearance and excellent bioavailability (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). To better understand the dramatic enhancement in the metabolic stability of <b>17</b> in the presence of human liver microsomes, a number of Cyp inhibition studies were performed and it was found that this compound demonstrated potent inhibition of Cyp 3A4 (96% at 1 μM).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> It is well established that the benzodioxole group can complex with the heme function of Cyp isozymes through a carbene metabolite.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> While it is important to note that inhibition of Cyp 3A4 can potentially result in drug–drug interactions, there is a substantial amount of clinical data within the field of HIV protease inhibitors wherein this has been shown to be manageable.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Furthermore, most currently prescribed HIV protease inhibitors are coadministered with the potent Cyp 3A4 inhibitor ritonavir. This boosted protease inhibitor regimen serves to enhance the overall exposure of the protease inhibitor that is concomitantly administered with ritonavir.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The resultant increases in the AUC, <i>C</i><sub>max</sub>, and <i>t</i><sub>1/2</sub> thereby lead to improved efficacy of the second protease inhibitor. Given the utility of this approach within the field of a chronically managed, protease-mediated disease state, we opted to pursue a similar strategy wherein the Cyp inhibition element would be incorporated within the framework of our BACE1 inhibitors.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vivo Aβ<sub>40</sub> Reduction in Naïve Rats at 4 h with <b>17</b> (30 mg/kg, po)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">dose <br /></br>(mg/kg)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">cellular IC<sub>50</sub><br /></br>(nM)</th><th class="colsep0 rowsep0" align="center" char=".">[plasma]<sub>total</sub><br /></br>(μM)</th><th class="colsep0 rowsep0" align="center" char=".">[plasma]<sub>unbound</sub><br /></br>(μM)</th><th class="colsep0 rowsep0" align="center" char=".">[brain]<br /></br>(μM)</th><th class="colsep0 rowsep0" align="center" char=".">[CSF]<br /></br>(μM)</th><th class="colsep0 rowsep0" align="center" char=".">CSF Aβ<sub>40</sub><br /></br>reduction (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">9.61</td><td class="colsep0 rowsep0" align="char" char=".">0.374</td><td class="colsep0 rowsep0" align="char" char=".">0.750</td><td class="colsep0 rowsep0" align="char" char=".">0.022</td><td class="colsep0 rowsep0" align="char" char=".">52</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Dosed as a solution in mg/kg oral dose (solution in 1% Tween/2%HPMC).</p></div></div></div><div class="NLM_p">While <b>17</b> showed potent inhibition of the BACE1 enzyme and demonstrated improved pharmacokinetic parameters, it also proved to be an excellent substrate for Pgp-mediated efflux. There is a wealth of literature supporting the notion that penetration across the blood–brain barrier (BBB) and into the CNS is substantially reduced for compounds which demonstrate low passive permeability and a high potential for Pgp-mediated efflux in vitro.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> This phenomenon held true when <b>17</b> was examined for its ability to acutely reduce CSF Aβ<sub>40</sub> levels in vivo. Toward this end, Sprague–Dawley rats were orally administered <b>17</b> and CSF Aβ<sub>40</sub> levels were measured 4 h post dose. As illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, a single 30 mg/kg dose of <b>17</b> provided a 52% reduction in CSF Aβ<sub>40</sub> levels. While this level of CSF Aβ<sub>40</sub> reduction was encouraging, the low brain to plasma ratio (<0.1) and, more importantly, the large disparity between unbound plasma drug levels and drug levels in the CSF highlighted the need to mitigate the potential for Pgp-mediated efflux. CSF drug levels were used as a surrogate marker for the unbound drug in the CNS, and a strong PK/PD relationship was observed within this series. In particular, it was demonstrated that robust CSF Aβ<sub>40</sub> reduction was only observed when drug levels in the CSF exceeded the cellular IC<sub>50</sub>.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The poor CNS partitioning of <b>17</b>, likely a reflection of its susceptibility to Pgp-mediated efflux, thus required exceedingly high plasma drug levels ([plasma]<sub>total</sub> = 9.61 μM and [plasma]<sub>unbound</sub> = 0.374 μM) in order to elicit a pharmacodynamic effect. This in turn has the potential to reduce the therapeutic window of an agent, as higher unbound plasma concentrations are required to compensate for the active transport out of the CNS.</div><div class="NLM_p">In light of the above-mentioned findings, subsequent optimization efforts within this series focused on a rational approach to mask Pgp recognition elements. Several strategies have been successfully utilized by medicinal chemists to influence the CNS penetration of small molecules by modulating active transport.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> We ultimately pursued a strategy wherein hydrogen bond donors contained within <b>17</b> were masked either by the introduction of flanking groups or intramolecular hydrogen bonds.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Given the crucial binding interactions between the catalytic aspartates of the BACE1 enzyme and the alcohol and the secondary amine of the inhibitors (vide infra), efforts focused on masking the hydrogen bond donor contained within the amide functionality.</div><div class="NLM_p">To this end, introduction of a 2-methoxyamide (<b>19</b>) provided a compound which maintained BACE1 potency, albeit with a slightly increased enzyme to cell shift. This compound, which has the ability to form an intramolecular hydrogen bond between the ethereal oxygen and the amide N–H, demonstrated only a slightly improved efflux ratio when compared to parent acetamide <b>15</b>. Alternatively, isobutyramide <b>20</b> was prepared to gauge the effect of simply increasing the steric bulk around the amide. Interestingly, while this compound showed a considerably reduced susceptibility to Pgp-mediated efflux, it also showed a substantial loss in potency against the BACE1 enzyme. In an effort to merge the potency of methoxyacetamide <b>19</b> with the beneficial efflux characteristics of isobutyramide <b>20</b>, compounds <b>21</b> and <b>22</b> were targeted. These compounds incorporated the ethereal oxygen of <b>19</b> with the additional steric bulk found in <b>20</b>. Both <b>21</b> and <b>22</b> showed a slight loss in potency against the BACE1 enzyme but exhibited considerably improved efflux ratios relative to <b>15</b>. Similar results could be obtained by replacing the ethereal oxygen in the amide tether with a fluorine atom (e.g., <b>23</b>). Compound <b>23</b> also showed a reduced potential for Pgp-mediated efflux; however, the increased hydrophobic nature of this inhibitor led to a slightly higher enzyme to cell shift. It is believed that the mitigated efflux of <b>19</b>–<b>23</b> results from an increase in steric bulk around the amide as well as a partial masking of the amide N–H by intramolecular hydrogen bonding. Pgp recognition could be eliminated by incorporating an <i>ortho</i>-fluoro substituted arylamide (<b>24</b>). While this compound showed no potential for efflux, it did show reduced potency against BACE1 and a very large enzyme to cell IC<sub>50</sub> shift. Introduction of a heteroatom into the aryl ring (<b>25</b>) served to reduce the enzyme to cell IC<sub>50</sub> shift while maintaining a low efflux ratio, yet <b>25</b> remained considerably less potent than <b>15</b>. To gauge whether the reduced efflux of aryl amides <b>24</b> and <b>25</b> was a result of steric congestion or hydrogen bonding, aryl amide <b>26</b> (which lacks the ability to hydrogen bond with the amide N–H) was prepared. Compound <b>26</b> demonstrated high efflux, suggesting that the reduced efflux of <b>24</b> and <b>25</b> results from intramolecular hydrogen bonding between the aryl fluoride and the amide N–H. Furthermore, compound <b>27</b>, a constitutional isomer of <b>25</b> which lacks an appropriately positioned fluorine atom to mask the amide N–H, demonstrated a high potential for efflux, further supporting the suggestion that the observed reduction in efflux with compounds <b>21</b>–<b>25</b> is indeed related to masking of the amide N–H and is not simply due to a modulation of overall polarity (i.e., PSA). In general, all of the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> demonstrated low turnover in human liver microsomes and moderate turnover in rat liver microsomes. Furthermore, with the exception of <b>15</b> and aryl amides <b>24</b> and <b>26</b>, all of the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> demonstrated improved passive permeability (>15 × 10<sup>–6</sup> cm/s).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. BACE1 SAR, in Vitro Metabolic Stability, Rat Pharmacokinetics, and Pgp Transport Properties</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/medium/jm-2012-00119p_0005.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/medium/jm-2012-00119p_0006.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Compounds were >95% pure by 1H NMR and HPLC.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Values represent the mean of at least two experiments.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Biochemical IC<sub>50</sub>.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">Compounds are incubation with microsomes for 30 min at a concentration of 1 μM.</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">Parental LLC-PK1 cell line.</p></div><div class="footnote" id="t3fn6"><sup>Table f</sup><p class="last">B/A–A/B ratio.</p></div></div><div></div></div><div class="NLM_p">Intrigued by the disparity in potency exhibited by isobutyramide <b>20</b> and (<i>R</i>)-2-methoxypropanamide <b>21</b>, we obtained an X-ray cocrystal of <b>21</b> and the BACE1 enzyme (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> As anticipated, this compound resides in the active site of the enzyme with the benzodioxolane ring system occupying S1 and the hydroxyl group and secondary amine each engaging one of the catalytic aspartates (Asp32 and Asp228). The spirocyclobutane ring and the neopentyl group flanking the azachroman ring system occupy S1′ and S2′, respectively. Inspection of the acetamide region of the molecule reveals that the amide N–H is interacting with Gly230 while the carbonyl and methoxy group are engaging Thr72 in a bidentate manner. This latter interaction between Thr72, a residue in the flap region of the BACE1 enzyme, and the methoxy group explains the considerable loss in potency that is observed in going from <b>21</b> to <b>20</b>.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The three residues Gly230, Thr231, and Thr72 form a relatively small pocket that prefers branched acetamides containing a hydrogen bond acceptor to interact with Thr72.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/medium/jm-2012-00119p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cocrystal structure of BACE1 complexed with <b>21</b>; the flap is depicted in blue. (left) Interactions in S1′ and S2′ as well as the hydrogen bonding between <b>21</b> and the catalytic aspartates. (right) Hydrogen bonding contacts between Gly230 and Thr72 residues and the amide of <b>21</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300119p&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As a result of their potent inhibition of BACE1, moderate turnover in rat liver microsomes and improved efflux parameters, compounds <b>21</b> and <b>23</b> were further profiled in vivo (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Both compounds showed moderate clearance, high <i>V</i><sub>dss</sub>, and half-lives of ∼3–5 h. Where the compounds differed was in oral bioavailability, with <b>21</b> being >100% and <b>23</b> being a much more modest 39%.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetic and In Vitro Parameters for BACE1 Inhibitors <b>21</b> and <b>23</b> in Rat</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">Cl<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a><br /></br>(L/h/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>dss</sub><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a><br /></br>(L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a><br /></br>(h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a><br /></br>(μM)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>max</sub><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a><br /></br>(h)</th><th class="colsep0 rowsep0" align="center" char=".">%<i>F</i><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">0.465</td><td class="colsep0 rowsep0" align="char" char=".">12.3</td><td class="colsep0 rowsep0" align="char" char=".">2.98</td><td class="colsep0 rowsep0" align="char" char=".">3.56</td><td class="colsep0 rowsep0" align="char" char=".">1.83</td><td class="colsep0 rowsep0" align="char" char=".">130</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">0.448</td><td class="colsep0 rowsep0" align="char" char=".">23.9</td><td class="colsep0 rowsep0" align="char" char=".">4.64</td><td class="colsep0 rowsep0" align="char" char=".">3.80</td><td class="colsep0 rowsep0" align="char" char=".">4.67</td><td class="colsep0 rowsep0" align="char" char=".">39</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">2 mg/kg iv dose (solution in 100% DMSO).</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">5 mg/kg oral dose (solution in 1% Tween/2%HPMC).</p></div></div></div><div class="NLM_p">Given its superior bioavailability in rats, a more extensive pharmacokinetic profile of <b>21</b> across dogs and rhesus monkeys was obtained (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Compound <b>21</b> exhibited low to moderate clearance in beagle dogs and elevated clearance in rhesus monkeys. In contrast to the profile observed in rats, low <i>V</i><sub>dss</sub> was seen in both species. This profile led to an extended half-life in dogs (∼10 h) and a relatively short half-life in rhesus monkeys (<2 h).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Beagle Dog and Rhesus Pharmacokinetics for <b>21</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">beagle dog PK</th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">rhesus PK</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">Cl<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a><br /></br>(L/h/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>dss</sub><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a><br /></br>(L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a><br /></br>(h)</th><th class="colsep0 rowsep0" align="center" char=".">Cl<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a><br /></br>(L/h/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>dss</sub><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a><br /></br>(L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a><br /></br>(h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">0.393</td><td class="colsep0 rowsep0" align="char" char=".">1.03</td><td class="colsep0 rowsep0" align="char" char=".">9.77</td><td class="colsep0 rowsep0" align="char" char=".">1.65</td><td class="colsep0 rowsep0" align="char" char=".">1.46</td><td class="colsep0 rowsep0" align="char" char=".">1.74</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">2 mg/kg iv dose (solution in 5%propylene glycol/95%dextrose).</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">10 mg/kg oral dose (solution in 5%propylene glycol/95%dextrose).</p></div></div></div><div class="NLM_p">On the basis of its pharmacokinetic profile, compound <b>21</b> was advanced to an in vivo study to examine its ability to reduce Aβ<sub>40</sub> levels in both the peripheral and central compartments. This study incorporated doses of 10, 30, and 100 mg/kg and included a number of time points to gain insight on the temporal component to Aβ<sub>40</sub> lowering. Compound <b>21</b> was orally administered to Sprague–Dawley rats, and Aβ<sub>40</sub> levels were measured 4 h postdose (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>; Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). A dose- and exposure-dependent decrease in Aβ<sub>40</sub> levels (10, 30, and 100 mg/kg) was observed in plasma, CSF, and brain. At the 4 h time point, substantial Aβ<sub>40</sub> reduction was observed peripherally but not centrally following a 10 mg/kg dose. However, at the same time point, a 30 mg/kg dose led to substantial drug levels in the CNS (brain, 1.02 μM; CSF, 0.114 μM) and a significant reduction in Aβ<sub>40</sub> in both the brain (44%) and CSF (61%). Furthermore, the large disparity previously observed between the unbound plasma and CSF drug levels following oral dosing of <b>17</b> (17-fold) was significantly reduced upon administration of <b>21</b> (<3-fold). The unbound plasma levels of <b>21</b> more closely resembled the measured CSF drug levels, demonstrating that the optimization of efflux in vitro was a useful means by which to improve brain penetration. Compound <b>21</b> was also examined in a time course study wherein Aβ<sub>40</sub> levels were measured at 4, 8, 16, and 24 h following a 100 mg/kg oral dose. As illustrated in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, <b>21</b> showed robust and sustained reduction of Aβ<sub>40</sub> levels in all compartments for at least 8 h. Aβ<sub>40</sub> levels in the CSF and brain returned to baseline after 16 h. The data in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> exemplify the PK/PD relationship observed between CNS Aβ<sub>40</sub> reduction and CSF drug levels. Notably, the improved distribution of <b>21</b> into the CNS (relative to <b>17</b>) serves to effectively increase the therapeutic window by reducing the systemic exposure required to achieve appropriate CNS drug levels. Efforts to further optimize this series of inhibitors are the subject of the companion paper.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vivo Aβ<sub>40</sub> Reduction in Naïve Rats with <b>21</b> (10, 30, and 100 mg/kg, po)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">dose <br /></br>(mg/kg)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">time <br /></br>(h)</th><th class="colsep0 rowsep0" align="center" char=".">[plasma]<sub>total</sub><br /></br>(μM)</th><th class="colsep0 rowsep0" align="center" char=".">[plasma]<sub>unbound</sub><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a><br /></br>(μM)</th><th class="colsep0 rowsep0" align="center" char=".">[brain] <br /></br>(μM)</th><th class="colsep0 rowsep0" align="center" char=".">[CSF] <br /></br>(μM)</th><th class="colsep0 rowsep0" align="center" char=".">plasma Aβ<sub>40</sub><br /></br>reduction (%)</th><th class="colsep0 rowsep0" align="center" char=".">CSF Aβ<sub>40</sub><br /></br>reduction (%)</th><th class="colsep0 rowsep0" align="center" char=".">brain Aβ<sub>40</sub><br /></br>reduction (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1.85</td><td class="colsep0 rowsep0" align="char" char=".">0.019</td><td class="colsep0 rowsep0" align="char" char=".">0.617</td><td class="colsep0 rowsep0" align="char" char=".">0.008</td><td class="colsep0 rowsep0" align="char" char=".">59</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">8.15</td><td class="colsep0 rowsep0" align="char" char=".">0.305</td><td class="colsep0 rowsep0" align="char" char=".">1.02</td><td class="colsep0 rowsep0" align="char" char=".">0.114</td><td class="colsep0 rowsep0" align="char" char=".">67</td><td class="colsep0 rowsep0" align="char" char=".">61</td><td class="colsep0 rowsep0" align="char" char=".">44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">16.2</td><td class="colsep0 rowsep0" align="char" char=".">1.12</td><td class="colsep0 rowsep0" align="char" char=".">3.44</td><td class="colsep0 rowsep0" align="char" char=".">0.563</td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="char" char=".">77</td><td class="colsep0 rowsep0" align="char" char=".">68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">15.3</td><td class="colsep0 rowsep0" align="char" char=".">1.03</td><td class="colsep0 rowsep0" align="char" char=".">3.24</td><td class="colsep0 rowsep0" align="char" char=".">0.477</td><td class="colsep0 rowsep0" align="char" char=".">68</td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="char" char=".">63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">3.05</td><td class="colsep0 rowsep0" align="char" char=".">0.057</td><td class="colsep0 rowsep0" align="char" char=".">0.829</td><td class="colsep0 rowsep0" align="char" char=".">0.056</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">0.705</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">0.571</td><td class="colsep0 rowsep0" align="char" char=".">BQ</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Dosed as a solution in mg/kg oral dose (solution in 1% Tween/2%HPMC).</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Saturable plasma protein binding was observed over the range of 1–100 μM.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></p></div></div></div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/medium/jm-2012-00119p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0011.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vivo Aβ<sub>40</sub> reduction in naïve rats with <b>21</b> (10, 30, and 100 mg/kg, po). *** <i>P</i> ≤ 0.0001; ** <i>P</i> ≤ 0.005.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300119p&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55323" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55323" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, a series of potent BACE1 inhibitors have been optimized to improve pharmacokinetic properties and enhance penetration into the CNS. This work began by introducing polar functionality to improve metabolic stability and identification of a series of benzodioxoloanes with improved clearance and bioavailability. This utilized a strategy wherein overall plasma exposure was boosted by inhibition of Cyp 3A4. Subsequent efforts focused on improving brain uptake. This was successfully accomplished by strategically introducing functional elements to mitigate Pgp-mediated efflux. Compound <b>21</b> demonstrated robust and dose dependent CNS Aβ<sub>40</sub> reduction and has served as a key stepping stone for future efforts. This work highlights the importance of optimizing across multiple parameters, in this case at the expense of potency, when trying to identify centrally active agents.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33684" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33684" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> BACE1 Enzymatic Assay</h3><div class="NLM_p last">BACE1 enzymatic activity was determined by the enhancement of fluorescence intensity upon enzymatic cleavage of the fluorescence resonance energy transfer substrate. The BACE1 recognition and cleavage sequence of the substrate is derived from the reported literature,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and the fluorophore and quencher dyes are attached to side chain of Lys residues at the termini of the substrate peptide. The human recombinant BACE1<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> assay was performed in 50 mM acetate, pH 4.5/8% DMSO/100 μM Genepol/0.002% Brij-35. In dose–response IC<sub>50</sub> assays, 10 point 1:3 serial dilutions of compound in DMSO were preincubated with the enzyme for 60 min at room temperature. Subsequently, the substrate was added to initiate the reaction. After 60 min at room temperature, the reaction was stopped by addition of 0.1 M Tris base to raise the pH above the enzyme active range and the increase of fluorescence intensity was measured on Safire II microplate reader (Tecan, Männedorf, Switzerland).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Cell-Based Assay</h3><div class="NLM_p last">Human embryonic kidney cells (HEK293) stably expressing APP<sub>SW</sub> were plated at a density of 100K cells/well in 96-well plates (Costar). The cells were cultivated for 6 h at 37 °C and 5% CO<sub>2</sub> in DMEM supplemented with 10% FBS. Cells were incubated overnight with test compounds at concentrations ranging from 0.0005 to 10 μM. Following incubation with the test compounds, the conditioned media was collected and the Aβ40 levels were determined using a sandwich ELISA. The IC<sub>50</sub> was calculated from the percent of control Aβ40 as a function of the concentration of the test compound. The sandwich ELISA to detect Aβ40 was performed in 96-well microtiter plates, which were precoated with goat antirabbit IgG (Pierce). The capture and detection antibody pair that was used to detect Aβ40 from cell supernatants consists of affinity purified pAβ40 (Invitrogen) and biotinylated 6E10 (Covance), respectively. Conditioned media was incubated with capture antibody overnight at 4 °C, followed by washing. The detecting antibody incubation was for 3 h at 4 °C, again followed by the wash steps as described previously. The plate was developed using Delfia reagents (Streptavidin–Europium and Enhancement solution (Perkin-Elmer)) and time-resolved fluorescence was measured on an EnVision multilabel plate reader (Perkin-Elmer).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Permeability Assay</h3><div class="NLM_p">The wild-type cell line LLC-PK1 (porcine renal epithelial cells, WT-LLC-PK1) was purchased from American Type Culture Collection (ATCC, Manassass, VA, USa). Transfections of WT-LLC-PK1 cells with human <i>MDR</i>1 gene (hMDR1-LLC-PK1) and rat <i>mdr1a</i> gene (rMdr1a-LLC-PK1) were generated. Cells were grown in Medium 199 supplemented with 10% fetal bovine serum.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Cells were seeded onto matrigel-coated transwell filter membranes at a density of 90000 cells/well. Media change was performed on day 3. Compound incubations were performed 5–6 days post seeding. All cultures were incubated at 37 °C in a humidified (95% relative humidity) atmosphere of 5% CO<sub>2</sub>/95% air.</div><div class="NLM_p">Prior to the transport experiment,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> culture medium was aspirated from both apical and basolateral wells, and cells were rinsed with warmed (37 °C) Hank’s balanced salt solution supplemented with 10 mM Hepes at pH 7.4 (HHBSS, Invitrogen, Grand Island, NY). HHBSS was removed from wells prior to dosing with test drugs at 5 μM in transport buffer (HHBSS containing 0.1% bovine serum albumin). Then 150 μL of transport buffer were added to receiver chambers prior to dosing in triplicate to apical or basolateral chambers. The dosed transwell plates containing the cell monolayers were incubated for 2 h at 37 °C on a shaking platform. At the end of the incubation period, 100 μL samples were collected from receiver reservoirs and analyzed by LC-MS/MS on an API4000 (Applied Biosystem, Foster City, CA) triple quadruple mass spectrometer interfaced with turbo IonSpray operated in positive mode using Analyst 1.4.2 software.</div><div class="NLM_p last">The apparent permeability coefficient (<i>P</i><sub>app</sub>) of all tested agents was estimated from the slope of a plot of cumulative amount of the agent versus time based on the following equation:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/jm-2012-00119p_m001.gif" alt="" /></img></span>where d<i>Q</i>/d<i>t</i> is the penetration rate of the agent (ng/s), <i>A</i> is the surface area of the cell layer on the Transwell (0.11 cm<sup>2</sup>), and <i>C</i><sub>0</sub> is the initial concentration of the test compound (ng/mL). Efflux ratio (ER) was calculated from the basolateral-to-apical permeability divided by the apical-to-basolateral permeability: ER = <i>P</i><sub>app</sub> B > A/<i>P</i><sub>app</sub> A > B.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> X-Ray Crystal Structure</h3><div class="NLM_p last">Recombinant human BACE1 residues 14–453 was overexpressed in bacteria as inclusion bodies and refolded using a procedure described by Patel et al.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Crystals were grown in similar conditions described in Patel et al.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> BACE1 protein was concentrated to 8 mg/mL in a buffer containing 20 mM Tris (pH 8.2), 150 mM NaCl, and 1 mM DTT. DMSO (3% v/v) was added to the protein immediately prior to crystallization. Apo crystals of BACE1 were grown at 20 °C using the hanging drop method/vapor diffusion method, and the drops contained 1 μL of BACE1 solution and 1 μL of reservoir solution. The reservoir solution consisted of 20% (w/v) PEG 5000 monomethylethyl ether (MME), 200 mM sodium citrate (pH 6.6), and 200 mM sodium iodide. Apo BACE1 crystal was soaked overnight in a 5.0 mM compound solution with 33% (w/v) PEG 5000 monomethylethyl ether (MME), 110 mM sodium citrate, 220 mM sodium iodide, and 10% DMSO (from compound dilution). The following day, the crystal was briefly transferred to a cryoprotectant (5.0 mM compound with 33% (w/v) PEG 5000 monomethylethyl ether (MME), 110 mM sodium citrate, 220 mM sodium iodide, 10% DMSO, and 22% glycerol) and flash frozen in liquid nitrogen. Data was collected at Advanced Light Source Beamline 5.0.2 (Lawrence Berkeley National Laboratory, Berkeley, CA, USA) at 100 K. Data was processed and scaled using HKL2000.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The crystals belong to the space group <i>P</i>6<sub>1</sub>22 with approximate unit cell dimensions of <i>a</i> = 103.694, <i>b</i> = 103.694 Å, <i>c</i> = 168.866 Å. Molecular replacement was performed using Phaser,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> using an apo BACE1 structure (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w50">1w50</a>) as a search model. The structure was refined using Refmac 5,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and the model with ligand was built with Coot.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Pharmacodynamic Assay</h3><div class="NLM_p last">Male Sprague–Dawley rats (175–200 g) were purchased from Harlan and were maintained on a 12 h light/dark cycle with unrestricted access to food and water until use. Rats were dosed orally with <b>17</b> and <b>21</b> in 2% HPMC, 1% Tween at pH 2.2. Rats were euthanized with CO<sub>2</sub> inhalation for 2 min, and the cisterna magna was quickly exposed by removing the skin and muscle above it. CSF (50–100 μL) was collected with a 30 gauge needle through the dura membrane covering the cisterna magna. Blood was withdrawn by cardiac puncture and plasma obtained by centrifugation for drug exposures. Brains were removed and, along with the CSF, immediately frozen on dry ice and stored at −80 °C until use. The frozen brains were subsequently homogenized in 10 volumes of (w/v) of 0.5% Triton X-100 in TBS with protease inhibitors. The homogenates were centrifuged at 100000 rpm for 30 min at 4 °C. The supernatants were analyzed for Aβ40 levels by immunoassay as follows: Meso Scale 96-well avidin plates were coated with Biotin-4G8 (Covance) and detected with ruthenium-labeled Fab specific for Aβ40. Plates were read in MSD Sector6000 imager according to manufacturer’s recommended protocol (Meso Scale Discovery, Inc.). Aβ40 concentrations were plotted using Graphpad Prism and analyzed by one-way ANOVA followed by Dunnett’s multiple comparison analysis to compare drug-treated animals to vehicle-treated controls.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Chemistry</h3><div class="NLM_p last">Unless otherwise noted, all materials were obtained from commercial suppliers and used without further purification. Anhydrous solvents were obtained from Aldrich or EM Science and used directly. All reactions involving air- or moisture-sensitive reagents were performed under a nitrogen or argon atmosphere. All microwave assisted reactions were conducted with a Smith synthesizer from Personal Chemistry, Uppsala, Sweden. Silica gel chromatography was performed using either glass columns packed with silica gel (230–400 mesh, EMD Chemicals, Gibbstown, NJ, USA) or prepacked silica gel cartridges (Biotage or ISCO). <sup>1</sup>H NMR spectra were recorded on a Bruker AV-400 (400 MHz) spectrometer at ambient temperature or on a Varian 400 MHz spectrometer. Chemical shifts are reported in parts per million (ppm, δ units) downfield from tetramethylsilane. Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), coupling constants, and number of protons. Purity for final compounds was greater than 95% unless otherwise noted and was measured using Agilent 1100 series high performance liquid chromatography (HPLC) systems with UV detection at 254 nm (system A, Agilent Zorbax Eclipse XDB-C8 4.6 mm × 150 mm, 5 μm, 5–100% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% TFA for 15 min at 1.5 mL/min; system B, Waters Xterra 4.6 mm ×150 mm, 3.5 μm, 5–95% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% TFA for 15 min at 1.0 mL/min). Exact mass confirmation was performed on an Agilent 1100 series high performance liquid chromatography (HPLC) system (Santa Clara, CA, USA) by flow injection analysis, eluting with a binary solvent system A and B (A, water with 0.1% FA; B, ACN with 0.1% FA) under isocratic conditions (50% A/50% B) at 0.2 mL/min with MS detection by an Agilent G1969A time-of-flight (TOF) mass spectrometer (Santa Clara, CA, USA).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (<i>S</i>)-<i>N</i>-((2<i>S</i>,3<i>S</i>)-1-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-3,4-bis(<i>tert</i>-butyldimethylsilyloxy)butan-2-yl)-2-methylpropane-2-sulfinamide (<b>5a</b>)</h3><div class="NLM_p last">A 500 mL flask charged with (<i>S</i>,<i>Z</i>)-<i>N</i>-((S)-2,3-bis(<i>tert</i>-butyldimethylsilyloxy)propylidene)-2-methylpropane-2-sulfinamide (2.50 g, 5.93 mmol) and tetramethylethylene diamine (2.75 g, 23.6 mmol) was cooled to −78 °C and treated with a solution of 3,4-dimethoxybenzylmagnesium chloride (2.5 g, 11.9 mmol). The reaction mixture was allowed to warm to ambient temperature and stir overnight. The reaction mixture was cooled to 10 °C, and saturated NH<sub>4</sub>Cl (50 L) and H<sub>2</sub>O (50 mL) were added. The layers were separated, and the aqueous layer was extracted with EtOAc (2 × 100 mL). The organics were combined, dried over MgSO<sub>4</sub>, filtered, and concentrated. The derived residue was purified by silica gel chromatography (0–25% EtOAc in hexanes) to give (<i>S</i>)-<i>N</i>-((2<i>S</i>,3<i>S</i>)-1-(benzo[<i>d</i>][1,3]dioxol-5-yl)-3,4-bis(<i>tert</i>-butyldimethylsilyloxy)butan-2-yl)-2-methylpropane-2-sulfinamide (1.44 g, 42% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 6.77 (d, <i>J</i> = 8.46, 1 H), 6.69–6.71 (m, 2 H), 4.12–4.16 (m, 1 H), 3.86 (s, 3 H), 3.85 (s, 3 H), 3.74–3.76 (m, 1 H), 3.54–3.68 (m, 3 H), 2.87 (dd, <i>J</i> = 14.15, 4.42 Hz, 1 H), 2.59 (dd, <i>J</i> = 14.27, 10.11 Hz, 1 H), 0.99 (s, 9 H), 0.94 (s, 9 H), 0.93 (s, 9 H), 0.17 (s, 3 H), 0.10 (s, 6 H), 0.09 (s, 3 H). MS, <i>m</i>/<i>z</i> = 574.3 [M + H]<sup>+</sup>. Calcd for C<sub>28</sub>H<sub>56</sub>NO<sub>5</sub>SSi<sub>2</sub>: 574.2.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (<i>S</i>)-<i>N</i>-((2<i>S</i>,3<i>S</i>)-1-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-3,4-bis(<i>tert</i>-butyldimethylsilyloxy)butan-2-yl)-2-methylpropane-2-sulfinamide (<b>5b</b>)</h3><div class="NLM_p last">A 2 L flask equipped with an addition funnel was charged with 15.0 g (586 mmol) of magnesium metal and 200 mL of THF. The resulting slurry was cooled to 0 °C, and a solution of 4-(chloromethyl)benzo[d][1,3]dioxole (100.0 g, 586 mmol) in 600 mL of dry THF was added dropwise such that the internal temperature did not exceed 5 °C (∼1 h). A separate 3-neck 5 L flask equipped with a mechanical stirrer and addition funnel was charged with (<i>S</i>,<i>Z</i>)-<i>N</i>-((<i>S</i>)-2,3-bis(<i>tert</i>-butyldimethylsilyloxy)propylidene)-2-methylpropane-2-sulfinamide (123.5 g, 293 mmol) in 1.0 L of THF. The mixture was cooled to −70 °C, and a solution of the derived Grignard reagent was added via addition funnel, keeping the internal temperature <−65 °C (∼1 h). The reaction mixture was allowed to warm to ambient temperature and stir overnight. The reaction mixture was cooled to 10 °C, and saturated NH<sub>4</sub>Cl (2.4 L) and H<sub>2</sub>O (300 mL) were added. The layers were separated, and the aqueous layer was extracted with EtOAc (2 × 2.5 L). The organics were combined, dried over MgSO<sub>4</sub>, filtered, and concentrated. The derived residue was purified by silica gel chromatography (0–25% EtOAc in hexanes) to give (<i>S</i>)-<i>N</i>-((2<i>S</i>,3<i>S</i>)-1-(benzo[<i>d</i>][1,3]dioxol-5-yl)-3,4-bis(<i>tert</i>-butyldimethylsilyloxy)butan-2-yl)-2-methylpropane-2-sulfinamide (153.4 g, 76% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 6.73 (d, <i>J</i> = 7.81, 1 H), 6.70 (s, 1 H), 6.65 (d, <i>J</i> = 7.73, 1 H), 5.93 (dd, <i>J</i> = 7.81, 1.20 Hz, 2 H), 3.71 (dt, <i>J</i> = 10.61, 4.7 Hz, 1 H), 3.47–3.63 (m, 3 H), 3.39 (dd, <i>J</i> = 9.55, 5.2 Hz, 1 H), 3.20 (dd, <i>J</i> = 14.02, 4.7 Hz, 1 H), 2.81 (dd, <i>J</i> = 14.01, 10.7 Hz, 1 H), 1.22 (s, 9 H), 0.92 (s, 9 H), 0.84 (s, 9 H), 0.09 (s, 3 H), 0.04 (s, 3 H), −0.01 (s, 3 H), −0.06 (s, 3 H). MS, <i>m</i>/<i>z</i> = 558.2 [M + H]<sup>+</sup>. Calcd for C<sub>27</sub>H<sub>52</sub>NO<sub>5</sub>SSi<sub>2</sub>: 558.3.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>tert</i>-Butyl (2<i>S</i>,3<i>S</i>)-3-(<i>tert</i>-Butyldimethylsilyloxy)-1-(3,4-dimethoxyphenyl)-4-hydroxybutan-2-ylcarbamate (<b>6a</b>)</h3><div class="NLM_p last">To a slurry of (<i>S</i>)-<i>N</i>-((2<i>S</i>,3<i>S</i>)-3,4-bis(<i>tert</i>-butyldimethylsilyloxy)-1-(3,4-dimethoxyphenyl)butan-2-yl)-2-methylpropane-2-sulfinamide (<b>5a</b>, 1.35 g, 2.35 mmol) in 20 mL of ethanol at 0 °C was added a solution of HCl (4 N in dioxane; 2.35 mL, 9.4 mmol). The mixture was maintained at 0 °C for 5 h before being allowed to warm to rt. TEA (1.64 mL, 11.8 mmol) was added, resulting in the formation of a thick white mixture. Dichloromethane (50 mL) was added followed by Boc anhydride (1.02 g, 4.7 mmol). The resulting solution was allowed to stir at ambient temperature overnight. The reaction was quenched with saturated NH<sub>4</sub>Cl (50 mL), and the organics were removed in vacuo. The mixture was diluted with dichloromethane (100 mL), and the mixture was poured into a separatory funnel containing water (100 mL). The layers were separated, and the aqueous layer was extracted with dichloromethane (2 × 100 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The derived residue was purified by silica gel chromatography (0–40% EtOAc in hexanes) to provide <i>tert</i>-butyl (2<i>S</i>,3<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-1-(3,4-dimethoxyphenyl)-4-hydroxybutan-2-ylcarbamate (<b>5a</b>, 785 mg, 73% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 6.69 (d, <i>J</i> = 7.93, 1), 6.54–3.67 (m, 2 H), 4.64 (d, <i>J</i> = 8.01 Hz, 1 H), 3.80–3 89 (m, 1 H), 3.74 (s, 3 H), 3.72 (s, 3 H), 3.60 (dd, <i>J</i> = 9.17, 4.7 Hz, 2 H), 3.57 (dd, <i>J</i> = 12.76, 4.4 Hz, 1 H), 2.85 (dd, <i>J</i> = 12.99, 4.4 Hz, 1 H), 2.40–2.67 (m, 2 H), 1.28 (s, 9 H), 0.92 (s, 9 H), 0.11 (s, 6 H). MS, <i>m</i>/<i>z</i> = 456.2 [M + H]<sup>+</sup>. Calcd for C<sub>23</sub>H<sub>42</sub>NO<sub>6</sub>Si: 456.2.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>tert</i>-Butyl (2<i>S</i>,3<i>S</i>)-1-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-hydroxybutan-2-ylcarbamate (<b>6b</b>)</h3><div class="NLM_p last">To a slurry of <i>N</i>-((2<i>S</i>,3<i>S</i>)-1-(benzo[<i>d</i>][1,3]dioxol-5-yl)-3,4-bis(<i>tert</i>-butyldimethylsilyloxy)butan-2-yl)-2-methylpropane-2-sulfinamide (<b>5b</b>, 4.40 g, 8.0 mmol) in 50 mL of ethanol at 0 °C was added a solution of HCl (4 N in dioxane; 12.0 mL, 47 mmol). The mixture was maintained at 0 °C for 5 h before being allowed to warm to rt. TEA (8.0 mL, 55 mmol) was added, resulting in the formation of a thick white mixture. Dichloromethane (50 mL) was added followed by Boc anhydride (4.0 g, 17 mmol). The resulting solution was allowed to stir at ambient temperature overnight. The reaction was quenched with saturated NH<sub>4</sub>Cl (200 mL), and the organics were removed in vacuo. The mixture was diluted with dichloromethane (100 mL), and the mixture was poured into a separatory funnel containing water (100 mL). The layers were separated, and the aqueous layer was extracted with dichloromethane (2 × 100 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The derived residue was purified by silica gel chromatography (0–40% EtOAc in hexanes) to provide 2.71 g (78% yield) of <i>tert</i>-butyl (2<i>S</i>,3<i>S</i>)-1-(benzo[<i>d</i>][1,3]dioxol-5-yl)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-hydroxybutan-2-ylcarbamate (<b>6b</b>) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 6.74 (d, <i>J</i> = 8.03, 1), 6.71 (s, 1 H), 6.65 (d, <i>J</i> = 8.34 Hz, 1 H), 5.93 (s, 2 H), 4.69 (d, <i>J</i> = 8.08 Hz, 1 H), 3.82–3.92 (m, 1 H), 3.72 (dd, <i>J</i> = 9.27, 5.3 Hz, 2 H), 3.62 (dd, <i>J</i> = 13.26, 4.2 Hz, 1 H), 2.91 (dd, <i>J</i> = 13.94, 4.9 Hz, 1 H), 2.66 (dd, <i>J</i> = 14.13, 9.4 Hz, 1 H), 2.48 (br s, 1 H), 1.38 (s, 9 H), 0.93 (s, 9 H), 0.11 (s, 3 H), 0.10 (s, 3 H). MS, <i>m</i>/<i>z</i> = 440.2 [M + H]<sup>+</sup>. Calcd for C<sub>22</sub>H<sub>38</sub>NO<sub>6</sub>Si: 440.2.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>tert</i>-Butyl (2<i>S</i>,3<i>S</i>)-3-(<i>tert</i>-Butyldimethylsilyloxy)-1-(3,4-dimethoxyphenyl)-4-oxobutan-2-ylcarbamate (<b>7a</b>)</h3><div class="NLM_p last">To a solution of <i>tert</i>-butyl (2<i>S</i>,3<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-1-(3,4-dimethoxyphenyl)-4-hydroxybutan-2-ylcarbamate (<b>6a</b>, 400 mg, 0.88 mmol) in 20 mL of dichloromethane was added NaHCO<sub>3</sub> (369 mg, 4.4 mmol) and Dess–Martin periodinane (465 mg, 1.1 mmol). After 15 min, the heterogeneous mixture was diluted with methylene chloride (5 mL), 10% aqueous NaHCO<sub>3</sub> (10 mL), and 10% aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (10 mL). The mixture was stirred vigorously for 0.5 h before the mixture was poured into a separatory funnel. The layers were separated, and the aqueous layer was extracted with methylene chloride (3 × 5 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The derived residue was purified by silica gel chromatography (0–25% EtOAc in hexanes) to provide <i>tert</i>-butyl (2<i>S</i>,3<i>S</i>)-1-(benzo[<i>d</i>][1,3]dioxol-5-yl)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-oxobutan-2-ylcarbamate (<b>7a</b>, 288 mg, 72% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 9.42 (s, 1 H), 6.80 (d, <i>J</i> = 8.15 Hz, 1 H), 6.75 (s, 1 H), 6.78 (dd, <i>J</i> = 8.01 Hz, 1 H), 3.74 (s, 3 H), 3.71 (s, 3H), 4.38 (d, <i>J</i> = 7.99 Hz, 1 H), 4.18 (s, 1 H), 2.76 (dd, <i>J</i> = 13.73, 7.3 Hz, 1 H), 2.59 (dd, <i>J</i> = 12.12, 8.1 Hz, 1 H), 1.45 (s, 9 H), 0.90 (s, 9 H), 0.00 (s, 6 H). MS, <i>m</i>/<i>z</i> = 454.3 [M + H]<sup>+</sup>. Calcd for C<sub>23</sub>H<sub>40</sub>NO<sub>6</sub>Si: 454.2</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>tert</i>-Butyl (2<i>S</i>,3<i>S</i>)-1-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-oxobutan-2-ylcarbamate (<b>7b</b>)</h3><div class="NLM_p last">To a solution of <i>tert</i>-butyl (2<i>S</i>,3<i>S</i>)-1-(benzo[<i>d</i>][1,3]dioxol-5-yl)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-hydroxybutan-2-ylcarbamate (<b>6b</b>, 4.3 g, 9.8 mmol) in 200 mL of dichloromethane was added NaHCO<sub>3</sub> (4.1 g, 49 mmol) and Dess–Martin periodinane (4.2 g, 9.9 mmol). After 15 min, the heterogeneous mixture was diluted with methylene chloride (25 mL), 10% aqueous NaHCO<sub>3</sub> (100 mL), and 10% aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (100 mL). The mixture was stirred vigorously for 0.5 h before the mixture was poured into a separatory funnel. The layers were separated, and the aqueous layer was extracted with methylene chloride (3 × 50 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The derived residue was purified by silica gel chromatography (0–25% EtOAc in hexanes) to provide <i>tert</i>-butyl (2<i>S</i>,3<i>S</i>)-1-(benzo[<i>d</i>][1,3]dioxol-5-yl)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-oxobutan-2-ylcarbamate (<b>7b</b>, 3.89 g, 91% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 9.29 (s, 1 H), 6.62 (d, <i>J</i> = 8.05 Hz, 1 H), 6.57 (s, 1 H), 6.53 (dd, <i>J</i> = 7.88 Hz, 1 H), 5.83 (s, 2 H), 4.44 (d, <i>J</i> = 8.28 Hz, 1 H), 4.12 (s, 1 H), 2.64 (dd, <i>J</i> = 14.33, 6.7 Hz, 1 H), 2.55 (dd, <i>J</i> = 13.02, 7.8 Hz, 1 H), 1.31 (s, 9 H), 0.88 (s, 9 H), 0.00 (s, 6 H). MS, <i>m</i>/<i>z</i> = 438.2 [M + H]<sup>+</sup>. Calcd for C<sub>22</sub>H<sub>36</sub>NO<sub>6</sub>Si: 438.2.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (<i>S</i>)-3-(3,4-Bis(difluoromethoxy)phenyl)-2-(<i>tert</i>-butoxycarbonylamino)propanoic Acid (<b>9a</b>)</h3><div id="sec5_13_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Step A</h4><div class="NLM_p last">To a solution of methyl 2-(<i>tert</i>-butoxycarbonyl)-2-(dimethoxyphosphoryl)acetate (2.31 g, 7.76 mmol) in 10 mL of CH<sub>2</sub>Cl<sub>2</sub> at 0 °C was added DBU (1.17 mL, 7.76 mmol) dropwise. To this solution was then added a solution of 3,4-bis(difluoromethoxy)benzaldehyde (1.76 g, 7.39 mmol) in 10 mL of CH<sub>2</sub>Cl<sub>2</sub> dropwise over 10 min. The mixture was allowed to warm to rt, where it was maintained for 2 h before being poured into saturated ammonium chloride (100 mL). The layers were separated, and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (50 mL). The combined organic layers were washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>. Filtration and concentration under reduced pressure provided an oil that was purified by silica gel chromatograph (0–50% ethyl acetate in hexanes) to provide (<i>Z</i>)-methyl 3-(3,4-bis(difluoromethoxy)phenyl)-2-(<i>tert</i>-butoxycarbonyl)acrylate (2.84 g, 93.9% yield) as a colorless oil that solidified upon standing. MS, <i>m</i>/<i>z</i> = 410.2 [M + H]<sup>+</sup>. Calcd for C<sub>17</sub>F<sub>4</sub>H<sub>20</sub>NO<sub>6</sub>: 410.1.</div></div><div id="sec5_13_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Step B</h4><div class="NLM_p last">To a slurry of (<i>Z</i>)-methyl 3-(3,4-bis(difluoromethoxy)phenyl)-2-(<i>tert</i>-butoxycarbonyl)acrylate (2.80 g, 6.840 mmol) in 25 mL of methanol was added (1<i>R</i>,2<i>S</i>)-2-<i>tert</i>-butyl-1-((1<i>R</i>,2<i>S</i>)-2-<i>tert</i>-butyl-2,3-dihydro-1<i>H</i>-isophosphindol-1-yl)-2,3-dihydro-1<i>H</i>-isophosphindole Rh(duanphos)COD-BF<sub>4</sub> (0.2327 g, 0.3420 mmol). The mixture was purged with hydrogen gas (3×) and then sealed at 50 psi. After 2 h, the pressure was relieved and the mixture was concentrated in vacuo. The derived residue was purified by silica gel chromatography (0–50% ethyl acetate in hexanes) to provide (<i>S</i>)-methyl 3-(3,4-bis(difluoromethoxy)phenyl)-2-(<i>tert</i>-butoxycarbonyl)propanoate (2.695 g, 95.78% yield) as a colorless oil. MS, <i>m</i>/<i>z</i> = 412.2 [M + H]<sup>+</sup>. Calcd for C<sub>17</sub>F<sub>4</sub>H<sub>22</sub>NO<sub>6</sub>: 412.2.</div></div><div id="sec5_13_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Step C</h4><div class="NLM_p last">To a solution of (<i>S</i>)-methyl 3-(3,4-bis(difluoromethoxy)phenyl)-2-(<i>tert</i>-butoxycarbonyl)propanoate (2.68 g, 7 mmol) in 20 mL of THF at 0 °C was added LiOH (0.2 M, 33 mL). After stirring for 1 h, additional LiOH (0.2 M, 33 mL) was added and stirring was continued for 30 min. The reaction was then transferred to a separatory funnel and was washed with ether (2 × 50 mL). The was aqueous layer was acidified with 2N HCl to a pH = 4 and was then extracted with ethyl acetate (3 × 100 mL). The combined organics were washed with water and brine and dried over sodium sulfate. Filtration and concentration provided (<i>S</i>)-3-(3,4-bis(difluoromethoxy)phenyl)-2-(<i>tert</i>-butoxycarbonyl)propanoic acid (2.60 g, 100% yield) as a colorless oil that was carried on without further purification. MS, <i>m</i>/<i>z</i> = 398.1 [M + H]<sup>+</sup>. Calcd for C<sub>16</sub>F<sub>4</sub>H<sub>20</sub>NO<sub>6</sub>: 398.2.</div></div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (<i>S</i>)-2-(<i>tert</i>-Butoxycarbonylamino)-3-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)propanoic Acid (<b>9b</b>)</h3><div id="sec5_14_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Step A</h4><div class="NLM_p last">A solution of methyl 2-(<i>tert</i>-butoxycarbonyl)-2-(dimethoxyphosphoryl)acetate (5.08 g, 17.1 mmol) in 15 mL of CH<sub>2</sub>Cl<sub>2</sub> was cooled to 0 °C and treated with DBU (2.57 mL, 17.1 mmol). The resulting solution was allowed to stir for 15 min before a solution of 2,3-dihydrobenzo[<i>b</i>][1,4]dioxine-6-carbaldehyde (2.670 g, 16.3 mmol) in 30 mL of CH<sub>2</sub>Cl<sub>2</sub> was added. The reaction mixture was allowed to slowly warm to room temperature overnight. The reaction mixture was quenched saturated NH<sub>4</sub>Cl (200 mL) and poured into a separatory funnel. The layers were separated, and the organic layer was washed sequentially with saturated NaHCO<sub>3</sub> and brine. The solution was dried over MgSO<sub>4</sub>, filtered, and concentrated. Purification of the crude residue by column chromatography provided (<i>Z</i>)-methyl 2-(<i>tert</i>-butoxycarbonyl)-3-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)acrylate (3.545 g, 65.0% yield) as a clear viscous oil. MS, <i>m</i>/<i>z</i> = 336.2 [M + H]<sup>+</sup>. Calcd for C<sub>17</sub>H<sub>22</sub>NO<sub>6</sub>: 336.1.</div></div><div id="sec5_14_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Step B</h4><div class="NLM_p last">A solution of (<i>Z</i>)-methyl 2-(<i>tert</i>-butoxycarbonyl)-3-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)acrylate (5.15 g, 15.4 mmol) and (1<i>R</i>,2<i>S</i>)-2-tert-butyl-1-((1<i>R</i>,2<i>S</i>)-2-<i>tert</i>-butyl-2,3-dihydro-1<i>H</i>-isophosphindol-1-yl)-2,3-dihydro-1<i>H</i>-isophosphindole Rh(duanphos)COD-BF<sub>4</sub> (0.104 g, 0.154 mmol) in 45 mL of MeOH was placed under 50 psi hydrogen in a pressure vessel and was allowed to stir at room temperature overnight. The resulting reaction mixture was concentrated, and the crude residue was filtered through a short plug of silica eluting with CH<sub>2</sub>Cl<sub>2</sub> to provide (<i>S</i>)-methyl 2-(<i>tert</i>-butoxycarbonyl)-3-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)propanoate (4.890 g, 94.4% yield) as a clear viscous oil. MS, <i>m</i>/<i>z</i> = 338.2 [M + H]<sup>+</sup>. Calcd for C<sub>17</sub>H<sub>24</sub>NO<sub>6</sub>: 338.2.</div></div><div id="sec5_14_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Step C</h4><div class="NLM_p last">A solution of (<i>S</i>)-methyl 2-(<i>tert</i>-butoxycarbonyl)-3-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)propanoate (3.0 g, 8.9 mmol) in 10 mL of THF and 10 mL of MeOH was cooled to 0 °C and treated with lithium hydroxide hydrate (1.9 g, 44 mmol), followed by 1 mL of water. The reaction mixture was allowed to stir at 0 °C for 2 h before being acidified to pH 4 with 6 N HCl. The mixture was then diluted with water (25 mL) and extracted with EtOAc (3 × 25 mL). The organics were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated to provide (<i>S</i>)-2-(<i>tert</i>-butoxycarbonyl)-3-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)propanoic acid (2.930 g, 102% yield) as a pale-yellow oil. This material was used in the next step without further purification. MS, <i>m</i>/<i>z</i> = 324.2 [M + H]<sup>+</sup>. Calcd for C<sub>16</sub>H<sub>22</sub>NO<sub>6</sub>: 324.1.</div></div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>S</i>)-4-(3,4-Bis(difluoromethoxy)phenyl)-3-(<i>tert</i>-butoxycarbonylamino)-2-oxobutyl Acetate (<b>10a</b>)</h3><div class="NLM_p last">To a solution of (<i>S</i>)-3-(3,4-bis(difluoromethoxy)phenyl)-2-(<i>tert</i>-butoxycarbonyl)propanoic acid (2.60 g, 7.0 mmol) in 100 mL of THF at 0 °C was added triethylamine (1.0 mL, 7.0 mmol) and isobutyl chloroformate (0.9 mL, 7.0 mmol). After stirring for 2 h, the reaction was filtered through a plug of Celite and then recooled to 0 °C. A solution of diazomethane in ether (0.5 M, 20 mL) was slowly added, and stirring was continued for 2 h before being poured into saturated sodium bicarbonate (500 mL). The aqueous layer was extracted with ethyl acetate (3 × 300 mL), and the combined organic layers were washed with water and then brine before being dried over Na<sub>2</sub>SO<sub>4</sub>. Filtration and concentration under reduced pressure provided (<i>S</i>)-<i>tert</i>-butyl 1-(3,4-bis(difluoromethoxy)phenyl)-4-diazo-3-oxobutan-2-ylcarbamate (2.84 g) as a yellow solid that was used immediately in the next step. A solution of the derived diazo ketone (2.84 g) in 100 mL of THF cooled to 0 °C was treated with HBr (33% in acetic acid; 1.0 mL, 8.0 mmol). After stirring for 10 min, potassium carbonate (1.0 g, 10 mmol) and sodium acetate (5.0 g, 65 mmol) were added. The THF was removed in vacuo, and 20 mL of DMF was introduced. Stirring was continued at rt for 30 min before the reaction was diluted with ethyl acetate (100 mL) and poured in water (300 mL). The aqueous layer was extracted with ethyl acetate (2 × 200 mL), and the combined organic layers were washed with water and then brine and dried over Na<sub>2</sub>SO<sub>4</sub>. Filtration and concentration under reduced pressure provided (<i>S</i>)-4-(3,4-bis(difluoromethoxy)phenyl)-3-(<i>tert</i>-butoxycarbonyl)-2-oxobutyl acetate (2.95 g, 99% yield) as a yellow oil. This material was used in the next step without further purification. MS, <i>m</i>/<i>z</i> = 454.2 [M + H]<sup>+</sup>. Calcd for C<sub>19</sub>F<sub>4</sub>H<sub>24</sub>NO<sub>7</sub>: 454.1.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>S</i>)-3-(<i>tert</i>-Butoxycarbonylamino)-4-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)-2-oxobutyl Acetate (<b>10b</b>)</h3><div class="NLM_p last">A solution of (<i>S</i>)-2-(<i>tert</i>-butoxycarbonylamino)-3-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)propanoic acid (2.9 g, 9.00 mmol) and DIPEA (2.0 mL, 14 mmol) in 27 mL of THF was cooled to 0 °C and treated with isobutyl chloroformate (2.0 mL, 14 mmol). The resulting solution was allowed to stir for 2 h before being filtered through a short plug of silica eluting with ether. The filtrate was concentrated to provide the corresponding mixed anhydride as a thick yellow oil. This oil was taken up in 30 mL of ether, cooled to 0 °C, and treated with a solution of diazomethane in ether (0.5 M, 27 mL). This solution was allowed to stir for 30 min before being poured into a separatory funnel containing saturated NaHCO<sub>3</sub> (500 mL). The layers were separated, and the aqueous layer was extracted with EtOAc (2 × 150 mL). The combined organic layers were washed with water and brine before being dried over MgSO<sub>4</sub>, filtered, and concentrated. Purification of the crude residue by column chromatography provided (<i>S</i>)-<i>tert</i>-butyl 4-diazo-1-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)-3-oxobutan-2-ylcarbamate (1.33 g, 42% yield) as a yellow oil. The derived diazo ketone was taken up in 15 mL of THF and was cooled to 0 °C before being treated with HBr (33% in acetic acid, 0.624 mL, 11.5 mmol). After stirring for 2 h, K<sub>2</sub>CO<sub>3</sub> (5.29 g, 38.3 mmol) and NaOAc (3.14 g, 38.3 mmol) were added, followed by 10 mL of DMF. The reaction mixture was allowed to warm to room temperature and stir for an additional 2 h before being diluted with EtOAc (200 mL) and washed with brine. The organics were dried over MgSO<sub>4</sub>, filtered, and concentrated to provide (<i>S</i>)-3-(<i>tert</i>-butoxycarbonyl)-4-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)-2-oxobutyl acetate (1.530 g, 105% yield) as a pale-yellow oil. This material was used in the next step without further purification. MS, <i>m</i>/<i>z</i> = 380.2 [M + H]<sup>+</sup>. Calcd for C<sub>19</sub>H<sub>26</sub>NO<sub>7</sub>: 380.2.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (4<i>S</i>)-<i>tert</i>-Butyl 4-(3,4-Bis(difluoromethoxy)benzyl)-5-formyl-2,2-dimethyloxazolidine-3-carboxylate (<b>11a</b>)</h3><div id="sec5_17_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Step A</h4><div class="NLM_p last">A 200 mL RB was charged with lithium tri-<i>tert</i>-butoxy-aluminum hydride (3.31 g, 13.0 mmol). To this was added 13 mL of THF, leading to an opaque mixture. After stirring for 5 min at rt, this mixture was cooled to −78 °C, at which point 75 mL of ethanol was added. A slurry of (<i>S</i>)-4-(3,4-bis(difluoromethoxy)phenyl)-3-(<i>tert</i>-butoxycarbonyl)-2-oxobutyl acetate (2950 mg, 6.51 mmol) in 25 mL of ethanol and 10 mL of methanol and 5 mL of THF precooled to −40 °C was added dropwise via a cannula over 10 min. This addition was followed with a 5 mL THF wash of the flask containing the ketone. After stirring for 1 h at −78 °C the reaction was quenched with 200 mL of 1 N HCl. The mixture was diluted with ethyl acetate (100 mL), and 100 mL of water the layers were separated. The organic layer was concentrated, and the aqueous layer was extracted with ethyl acetate (2 × 200 mL). The combined organics were washed with water and brine and dried over sodium sulfate. Filtration and concentration provided (2<i>S</i>,3<i>S</i>)-4-(3,4-bis(difluoromethoxy)phenyl)-3-(<i>tert</i>-butoxycarbonyl)-2-hydroxybutyl acetate (2.90 g, 97.9% yield) as yellow oil that began to solidify upon cooling. MS, <i>m</i>/<i>z</i> = 456.2 [M + H]<sup>+</sup>. Calcd for C<sub>19</sub>F<sub>4</sub>H<sub>26</sub>NO<sub>7</sub>: 456.2.</div></div><div id="sec5_17_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Step B</h4><div class="NLM_p last">To a solution of (2<i>S</i>,3<i>S</i>)-4-(3,4-bis(difluoromethoxy)phenyl)-3-(<i>tert</i>-butoxycarbonyl)-2-hydroxybutyl acetate (2.99 g, 6.57 mmol) in 20 mL of DMF was added 2-methoxy-1-propene (3.71 mL, 39.4 mmol) followed by CSA (0.763 g, 3.28 mmol). The mixture was stirred at rt for 4 h before another 1.5 mL of methoxy propene and 200 mg of CSA were added. The reaction was stirred at rt overnight before being diluted with ethyl acetate (50 mL) and poured in saturated sodium bicarbonate (250 mL). The layers were separated, and the aqueous layer was extracted with ethyl acetate (3 × 100 mL). The combined organic layers were washed with water and then brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. Concentration under reduced pressure provided (5<i>S</i>)-<i>tert</i>-butyl 5-(3,4-bis(difluoromethoxy)benzyl)-4-(acetoxymethyl)-2,2-dimethylpyrrolidine-1-carboxylate (3.10 g, 95.7% yield) as an orange oil that was carried on as is. MS, <i>m</i>/<i>z</i> = 496.2 [M + H]<sup>+</sup>. Calcd for C<sub>22</sub>F<sub>4</sub>H<sub>30</sub>NO<sub>7</sub>: 496.2.</div></div><div id="sec5_17_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Step C</h4><div class="NLM_p last">To a solution of (5<i>S</i>)-<i>tert</i>-butyl 5-(3,4-bis(difluoromethoxy)benzyl)-4-(acetoxymethyl)-2,2-dimethylpyrrolidine-1-carboxylate (3.10 g, 6.28 mmol) in 50 mL of methanol at 0 °C was added potassium carbonate (2.60 g, 18.8 mmol). After stirring for 1 h at 0 °C, 200 mL of water and 200 mL of ethyl acetate were added. The reaction was stirred at rt for 2 h, and then the organics were removed in vacuo. The mixture was diluted with ethyl acetate (100 mL) and poured in water (50 mL). The layers were separated, and the aqueous layer was extracted with ethyl acetate (3 × 100 mL). The combined organic layers were washed with water and then brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. Concentration under reduced pressure and purified by silica gel chromatography (0–50% ethyl acetate in hexanes) provided (5<i>S</i>)-<i>tert</i>-butyl 5-(3,4-bis(difluoromethoxy)benzyl)-4-(hydroxymethyl)-2,2-dimethylpyrrolidine-1-carboxylate (1.95 g, 68.8% yield) as a colorless oil. MS, <i>m</i>/<i>z</i> = 454.2 [M + H]<sup>+</sup>. Calcd for C<sub>20</sub>F<sub>4</sub>H<sub>28</sub>NO<sub>6</sub>: 454.2.</div></div><div id="sec5_17_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Step D</h4><div class="NLM_p last">A solution of (5<i>S</i>)-<i>tert</i>-butyl 5-(3,4-bis(difluoromethoxy)benzyl)-4-(hydroxymethyl)-2,2-dimethylpyrrolidine-1-carboxylate (1.93 g, 4270 μmol) in 200 mL of CH<sub>2</sub>Cl<sub>2</sub> was treated with Dess–Martin periodinane (1995 mg, 4703 μmol) and sodium bicarbonate (1796 mg, 21375 μmol). The mixture was stirred for 30 min before being diluted with CH<sub>2</sub>Cl<sub>2</sub> (25 mL) and quenched with 10% aqueous NaHCO<sub>3</sub> and 10% Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (250 mL). After stirring vigorously for 0.5 h, the layers were separated and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 100 mL). The combined organic layers were washed with water and then brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. Concentration under reduced pressure and purification by silica gel chromatography (0–50% ethyl acetate in hexanes) provided (5<i>S</i>)-<i>tert</i>-butyl 5-(3,4-bis(difluoromethoxy)benzyl)-4-formyl-2,2-dimethylpyrrolidine-1-carboxylate (1.61 mg, 83.8% yield) as a yellow oil. MS, <i>m</i>/<i>z</i> = 452.2 [M + H]<sup>+</sup>. Calcd for C<sub>20</sub>F<sub>4</sub>H<sub>26</sub>NO<sub>6</sub>: 452.2.</div></div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (4<i>S</i>)-<i>tert</i>-Butyl 4-((2,3-Dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)methyl)-5-formyl-2,2-dimethyloxazolidine-3-carboxylate (<b>11b</b>)</h3><div id="sec5_18_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Step A</h4><div class="NLM_p last">A solution of (<i>S</i>)-3-(<i>tert</i>-butoxycarbonylamino)-4-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)-2-oxobutyl acetate (1.53 g, 4.00 mmol) in 40 mL of EtOH cooled to 0 °C was added dropwise via a cannula to a solution of lithium tri-<i>tert</i>-butoxyaluminum hydride (8 mL, 8 mmol) in 20 mL of EtOH cooled to −78 °C. After stirring for 2 h, the reaction was quenched with 10 mL of 1N HCl and diluted with EtOAc (50 mL). The organics were washed with water and brine before being dried over MgSO<sub>4</sub>. Filtration and concentration provided a residue that was purified by column chromatography to give (2<i>S</i>,3<i>S</i>)-3-(<i>tert</i>-butoxycarbonyl)-4-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)-2-hydroxybutyl acetate (1.26 g, 82% yield) as a white solid. MS, <i>m</i>/<i>z</i> = 382.2 [M + H]<sup>+</sup>. Calcd for C<sub>19</sub>H<sub>28</sub>NO<sub>7</sub>: 382.2.</div></div><div id="sec5_18_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Step B</h4><div class="NLM_p last">A solution of (2<i>S</i>,3<i>S</i>)-3-(<i>tert</i>-butoxycarbonyl)-4-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)-2-hydroxybutyl acetate (1.26 g, 3.30 mmol) in 4 mL DMF was treated with CSA (0.23 g, 0.99 mmol) followed by 2,2-dimethoxypropane (1.2 mL, 9.9 mmol). The mixture was allowed to stir at room temperature overnight before an additional portion of CSA and methoxypropene were added. The mixture was allowed to stir at room temperature for an additional 2 h, at which point K<sub>2</sub>CO<sub>3</sub> (1.40 g, 9.90 mmol) was added followed by 3 mL of MeOH. The reaction was maintained for 2 h before being diluted with EtOAc (50 mL) and washed with water and brine. The organics were dried over MgSO<sub>4</sub>, filtered, and concentrated. Purification of the crude residue by column chromatography gave (4<i>S</i>,5<i>S</i>)-<i>tert</i>-butyl 4-((2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)methyl)-5-(hydroxymethyl)-2,2-dimethyloxazolidine-3-carboxylate (0.582 g, 46% yield) as a colorless oil. MS, <i>m</i>/<i>z</i> = 380.2 [M + H]<sup>+</sup>. Calcd for C<sub>20</sub>H<sub>30</sub>NO<sub>6</sub>: 380.2.</div></div><div id="sec5_18_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Step C</h4><div class="NLM_p last">A solution of (4<i>S</i>,5<i>S</i>)-<i>tert</i>-butyl 4-((2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)methyl)-5-(hydroxymethyl)-2,2-dimethyloxazolidine-3-carboxylate (0.582 g, 1.53 mmol) in 10 mL of DCM was treated with Dess–Martin periodinane (0.716 g, 1.69 mmol) and allowed to stir at room temperature for 1 h. The reaction mixture was treated with 1 mL of saturated NaHCO<sub>3</sub> solution followed by sodium thiosulfate (1.21 g, 7.67 mmol). The mixture was stirred vigorously for 1 h before being diluted with EtOAc (30 mL) and washed with saturated NaHCO<sub>3</sub> (50 mL) and brine. The organics were dried over MgSO<sub>4</sub>, filtered, and concentrated. Purification of the crude residue by column chromatography provided (4<i>S</i>,5<i>S</i>)-<i>tert</i>-butyl 4-((2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)methyl)-5-formyl-2,2-dimethyloxazolidine-3-carboxylate (0.537 g, 92.8% yield) as a colorless oil. MS, <i>m</i>/<i>z</i> = 378.2 [M + H]<sup>+</sup>. Calcd for C<sub>20</sub>H<sub>28</sub>NO<sub>6</sub>: 378.2.</div></div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (2<i>R</i>,3<i>S</i>)-3-Amino-4-(3,4-dimethoxyphenyl)-1-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ol trichloride (<b>13a</b>)</h3><div id="sec5_19_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Step A</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl (2<i>S</i>,3<i>S</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-1-(3,4-dimethoxyphenyl)-4-oxobutan-2-ylcarbamate (<b>7a</b>, 280 mg, 0.617 mmol) and (<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridin]-4′-amine (<b>7</b>, 161 mg, 0.617 mmol) in 5 mL of CH<sub>2</sub>Cl<sub>2</sub> was added trimethylorthoformate (0.54 mL, 4.93 mmol). After stirring for 20 min, NaBH(OAc)<sub>3</sub> (523 mg, 2.50 mmol) was added and the mixture was stirred for 1 h before being diluted with CH<sub>2</sub>Cl<sub>2</sub> (5 mL) and saturated Rochelle’s Salt (25 mL). After stirring vigorously for 1 h, the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 10 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. Concentration under reduced pressure provided <i>tert</i>-butyl (2<i>S</i>,3<i>R</i>)-3-(<i>tert</i>-butyldimethylsilyloxy)-1-(3,4-dimethoxyphenyl)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ylcarbamate (431 mg, 100% yield) as a yellow foam. MS, <i>m</i>/<i>z</i> = 698.5 [M + H]<sup>+</sup>. Calcd for C<sub>39</sub>H<sub>64</sub>N<sub>3</sub>O<sub>6</sub>Si: 698.2. This material was carried directly into the next step without further purification.</div></div><div id="sec5_19_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Step B</h4><div class="NLM_p last">A solution of <i>tert</i>-butyl (2<i>S</i>,3<i>R</i>)-1-(3,4-dimethoxyphenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ylcarbamate (345 mg, 0.59 mmol) was taken up in methanol (5 mL) and treated with HCl (4 M in dioxane, 3.6 mL, 9.2 mmol). The solution was heated at 55 °C for 2 h before being cooled to ambient temperature and concentrated in vacuo to provide (2<i>R</i>,3<i>S</i>)-3-amino-4-(3,4-dimethoxyphenyl)-1-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ol trichloride (<b>13a</b>, 350 mg, 100% yield) as a pale-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.12 (s, 1 H), 9.55 (s, 1 H), 8.12 (d, <i>J</i> = 1.76 Hz, 1 H), 7.75 (d, <i>J</i> = 2.22 Hz, 1 H), 6.78 (d, <i>J</i> = 1.23 Hz, 1 H), 6.76 (d, <i>J</i> = 7.34 Hz, 1 H), 6.80 (d, <i>J</i> = 87.78 Hz, 1 H), 4.89–4.81 (m, 2 H), 4.54 (m, 4 H), 4.21 (d, <i>J</i> = 9.89 Hz, 1 H), 3.89 (s, 6 H), 3.19–3.51 (m, 2 H), 2.75–2.95 (m, 3 H), 2.56 (dd, <i>J</i> = 12.22, 5.87 Hz, 1 H), 2.15–2.35 (m, 3 H), 1.93–2.11 (m, 2 H), 1.71–1.79 (m, 1 H), 0.89 (s, 9 H). MS, <i>m</i>/<i>z</i> = 483.3 [M + H]<sup>+</sup>. Calcd for C<sub>28</sub>H<sub>41</sub>N<sub>3</sub>O<sub>4</sub>: 483.2.</div></div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (2<i>R</i>,3<i>S</i>)-3-Amino-4-(benzo[<i>d</i>][1,3]dioxol-5-yl)-1-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ol Trichloride (<b>13b</b>)</h3><div id="sec5_20_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Step A</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl (2<i>S</i>,3<i>S</i>)-1-(benzo[<i>d</i>][1,3]dioxol-5-yl)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-oxobutan-2-ylcarbamate (<b>7b</b>, 3.24 g, 7.4 mmol) and (<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridin]-4′-amine (<b>7</b>, 1.93 g, 7.4 mmol) in CH<sub>2</sub>Cl<sub>2</sub> was added trimethylorthoformate (6.0 mL, 54 mmol). After stirring for 20 min, NaBH(OAc)<sub>3</sub> (6.34 g, 30 mmol) was added and the mixture was stirred for 1 h before being diluted with CH<sub>2</sub>Cl<sub>2</sub> (50 mL) and saturated Rochelle’s Salt (250 mL). After stirring vigorously for 1 h, the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 100 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. Concentration under reduced pressure provided <i>tert</i>-butyl (2<i>S</i>,3<i>R</i>)-1-(benzo[<i>d</i>][1,3]dioxol-5-yl)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ylcarbamate (5.02 g, 99% yield) as a yellow foam. MS, <i>m</i>/<i>z</i> = 682.2 [M + H]<sup>+</sup>. Calcd for C<sub>38</sub>H<sub>60</sub>N<sub>3</sub>O<sub>6</sub>Si: 682.4. This material was carried directly into the next step without further purification.</div></div><div id="sec5_20_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Step B</h4><div class="NLM_p last">A solution of (2<i>S</i>,3<i>R</i>)-1-(benzo[<i>d</i>][1,3]dioxol-5-yl)-3-(<i>tert</i>-butyldimethylsilyloxy)-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ylcarbamate (5.02 g, 7.4 mmol) was taken up in methanol (35 mL) and treated with HCl (4 M in dioxane, 46 mL, 185 mmol). The solution was heated at 55 °C for 2 h before being cooled to ambient temperature and concentrated in vacuo to provide (2<i>R</i>,3<i>S</i>)-3-amino-4-(benzo[<i>d</i>][1,3]dioxol-5-yl)-1-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ol trichloride (<b>8</b>, 4.16 g, 98% yield) as a pale-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.28 (s, 1 H), 9.60 (s, 1 H), 8.28 (d, <i>J</i> = 1.53 Hz, 1 H), 7.96 (d, <i>J</i> = 1.95 Hz, 1 H), 6.98 (d, <i>J</i> = 1.41 Hz, 1 H), 6.85 (d, <i>J</i> = 7.97 Hz, 1 H), 6.80 (dd, <i>J</i> = 8.02, 1.6 Hz, 1 H), 5.99 (s, 1 H), 5.98 (s, 1 H), 4.75–4.79 (m, 2 H), 4.68 (br s, 4 H), 4.39 (d, <i>J</i> = 10.21 Hz, 1 H), 3.41–3.51 (m, 1 H), 3.22–3.34 (m, 1 H), 2.91–3.00 (m, 1 H), 2.75–2.91 (m, 2 H), 2.67 (dd, <i>J</i> = 13.16, 6.02 Hz, 1 H), 2.37–2.48 (m, 2 H), 2.15–2.25 (m, 2 H), 1.97–2.09 (m, 2 H), 1.81–1.93 (m, 1 H), 1.68–1.79 (m, 1 H), 0.88 (s, 9 H). MS, <i>m</i>/<i>z</i> = 468.2 [M + H]<sup>+</sup>. Calcd for C<sub>27</sub>H<sub>38</sub>N<sub>3</sub>O<sub>4</sub>: 468.3.</div></div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (2<i>R</i>,3<i>S</i>)-3-Amino-4-(3,4-bis(difluoromethoxy)phenyl)-1-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ol Trichloride (<b>13c</b>)</h3><div id="sec5_21_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Step A</h4><div class="NLM_p last">To a solution of (<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridin]-4′-amine (923 mg, 3544 μmol) and (4<i>S</i>)-<i>tert</i>-butyl 4-(3,4-bis(difluoromethoxy)benzyl)-5-formyl-2,2-dimethyloxazolidine-3-carboxylate (1.60 g, 3544 μmol) in 25 mL of CH<sub>2</sub>Cl<sub>2</sub> was added trimethylorthoformate (3.13 mL, 28356 μmol). The solution was stirred for 20 min before NaBH(OAc)<sub>3</sub> (3.00 g, 14178 μmol) was added, and the resulting slurry was stirred for an additional 2 h. The mixture was then diluted with CH<sub>2</sub>Cl<sub>2</sub> (50 mL) and poured into a 1 L flask containing saturated Rochelle’s salt (250 mL). After stirring vigorously for 0.5 h, the layers were separated and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 100 mL). The combined organic layers were washed with water and then brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered to provide (4<i>S</i>,5<i>R</i>)-<i>tert</i>-butyl 4-(3,4-bis(difluoromethoxy)benzyl)-2,2-dimethyl-5-(((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)methyl)oxazolidine-3-carboxylate (2.39 g, 97% yield) as a pale-yellow oil. MS, <i>m</i>/<i>z</i> = 696.2 [M + H]<sup>+</sup>. Calcd for C<sub>36</sub>F<sub>4</sub>H<sub>50</sub>N<sub>3</sub>O<sub>6</sub>: 696.4. This material was carried directly into the next step without further purification.</div></div><div id="sec5_21_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Step B</h4><div class="NLM_p last">A solution of (4<i>S</i>,5<i>R</i>)-<i>tert</i>-butyl 4-(3,4-bis(difluoromethoxy)benzyl)-2,2-dimethyl-5-(((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)methyl)oxazolidine-3-carboxylate (2.39 g, 3.43 mmol) in 10 mL of methanol was treated with a solution of HCl in dioxane (4.0 M, 22 mL). The resulting yellow solution was heated at 55 °C for 20 min before being concentrated and azeotropped twice from benzene to provide (2<i>R</i>,3<i>S</i>)-3-amino-4-(3,4-bis(difluoromethoxy)phenyl)-1-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ol trichloride (2.28 mg, 100% yield) as a yellow solid. MS, <i>m</i>/<i>z</i> = 556.2 [M + H]<sup>+</sup>. Calcd for C<sub>28</sub>F<sub>4</sub>H<sub>38</sub>N<sub>3</sub>O<sub>4</sub>: 556.3. This material was carried directly into the next step without further purification.</div></div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (2<i>R</i>,3<i>S</i>)-3-Amino-4-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)-1-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ol Trichloride (<b>13d</b>)</h3><div id="sec5_22_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Step A</h4><div class="NLM_p last">A solution of (<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridin]-4′-amine (0.37 g, 1.4 mmol) and (4<i>S</i>)-<i>tert</i>-butyl 4-((2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)methyl)-5-formyl-2,2-dimethyloxazolidine-3-carboxylate (0.54 g, 1.4 mmol) in 5.0 mL of CH<sub>2</sub>Cl<sub>2</sub> was treated with trimethyl orthoformate (1.3 mL, 11 mmol) and allowed to stir at room temperature for 1 h. Sodium triacetoxyborohydride (1.2 g, 5.7 mmol) was added, and the reaction mixture was allowed to stir for an additional hour before being quenched with saturated NH<sub>4</sub>Cl (100 mL) and MeOH (2 mL). The pH of the mixture was adjusted to 11 with NH<sub>4</sub>OH, and the solution and was treated with saturated Rochelle’s salt solution (50 mL). After stirring for an additional hour, the reaction mixture was diluted with EtOAc (100 mL), washed with water and brine, and then dried over MgSO<sub>4</sub>. Filtration and concentration provided a residue that was purified by column chromatography to provide (4<i>S</i>,5<i>R</i>)-<i>tert</i>-butyl 4-((2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)methyl)-2,2-dimethyl-5-(((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)methyl)oxazolidine-3-carboxylate (0.808 g, 91% yield) as a white solid. MS, <i>m</i>/<i>z</i> = 622.2 [M + H]<sup>+</sup>. Calcd for C<sub>36</sub>H<sub>52</sub>N<sub>3</sub>O<sub>6</sub>: 622.4.</div></div><div id="sec5_22_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Step B</h4><div class="NLM_p last">A solution of (4<i>S</i>,5<i>R</i>)-<i>tert</i>-butyl 4-((2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)methyl)-2,2-dimethyl-5-(((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)methyl)oxazolidine-3-carboxylate (0.170 g, 0.3 mmol) in 5 mL of CH<sub>2</sub>Cl<sub>2</sub> was treated with HCl in dioxane (4 N, 1.0 mL). The resulting yellow solution was allowed to stir at room temperature for 2 h before the reaction mixture was diluted with EtOAc (50 mL). The organic solution was then sequentially washed with 2N NaOH and brine before being dried over MgSO<sub>4</sub>. Filtration and concentration yielded (2<i>R</i>,3S)-3-amino-4-(2,3-dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)-1-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ol trichloride (0.108 g, 82% yield) as an off-white solid. MS, <i>m</i>/<i>z</i> = 482.2 [M + H]<sup>+</sup>. Calcd for C<sub>28</sub>H<sub>40</sub>N<sub>3</sub>O<sub>4</sub>: 482.3. This material was carried directly into the next step without further purification.</div></div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(3,4-Dimethoxyphenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)acetamide (<b>15</b>)</h3><div class="NLM_p last">To a solution of (2<i>R</i>,3<i>S</i>)-3-amino-4-(3,4-dimethoxyphenyl)-1-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ol (<b>13a</b>, 300 mg, 0.27 mmol) in DMF (3.0 mL) were sequentially added DIPEA (0.442 mL, 2.54 mmol) and <i>N</i>-acetylimidazole (56 mg, 0.51 mmol). The resulting slurry was maintained at room temperature for 10 h, at which point the organics were removed in vacuo and the derived residue was purified by silica gel chromatography (0–5% MeOH in CH<sub>2</sub>C<sub>l2</sub>) to provide <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(3,4-dimethoxyphenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)acetamide (<b>9a</b>, 205 mg, 54% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.51 (s, 1 H), 7.47 (s, 1 H), 6.36 (d, <i>J</i> = 8.31 Hz, 1 H), 6.35 (s, 1 H), 6.28 (d, <i>J</i> = 8.21 Hz, 1 H), 4.36–4.44 (m, 1 H), 3.46–3.54 (m, 2 H), 3.62 (s, 3 H), 3.60 (s, 3 H), 2.82–2.85 (m, 4 H), 2.64 (dd, <i>J</i> = 14.14, 3.66 Hz, 1 H), 2.54 (dd, <i>J</i> = 12.44, 9.16 Hz, 1 H), 2.24 (dd, <i>J</i> = 13.07, 6.13 Hz, 1 H), 2.04–2.14 (m, 1 H), 2.04 (s, 3 H), 1.35–1.84 (m, 9 H), 0.44 (s, 9 H). LCMS (99%). HRMS (ESI+) calcd for [C<sub>30</sub>H<sub>43</sub>N<sub>3</sub>O<sub>5</sub> + H]<sup>+</sup>, 526.3275; found, 526.3256.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(3,4-Bis(difluoromethoxy)phenyl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)acetamide (<b>16</b>)</h3><div class="NLM_p last">The title compound was prepared from amine <b>13c</b> using a method analogous to the preparation of compound <b>15</b>. Yield, 195 mg, 39%. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>) δ 8.01 (dd, <i>J</i> = 10.4, 1.61 Hz, 2 H), 7.14–7.24 (m, 2 H), 6.78 (dd, <i>J</i> = 147, 6.16 Hz, 2 H), 6.74 (d, <i>J</i> = 6.26 Hz, 1 H), 4.78 (dd, <i>J</i> = 10.7, 6.41 Hz, 1 H), 3.80–3.87 (m, 2 H), 3.24–3.37 (m, 3 H), 2.77 (dd, <i>J</i> = 13.3, 6.57 Hz, 1 H), 2.53–2.65 (m, 4 H), 2.32 (td, <i>J</i> = 8.00, 4.51 Hz, 1 H), 2.18–2.25 (m, 1 H), 1.98–2.20 (m, 3 H), 1.92 (s, 3 H), 1.82–1.87 (m, 1 H), 0.92 (s, 9 H). MS <i>m</i>/<i>z</i> = 598.2 [M + H]<sup>+</sup>. Calcd for C<sub>30</sub>F<sub>4</sub>H<sub>40</sub>N<sub>3</sub>O<sub>5</sub>: 598.3. LCMS (100%). HRMS (ESI+) calcd for [C<sub>30</sub>F<sub>4</sub>H<sub>39</sub>N<sub>3</sub>O<sub>5</sub> + H]<sup>+</sup>, 598.2899; found, 598.2903.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)acetamide (<b>17</b>)</h3><div class="NLM_p last">To a solution of (2<i>R</i>,3<i>S</i>)-3-amino-4-(benzo[<i>d</i>][1,3]dioxol-5-yl)-1-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-ol dichloride (<b>13b</b>, 276 mg, 0.48 mmol) in dichloromethane (3.0 mL) were sequentially added DIPEA (0.53 mL, 2.88 mmol) and <i>N</i>-acetylimidazole (53 mg, 0.48 mmol). The resulting slurry was maintained at room temperature for 10 h, at which point the organics were removed in vacuo and the derived residue was purified by silica gel chromatography (0–5% MeOH in CH<sub>2</sub>C<sub>l2</sub>) to provide <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(benzo[<i>d</i>][1,3]dioxol-5-yl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)acetamide (<b>17</b>, 176 mg, 72% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, MeOH) δ 8.00 (m, 2 H), 6.61–6.79 (m, 3 H), 5.89 (s, 2 H), 4.88 (dd, <i>J</i> = 11.33, 6.13 Hz, 1 H), 3.90–4.02 (m, 2 H), 3.30–3.35 (m, 1 H), 2.97–3.15 (m, 2 H), 2.75 (dd, <i>J</i> = 13.11, 6.19 Hz, 1 H), 2.53 (s, 3H), 2.48–2.65 (m, 1 H), 2.18–2.39 (m, 3 H), 2.12 (t, <i>J</i> = 12.23 Hz, 1 H), 1.92–2.04 (m, 1 H), 1.78–1.91 (m, 6 H), 0.93 (s, 9 H). MS <i>m</i>/<i>z</i> = 510.2 [M + H]<sup>+</sup>. Calcd for C<sub>29</sub>H<sub>40</sub>N<sub>3</sub>O<sub>5</sub>: 510.3. LCMS (99%). HRMS (ESI+) calcd for [C<sub>29</sub>H<sub>39</sub>N<sub>3</sub>O<sub>5</sub> + H]<sup>+</sup>, 510.2962; found, 510.2953.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(2,3-Dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)acetamide (<b>18</b>)</h3><div class="NLM_p last">The title compound was prepared from amine <b>13d</b> using a method analogous to the preparation of compound <b>17</b>. Yield, 84 mg, 48%. <sup>1</sup>H NMR (400 MHz, MeOH) δ 7.86 (d, <i>J</i> = 1.90 Hz, 1 H), 7.79 (s, 1 H), 6.66–6.76 (m, 3 H), 6.50 (d, <i>J</i> = 7.81 Hz, 1 H), 4.17–4.26 (m, 5 H), 3.91–3.99 (m, 1 H), 3.91–3.61–3.64 (m, 1 H), 3.01 (dd, <i>J</i> = 14.2, 3.62 Hz, 1 H), 2.88 (d, <i>J</i> = 5.33 Hz, 2 H), 2.42–2.54 (m, 3 H), 2.44 (s, 3 H), 2.09–2.25 (m, 6 H), 1.74–1.80 (m, 4 H), 0.88 (s, 9 H). MS <i>m</i>/<i>z</i> = 524.2 [M + H]<sup>+</sup>. Calcd for C<sub>30</sub>H<sub>42</sub>N<sub>3</sub>O<sub>5</sub>: 524.3. LCMS (97%). HRMS (ESI+) calcd for [C<sub>30</sub>H<sub>41</sub>N<sub>3</sub>O<sub>5</sub> + H]<sup>+</sup>, 524.3119; found, 524.3121.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxyacetamide (<b>19</b>)</h3><div class="NLM_p last">To a vial charged with 2-methoxyacetic acid (0.465 g, 5.16 mmol) were sequentially added CH<sub>2</sub>Cl<sub>2</sub> (15 mL) and di(1<i>H</i>-imidazol-1-yl)methanone (0.837 g, 5.16 mmol). The reaction was maintained at ambient temperature for 10 min before being added to a separate flask containing a solution of amine <b>13b</b> (2.84 g, 4.92 mmol), CH<sub>2</sub>Cl<sub>2</sub> (60 mL), and DIPEA (4.29 mL, 24.6 mmol). The resulting solution was maintained at ambient temperature for 10 h before being diluted with CH<sub>2</sub>Cl<sub>2</sub> (70 mL) and poured into a separatory funnel containing 1 N NaOH (150 mL). The layers were separated, and the organics were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The derived residue was purified by silica gel chromatography (0–10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to provide the title compound (2.05 g, 77% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, MeOH) δ 7.99 (s, 1 H), 7.86 (s, 1 H), 6.57–6.84 (m, 3 H), 5.90 (s, 2 H), 4.84 (dd, <i>J</i> = 11.56, 6.51 Hz, 1 H), 3.94–4.09 (m, 2 H), 3.87 (d, <i>J</i> = 15.87 Hz, 1 H), 3.71 (d, <i>J</i> = 15.88 Hz, 1 H), 3.29 (s, 3 H), 3.11 (dd, <i>J</i> = 13.89, 3.41 Hz, 1 H), 3.02 (dd, <i>J</i> = 12.38, 8.97 Hz, 1 H), 2.65–2.77 (m, 2 H), 2.49–2.64 (m, 4 H), 2.25–2.37 (m, 2 H), 2.10 (t, <i>J</i> = 11.87 Hz, 1 H), 1.92–2.04 (m, 1 H), 1.79–1.93 (m, 1 H), 0.94 (s, 9 H). MS <i>m</i>/<i>z</i> = 540.2 [M + H]<sup>+</sup>. Calcd for C<sub>30</sub>H<sub>42</sub>N<sub>3</sub>O<sub>6</sub>: 540.3. LCMS (98%). HRMS (ESI+) calcd for [C<sub>30</sub>H<sub>41</sub>N<sub>3</sub>O<sub>6</sub> + H]<sup>+</sup>, 540.3068; found, 540.3058.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)isobutyramide (<b>20</b>)</h3><div class="NLM_p last">To a 25 mL flask charged with amine <b>13b</b> (150 mg, 0.26 mmol) and CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added DIPEA (47 μL, 0.26 mmol) followed by isobutyryl chloride (27.7 mg, 0.26 mmol). The mixture was allowed to stir at rt for 1 h before being concentrated in vacuo and purified by HPLC to provide the title compound (3× TFA salt, 167 mg, 73% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.95–9.21 (s, 1 H), 7.95 (d, <i>J</i> = 1.96 Hz, 1 H), 7.83 (d, <i>J</i> = 1.76 Hz, 1 H), 7.69 (d, <i>J</i> = 8.22 Hz, 1 H), 6.74–6.84 (m, 2 H), 6.59–6.73 (m, 1 H), 5.94 (s, 2 H), 4.68–4.89 (m, 1 H), 3.72–3.93 (m, 2 H), 3.02–3.22 (m, 1 H), 2.76–2.96 (m, 2 H), 2.53–2.68 (m, 3 H), 2.41 (m, 3 H), 2.11–2.34 (m, 3 H), 1.93–2.09 (m, 2 H), 1.81–1.93 (m, 1 H), 1.66–1.81 (m, 1 H), 0.91 (d, <i>J</i> = 6.75 Hz, 3 H), 0.87 (s, 9 H), 0.81 (d, <i>J</i> = 6.85 Hz, 3 H). MS <i>m</i>/<i>z</i> = 538.2 [M + H]<sup>+</sup>. Calcd for C<sub>31</sub>H<sub>44</sub>N<sub>3</sub>O<sub>5</sub>: 538.3. LCMS (98%). HRMS (ESI+) calcd for [C<sub>31</sub>H<sub>43</sub>N<sub>3</sub>O<sub>5</sub> + H]<sup>+</sup>, 538.3275; found, 538.3205.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (<i>R</i>)-<i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-methoxypropanamide (<b>21</b>)</h3><div class="NLM_p last">The title compound was prepared from amine <b>13b</b> using a method analogous to the preparation of compound <b>19</b>. Yield, 16.1 g, 91%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.76 (d, <i>J</i> = 2.0 Hz, 1 H), 7.66–7.71 (m, 1 H), 7.6 (d, <i>J</i> = 9.22 Hz, 1 H), 6.72–6.79 (m, 2 H), 6.63 (dd, <i>J</i> = 7.89, 1.33 Hz, 1 H), 5.92 (d, <i>J</i> = 2.65 Hz, 2 H), 4.88 (d, <i>J</i> = 5.81 Hz, 1 H), 3.89–3.99 (m, 1 H), 3.79–3.89 (m, 1 H), 3.44–3.55 (m, 2 H), 3.04 (s, 3 H), 2.97 (dd, <i>J</i> = 13.89, 3.41 Hz, 1 H), 2.58 (dd, <i>J</i> = 13.96, 10.93 Hz, 3 H), 2.27–2.41 (m, 4 H), 2.17 (t, <i>J</i> = 9.22 Hz, 1 H), 2.08 (t, <i>J</i> = 7.89 Hz, 3 H), 1.76–1.89 (m, 1 H), 1.66–1.75 (m, 1 H), 1.57–1.67 (m, 1 H), 1.07 (d, <i>J</i> = 6.69 Hz, 3 H), 0.85 (s, 9 H). MS <i>m</i>/<i>z</i> = 554.2 [M + H]<sup>+</sup>. Calcd for C<sub>31</sub>H<sub>44</sub>N<sub>3</sub>O<sub>6</sub>: 554.3. LCMS (100%). HRMS (ESI+) calcd for [C<sub>31</sub>H<sub>43</sub>N<sub>3</sub>O<sub>6</sub> + H]<sup>+</sup>, 554.3225; found, 554.3214.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (<i>S</i>)-<i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)tetrahydrofuran-2-carboxamide (<b>22</b>)</h3><div class="NLM_p last">The title compound was prepared from amine <b>13b</b> using a method analogous to the preparation of compound <b>19</b>. Yield, 1.79 g, 85%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.77 (s, 1 H), 7.68 (s, 1 H), 7.56 (d, <i>J</i> = 9.59 Hz, 1 H), 6.70–6.81 (m, 2 H), 6.62 (d, <i>J</i> = 8.02 Hz, 1 H), 5.94 (s, 2 H), 4.88 (d, <i>J</i> = 5.58 Hz, 1 H), 4.04 (dd, <i>J</i> = 8.12, 4.79 Hz, 1 H), 3.82–3.98 (m, 2 H), 3.73–3.82 (m, 1 H), 3.65–3.74 (m, 1 H), 3.47–3.59 (m, 1 H), 2.92 (dd, <i>J</i> = 14.18, 3.91 Hz, 1 H), 2.56–2.68 (m, 3 H), 2.27–2.42 (m, 4 H), 2.14–2.25 (m, 1 H), 1.93–2.13 (m, 4 H), 1.60–1.90 (m, 6 H), 0.86 (s, 9 H). MS <i>m</i>/<i>z</i> = 566.4 [M + H]<sup>+</sup>. Calcd for C<sub>32</sub>H<sub>44</sub>N<sub>3</sub>O<sub>6</sub>: 566.3. LCMS (99%). HRMS (ESI+) calcd for [C<sub>32</sub>H<sub>43</sub>N<sub>3</sub>O<sub>6</sub> + H]<sup>+</sup>, 566.3225; found, 566.3214.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (<i>R</i>)-<i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-fluoropropanamide (<b>23</b>)</h3><div class="NLM_p last">The title compound was prepared from amine <b>13b</b> using a method analogous to the preparation of compound <b>19</b>. Yield, 38 mg, 74%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.83 (dd, <i>J</i> = 9.34, 1.71 Hz, 1 H), 7.77 (d, <i>J</i> = 2.25 Hz, 1 H), 7.67 (d, <i>J</i> = 1.86 Hz, 1 H), 6.77 (d, <i>J</i> = 7.92 Hz, 1 H), 6.74 (d, <i>J</i> = 1.56 Hz, 1 H), 6.64 (dd, <i>J</i> = 7.87, 1.61 Hz, 1 H), 5.93 (d, <i>J</i> = 4.01 Hz, 2 H), 4.92 (d, <i>J</i> = 5.67 Hz, 1 H), 4.80 (dq, <i>J</i> = 49.3, 6.56 Hz, 1 H), 3.91–4.01 (m, 1 H), 3.81–3.91 (m, 1 H), 3.56 (quin, <i>J</i> = 5.80 Hz, 1 H), 2.96 (dd, <i>J</i> = 13.55, 3.67 Hz, 1 H), 2.58–2.66 (m, 3 H), 2.28–2.41 (m, 4 H), 2.15–2.25 (m, 1 H), 2.10 (t, <i>J</i> = 7.97 Hz, 2 H), 1.97–2.06 (m, 1 H), 1.77–1.89 (m, 1 H), 1.59–1.77 (m, 2 H), 1.19 (dd, <i>J</i> = 24.45, 6.65 Hz, 3 H), 0.86 (s, 9 H). MS <i>m</i>/<i>z</i> = 542.4 [M + H]<sup>+</sup>. Calcd for C<sub>30</sub>FH<sub>41</sub>N<sub>3</sub>O<sub>5</sub>: 542.3. LCMS (99%). HRMS (ESI+) calcd for [C<sub>30</sub>FH<sub>40</sub>N<sub>3</sub>O<sub>5</sub> + H]<sup>+</sup>, 542.3025; found, 542.3017.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-fluorobenzamide (<b>24</b>)</h3><div class="NLM_p last">A solution of amine <b>13b</b> (150 mg, 0.26 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was treated sequentially with HATU (99 mg, 0.26 mmol), 2-fluorobenzoic acid (36 mg, 0.26 mmol), and DIPEA (0.23 mL, 1.30 mmol). The reaction was maintained at ambient temperature for 3 h before being quenched with 0.1 mL of 5 N HCl. The mixture was concentrated to dryness and purified by HPLC to provide the title compound (75 mg, 35% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.17 (d, <i>J</i> = 9.29 Hz, 1 H), 7.96 (d, <i>J</i> = 1.96 Hz, 1 H), 7.83 (d, <i>J</i> = 2.05 Hz, 1 H), 7.46–7.56 (m, 1 H), 7.40 (td, <i>J</i> = 7.48, 1.76 Hz, 1 H), 7.20–7.31 (m, 2 H), 6.78–6.90 (m, 2 H), 6.73 (dd, <i>J</i> = 7.92, 1.57 Hz, 1 H), 5.96 (s, 2 H), 5.83 (br s, 1 H), 4.68–4.85 (m, 1 H), 4.05–4.19 (m, 1 H), 3.95–4.06 (m, 1 H), 3.16–3.32 (m, 1 H), 2.98 (dd, <i>J</i> = 13.60, 3.52 Hz, 2 H), 2.70 (dd, <i>J</i> = 14.08, 10.47 Hz, 1 H), 2.60 (dd, <i>J</i> = 13.84, 6.80 Hz, 1 H), 2.35–2.46 (m, 3 H), 2.11–2.27 (m, 3 H), 1.96–2.09 (m, 2 H), 1.80–1.94 (m, 1 H), 1.66–1.80 (m, 1 H), 0.86 (s, 9 H). MS <i>m</i>/<i>z</i> = 590.4 [M + H]<sup>+</sup>. Calcd for C<sub>34</sub>FH<sub>41</sub>N<sub>3</sub>O<sub>5</sub>: 590.3. LCMS (100%). HRMS (ESI+) calcd for [C<sub>34</sub>FH<sub>40</sub>N<sub>3</sub>O<sub>5</sub> + H]<sup>+</sup>, 590.3025; found, 590.3015.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-2-fluoronicotinamide (<b>25</b>)</h3><div class="NLM_p last">The title compound was prepared from amine <b>13b</b> using a method analogous to the preparation of compound <b>24</b>. Yield, 125 mg, 39%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 10.14 (br s, 2 H), 8.91 (s, 1 H), 8.26 (d, <i>J</i> = 17.94 Hz, 2 H), 7.88–8.13 (m, 1 H), 7.52 (s, 1 H), 6.56–6.82 (m, 3 H), 5.88 (s, 2 H), 5.00–5.20 (m, 1 H), 4.39 (dd, <i>J</i> = 7.58, 5.43 Hz, 2 H), 3.35–3.54 (m, 1 H), 2.77–3.21 (m, 6 H), 2.13–2.77 (m, 7 H), 1.93–2.07 (m, 1 H), 1.74–1.93 (m, 1 H), 0.92 (s, 9 H). MS <i>m</i>/<i>z</i> = 591.1 [M + H]<sup>+</sup>. Calcd for C<sub>33</sub>FH<sub>40</sub>N<sub>4</sub>O<sub>5</sub>: 591.3. LCMS (99%). HRMS (ESI+) calcd for [C<sub>33</sub>FH<sub>39</sub>N<sub>4</sub>O<sub>5</sub> + H]<sup>+</sup>, 591.2977; found, 591.2968.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)nicotinamide (<b>26</b>)</h3><div class="NLM_p last">The title compound was prepared from amine <b>13b</b> using a method analogous to the preparation of compound <b>24</b>. Yield, 119 mg, 53%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.11 (br s, 2 H), 8.93 (d, <i>J</i> = 2.25 Hz, 1 H), 8.71 (dd, <i>J</i> = 4.84, 1.61 Hz, 1 H), 8.48 (d, <i>J</i> = 8.90 Hz, 1 H), 8.11 (dt, <i>J</i> = 8.00, 1.92 Hz, 1 H), 7.95 (d, <i>J</i> = 2.05 Hz, 1 H), 7.84 (s, 1 H), 7.52 (dd, <i>J</i> = 8.56, 4.94 Hz, 1 H), 6.86 (d, <i>J</i> = 1.47 Hz, 1 H), 6.71–6.82 (m, 2 H), 5.93 (s, 2 H), 4.72–4.82 (m, 2 H), 4.09–4.19 (m, 1 H), 4.01–4.09 (m, 1 H), 3.23–3.33 (m, 1 H), 2.99 (dd, <i>J</i> = 14.38, 3.52 Hz, 2 H), 2.77 (dd, <i>J</i> = 13.99, 10.86 Hz, 1 H), 2.63 (dd, <i>J</i> = 12.86, 6.31 Hz, 1 H), 2.36–2.47 (m, 4 H), 2.13–2.27 (m, 2 H), 1.97–2.11 (m, 2 H), 1.82–1.95 (m, 1 H), 1.69–1.79 (m, 1 H), 0.85 (s, 9 H). MS <i>m</i>/<i>z</i> = 573.2 [M + H]<sup>+</sup>. Calcd for C<sub>33</sub>H<sub>41</sub>N<sub>4</sub>O<sub>5</sub>: 573.3. LCMS (99%). HRMS (ESI+) calcd for [C<sub>33</sub>H<sub>40</sub>N<sub>4</sub>O<sub>5</sub> + H]<sup>+</sup>, 573.3071; found, 573.3102.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>N</i>-((2<i>S</i>,3<i>R</i>)-1-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-3-hydroxy-4-((<i>S</i>)-6′-neopentyl-3′,4′-dihydrospiro[cyclobutane-1,2′-pyrano[2,3-<i>b</i>]pyridine]-4′-ylamino)butan-2-yl)-6-fluoronicotinamide (<b>27</b>)</h3><div class="NLM_p last">The title compound was prepared from amine <b>13b</b> using a method analogous to the preparation of compound <b>24</b> to provide the title compound as a tris TFA salt. Yield, 162 mg, 66%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.10 (br s, 2 H), 8.61 (d, <i>J</i> = 2.45 Hz, 1 H), 8.49 (d, <i>J</i> = 8.41 Hz, 1 H), 8.29 (td, <i>J</i> = 8.22, 2.45 Hz, 1 H), 8.03–8.09 (m, 1 H), 7.95 (d, <i>J</i> = 1.96 Hz, 1 H), 7.82 (d, <i>J</i> = 1.96 Hz, 1 H), 7.30 (dd, <i>J</i> = 8.61, 2.54 Hz, 1 H), 6.85 (d, <i>J</i> = 1.56 Hz, 1 H), 6.71–6.80 (m, 2 H), 5.93 (s, 3 H), 4.71–4.82 (m, 1 H), 3.99–4.18 (m, 2 H), 3.21–3.31 (m, 1 H), 2.92–3.03 (m, 2 H), 2.74 (dd, <i>J</i> = 13.69, 10.66 Hz, 1 H), 2.62 (dd, <i>J</i> = 13.01, 6.16 Hz, 1 H), 2.31–2.46 (m, 3 H), 2.11–2.27 (m, 1 H), 1.95–2.10 (m, 1 H), 1.81–1.94 (m, 1 H), 1.61–1.81 (m, 1 H), 0.85 (s, 9 H). MS <i>m</i>/<i>z</i> = 591.3 [M + H]<sup>+</sup>. Calcd for C<sub>33</sub>FH<sub>40</sub>N<sub>4</sub>O<sub>5</sub>: 591.3. LCMS (98%). HRMS (ESI+) calcd for [C<sub>33</sub>FH<sub>39</sub>N<sub>4</sub>O<sub>5</sub> + H]<sup>+</sup>, 591.2977; found, 591.2999.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72"><a href="/doi/suppl/10.1021/jm300119p">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83322" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83322" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental section; coordinates for co-crystal of BACE1 + compound <b>21</b>.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300119p/suppl_file/jm300119p_si_001.pdf">jm300119p_si_001.pdf (95.88 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm300119p" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51728" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51728" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew M. Weiss</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3d50504a58544e4e7d5c505a5853135e5250"><span class="__cf_email__" data-cfemail="513c3c263438222211303c36343f7f323e3c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Toni Williamson</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Safura Babu-Khan</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael D. Bartberger</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Brown</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kui Chen</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuan Cheng</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Citron</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael D. Croghan</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas A. Dineen</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joel Esmay</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Russell F. Graceffa</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott S. Harried</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dean Hickman</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen A. Hitchcock</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel B. Horne</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongbing Huang</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronke Imbeah-Ampiah</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ted Judd</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew R. Kaller</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles R. Kreiman</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel S. La</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vivian Li</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patricia Lopez</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Louie</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Holger Monenschein</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas T. Nguyen</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lewis D. Pennington</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claire Rattan</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tisha San Miguel</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">E.Allen  Sickmier</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert C. Wahl</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul H. Wen</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Wood</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiufen Xue</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryant H. Yang</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vinod F. Patel</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenge Zhong</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Chemistry Research and Discovery, ‡Neuroscience, §HTS Molecular Pharmacology, ∥Molecular Structure, ⊥Pharmacokinetics
and Drug Metabolism, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States,
and One Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d240e6013-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55235" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55235" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Larry Miller for analytical support. We also thank Douglas Whittington for generating crystallographic figures presented in the manuscript. The Advanced Light Source is supported by the U.S. Department of Energy under contract no. DE-AC02-05CH11231.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i74" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i74"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i75" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i75"> Abbreviations Used</h2><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">β-amyloid</p></td></tr><tr><td class="NLM_term">HEA</td><td class="NLM_def"><p class="first last">hydroxythethyl amine</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">BACE1</td><td class="NLM_def"><p class="first last">β-site APP cleaving enzyme</p></td></tr><tr><td class="NLM_term">Pgp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48122" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48122" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Alzheimer’s Association</span><span class="NLM_x">. </span><span> </span><span class="NLM_article-title">Alzheimer’s disease facts and figures</span>.  <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=20298981" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=158-194&issue=6&author=Alzheimer%E2%80%99s+Association&title=Alzheimer%E2%80%99s+disease+facts+and+figures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520facts%2520and%2520figures%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2010%26issue%3D6%26spage%3D158%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Translating cell biology into therapeutic advances in Alzheimer’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">399</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 6738</span><span class="NLM_x">) </span> <span class="NLM_fpage">A23</span><span class="NLM_x">–</span> <span class="NLM_lpage">A31</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=1999&pages=A23-A31&issue=Suppl.+6738&author=D.+J.+Selkoe&title=Translating+cell+biology+into+therapeutic+advances+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DTranslating%2520cell%2520biology%2520into%2520therapeutic%2520advances%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D1999%26volume%3D399%26issue%3DSuppl.%25206738%26spage%3DA23%26epage%3DA31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cummings, J. L.</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1056%2FNEJMra040223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=15229308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltlOjsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2004&pages=56-67&author=J.+L.+Cummings&title=Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Cummings, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-67</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review on Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE6JT2vPzAVrVg90H21EOLACvtfcHk0ljmdEiJZgMnbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltlOjsb8%253D&md5=ec3a7d85cdfbeb7ea5cfaeeefc3a94ad</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1056%2FNEJMra040223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra040223%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D351%26spage%3D56%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Querfurth, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1056%2FNEJMra0909142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=20107219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=329-344&author=H.+W.+Querfurthauthor=F.+M.+LaFerla&title=Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Querfurth, Henry W.; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-344</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The role of β-amyloid peptide in spontaneous self-aggregation in brain in Alzheimer's disease is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPeniV_Jn6orVg90H21EOLACvtfcHk0ljmdEiJZgMnbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D&md5=c116f6a6b8fed9af9f5282cc4b755c70</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0909142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0909142%26sid%3Dliteratum%253Aachs%26aulast%3DQuerfurth%26aufirst%3DH.%2BW.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D329%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Leon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2006&pages=387-403&author=K.+Blennowauthor=M.+J.+de+Leonauthor=H.+Zetterberg&title=Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3Dde%2BLeon%26aufirst%3DM.%2BJ.%26aulast%3DZetterberg%26aufirst%3DH.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2006%26volume%3D368%26spage%3D387%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Williams, M.</span><span> </span><span class="NLM_article-title">Progress in Alzheimer’s disease drug discovery: an update</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=23-34&author=M.+Williams&title=Progress+in+Alzheimer%E2%80%99s+disease+drug+discovery%3A+an+update"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DProgress%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520drug%2520discovery%253A%2520an%2520update%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D23%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Goedert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillantini, M. G.</span><span> </span><span class="NLM_article-title">A century of Alzheimer’s Disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=777-781&author=M.+Goedertauthor=M.+G.+Spillantini&title=A+century+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26atitle%3DA%2520century%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D777%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+Amyloid+Hypothesis+of+Alzheimer%E2%80%99s+Disease%3A+Progress+and+Problems+on+the+Road+to+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lhGx42JiXPihA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Amyloid%2520Hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Progress%2520and%2520Problems%2520on%2520the%2520Road%2520to%2520Therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Prasher, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessling, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, E. M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barber, S. P. C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, A. C.</span><span> </span><span class="NLM_article-title">Molecular Mapping of Iiv Alzheimer-Type Dementia in Down’s Syndrome</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1002%2Fana.410430316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=9506555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADyaK1cXitFart7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1998&pages=380-383&author=V.+P.+Prasherauthor=M.+J.+Farrerauthor=A.+M.+Kesslingauthor=E.+M.+C.+Fisherauthor=R.+J.+Westauthor=S.+P.+C+Barberauthor=A.+C.+Butler&title=Molecular+Mapping+of+Iiv+Alzheimer-Type+Dementia+in+Down%E2%80%99s+Syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mapping of Alzheimer-type dementia in Down's syndrome</span></div><div class="casAuthors">Prasher, V. P.; Farrer, Matthew J.; Kessling, Anna M.; Fisher, Elizabeth M. C.; West, R. J.; Barber, P. C.; Butler, A. C.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">380-383</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">Previous research has hypothesized an assocn. between Alzheimer's disease and the amyloid precursor protein (APP) gene found on chromosome 21.  The case of a 78-yr-old woman with Down's syndrome with partial trisomy 21 [46,XX,rec(21)dup q, inv(21) (p12q22.1)] is reported.  No evidence of Alzheimer's disease was found on neuropsychol., magnetic resonance imaging, and neuropathol. assessment.  The gene sequence for APP was present in only two copies.  This case further supports the hypothesis that Alzheimer's disease is assocd. with trisomy for proximal chromosome 21q, including the APP gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWqCnda6vForVg90H21EOLACvtfcHk0lhGx42JiXPihA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitFart7g%253D&md5=0a2aa8d05adbcd573235f12d2ab4f8da</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1002%2Fana.410430316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410430316%26sid%3Dliteratum%253Aachs%26aulast%3DPrasher%26aufirst%3DV.%2BP.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26aulast%3DKessling%26aufirst%3DA.%2BM.%26aulast%3DFisher%26aufirst%3DE.%2BM.%2BC.%26aulast%3DWest%26aufirst%3DR.%2BJ.%26aulast%3DBarber%26aufirst%3DS.%2BP.%2BC%26aulast%3DButler%26aufirst%3DA.%2BC.%26atitle%3DMolecular%2520Mapping%2520of%2520Iiv%2520Alzheimer-Type%2520Dementia%2520in%2520Down%25E2%2580%2599s%2520Syndrome%26jtitle%3DAnn.%2520Neurol.%26date%3D1998%26volume%3D43%26spage%3D380%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">BACE1: The β-Secretase Enzyme in Alzheimer’s Disease</span> <span class="citation_source-journal">J. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">1–2</span><span class="NLM_x">) </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1385%2FJMN%3A23%3A1-2%3A105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=15126696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks12jtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=105-114&issue=1%E2%80%932&author=R.+Vassar&title=BACE1%3A+The+%CE%B2-Secretase+Enzyme+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1. The β-secretase enzyme in Alzheimer's disease</span></div><div class="casAuthors">Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">105-113</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Data that have accumulated for well over a decade have implicated the β-amyloid (Aβ) peptide as a central player in the pathogenesis of Alzheimer's disease (AD).  Amyloid plaques, composed primarily of Aβ progressively form in the brains of AD patients, and mutations in three genes (amyloid precursor protein [APP] and presenilin 1 and 2 [PS1 and PS2]) cause early-onset familial AD (FAD) by directly increasing prodn. of the toxic, plaque-promoting Aβ42 peptide.  Given the strong assocn. between Aβ and AD, it is likely that therapeutic strategies to lower the levels of Aβ in the brain should prove beneficial for the treatment of AD.  One such strategy could involve inhibiting the enzymes that generate Aβ.  Aβ is a product of catabolism of the large type-I membrane protein APP.  Two proteases, called β- and γ-secretase, endoproteolyzed APP to liberate the Aβ peptide.  Recently, the mols. responsible for these proteolytic activities have been identified.  Several lines of evidence suggest that the PS1 and PS2 proteins are γ-secretase, and the identity of β-secretase has been shown to be the novel transmembrane aspartic protease, β-site APP-cleaving enzyme 1 (BACE1; also called Asp2 and memapsin 2).  BACE2, a protease homologous to BACE1, was also identified, and together the two enzymes define a new family of transmembrane aspartic proteases.  BACE1 exhibits all the functional properties of β-secretase, and as the key enzyme that initiates the formation of Aβ, BACE1 is an attractive drug target for AD.  This review discusses the identification and initial characterization of BACE1 and BACE2, and summarizes recent studies of BACE1 knockout mice that have validated BACE1 as the authentic β-secretase in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzcKcTBX0jSLVg90H21EOLACvtfcHk0lizD9Nyeuv-ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks12jtr4%253D&md5=374a70b4cb76ebda767218550a6601a2</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1385%2FJMN%3A23%3A1-2%3A105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FJMN%253A23%253A1-2%253A105%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DBACE1%253A%2520The%2520%25CE%25B2-Secretase%2520Enzyme%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2004%26volume%3D23%26issue%3D1%25E2%2580%25932%26spage%3D105%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberburg, I.</span><span> </span><span class="NLM_article-title">Cellular mechanisms of β-amyloid production and secretion</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">11049</span><span class="NLM_x">–</span> <span class="NLM_lpage">11053</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1073%2Fpnas.96.20.11049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=10500121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADyaK1MXmvVCntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=11049-11053&author=S.+Sinhaauthor=I.+Lieberburg&title=Cellular+mechanisms+of+%CE%B2-amyloid+production+and+secretion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular mechanisms of β-amyloid production and secretion</span></div><div class="casAuthors">Sinha, Sukanto; Lieberburg, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11049-11053</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review with 46 refs.  The major constituent of senile plaques in Alzheimer's disease is a 42-aa peptide, referred to as β-amyloid (Aβ).  Aβ is generated from a family of differentially spliced, type-1 transmembrane domain (TM)-contg. proteins, called APP, by endoproteolytic processing.  The major, relatively ubiquitous pathway of APP metab. in cell culture involves cleavage by α-secretase, which cleaves within the Aβ sequence, thus precluding Aβ formation and deposition.  An alternate secretory pathway, enriched in neurons and brain, leads to cleavage of APP at the N terminus of the Aβ peptide by β-secretase, thus generating a cell-assocd. β-C-terminal fragment (β-CTF).  A pathogenic mutation at codons 670/671 in APP (APP "Swedish") leads to enhanced cleavage at the β-secretase scissile bond and increased Aβ formation.  An inhibitor of vacuolar ATPase, bafilomycin, selectively inhibits the action of β-secretase in cell culture, suggesting a requirement for an acidic intracellular compartment for effective β-secretase cleavage of APP.  β-CTF is cleaved in the TM domain by γ-secretase(s), generating both Aβ 1-40 (90%) and Aβ 1-42 (10%).  Pathogenic mutations in APP at codon 717 (APP "London") lead to an increased proportion of Aβ 1-42 being produced and secreted.  Missense mutations in PS-1, localized to chromosome 14, are pathogenic in the majority of familial Alzheimer's pedigrees.  These mutations also lead to increased prodn. of Aβ 1-42 over Aβ 1-40.  Knockout of PS-1 in transgenic animals leads to significant inhibition of prodn. of both Aβ 1-40 and Aβ 1-42 in primary cultures, indicating that PS-1 expression is important for γ-secretase cleavages.  Peptide aldehyde inhibitors that block Aβ prodn. by inhibiting γ-secretase cleavage of β-CTF have been discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy2KZEsg4xkrVg90H21EOLACvtfcHk0lizD9Nyeuv-ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvVCntLc%253D&md5=7a48271061bce0b2aee1a60fd305662d</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.20.11049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.20.11049%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DLieberburg%26aufirst%3DI.%26atitle%3DCellular%2520mechanisms%2520of%2520%25CE%25B2-amyloid%2520production%2520and%2520secretion%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D11049%26epage%3D11053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">beta-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease bace</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=beta-Secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+bace"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0lizD9Nyeuv-ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3Dbeta-Secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520bace%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintzer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, J. L.</span><span> </span><span class="NLM_article-title">Disease-modifying therapies in Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1016%2Fj.jalz.2007.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=18631951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlSmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=65-79&author=S.+Sallowayauthor=J.+Mintzerauthor=M.+F.+Weinerauthor=J.+L.+Cummings&title=Disease-modifying+therapies+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Disease-modifying therapies in Alzheimer's disease</span></div><div class="casAuthors">Salloway, Stephen; Mintzer, Jacobo; Weiner, Myron F.; Cummings, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & Dementia</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">65-79</span>CODEN:
                <span class="NLM_cas:coden">ADLEBN</span>;
        ISSN:<span class="NLM_cas:issn">1552-5260</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a chronic, progressive, neurodegenerative disorder that places a substantial burden on patients, their families, and society.  The disease affects approx. 5 million individuals in the United States, with an annual cost of care greater than $100 billion.  During the past dozen years, several agents have been approved that enhance cognition and global function of AD patients, and recent advances in understanding AD pathogenesis has led to the development of numerous compds. that might modify the disease process.  A wide array of antiamyloid and neuroprotective therapeutic approaches are under investigation on the basis of the hypothesis that amyloid beta (Aβ) protein plays a pivotal role in disease onset and progression and that secondary consequences of Aβ generation and deposition, including tau hyperphosphorylation and neurofibrillary tangle formation, oxidn., inflammation, and excitotoxicity, contribute to the disease process.  Interventions in these processes with agents that reduce amyloid prodn., limit aggregation, or increase removal might block the cascade of events comprising AD pathogenesis.  Reducing tau hyperphosphorylation, limiting oxidn. and excitotoxicity, and controlling inflammation might be beneficial disease-modifying strategies.  Potentially neuroprotective and restorative treatments such as neurotrophins, neurotrophic factor enhancers, and stem cell-related approaches are also under investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDVz15jwhEbrVg90H21EOLACvtfcHk0ljEfsryE8n78A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlSmtb0%253D&md5=626e36a2b80a383e57173f52e7722a86</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2007.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2007.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DMintzer%26aufirst%3DJ.%26aulast%3DWeiner%26aufirst%3DM.%2BF.%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26atitle%3DDisease-modifying%2520therapies%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2008%26volume%3D4%26spage%3D65%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: strategies for disease modification</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=387-398&author=M.+Citron&title=Alzheimer%E2%80%99s+disease%3A+strategies+for+disease+modification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520strategies%2520for%2520disease%2520modification%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D387%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T.</span><span> </span><span class="NLM_article-title">The secretases: enzymes with therapeutic potential in Alzheimer disease</span> <span class="citation_source-journal">Nature Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1038%2Fnrneurol.2009.218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=20139999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=99-107&author=B.+De+Strooperauthor=R.+Vassarauthor=T.+Golde&title=The+secretases%3A+enzymes+with+therapeutic+potential+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">The secretases: enzymes with therapeutic potential in Alzheimer disease</span></div><div class="casAuthors">De Strooper, Bart; Vassar, Robert; Golde, Todd</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-107</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The three secretases that process amyloid precursor protein are central to the generation of amyloid-β, and the accumulation of this peptide in extracellular plaques is one of the hallmarks of Alzheimer disease.  In this Review, De Strooper et al. discuss the evidence that suggests that these enzymes are potential therapeutic targets for Alzheimer disease drug treatments.  The amyloid hypothesis has yielded a series of well-validated candidate drug targets with potential for the treatment of Alzheimer disease (AD).  Three proteases that are involved in the processing of amyloid precursor protein-α-secretase, β-secretase and γ-secretase-are of particular interest as they are central to the generation and modulation of amyloid-β peptide and can be targeted by small compds. in vitro and in vivo.  Given that these proteases also fulfill other important biol. roles, inhibiting their activity will clearly be inherently assocd. with mechanism-based toxicity.  Carefully detg. a suitable therapeutic window and optimizing the selectivity of the drug treatments towards amyloid precursor protein processing might be ways of overcoming this potential complication.  Secretase inhibitors are likely to be the first small-mol. therapies aimed at AD modification that will be fully tested in the clinic.  Success or failure of these first-generation AD therapies will have enormous consequences for further drug development efforts for AD and possibly other neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBldqS_TKy7Vg90H21EOLACvtfcHk0ljEfsryE8n78A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D&md5=40135a0a59da6b70e4856a81ddfa6088</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2009.218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2009.218%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DGolde%26aufirst%3DT.%26atitle%3DThe%2520secretases%253A%2520enzymes%2520with%2520therapeutic%2520potential%2520in%2520Alzheimer%2520disease%26jtitle%3DNature%2520Rev.%2520Neurol.%26date%3D2010%26volume%3D6%26spage%3D99%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">beta-Secretase inhibition for the treatment of Alzheimer’s disease—promise and challenge</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=92-97&author=M.+Citron&title=beta-Secretase+inhibition+for+the+treatment+of+Alzheimer%E2%80%99s+disease%E2%80%94promise+and+challenge"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3Dbeta-Secretase%2520inhibition%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%25E2%2580%2594promise%2520and%2520challenge%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2004%26volume%3D25%26spage%3D92%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="note"><p class="first last">For recent reviews and work in this area, please see the following:</p></div><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=560-574&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D560%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Design and Synthesis of 5,5′-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901414e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1146-1158&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=S.+Jacobsenauthor=R.+L.+Magoldaauthor=M.+Pangalosauthor=A.+J.+Robichaud&title=Design+and+Synthesis+of+5%2C5%E2%80%B2-Disubstituted+Aminohydantoins+as+Potent+and+Selective+Human+%CE%B2-Secretase+%28BACE1%29+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 5,5'-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Erdei, Jim; Gunawan, Iwan; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Jacobsen, Steve; Magolda, Ronald L.; Pangalos, Menelas; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1146-1158</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit low nanomolar potency for BACE1, show comparable activity in a cell-based (ELISA) assay, and demonstrate > 100 × selectivity for the other structurally related aspartyl proteases BACE2, cathepsinD, renin, and pepsin.  On the basis of the cocrystal structure of the HTS-hit I in the BACE1 active site and by use of a structure-based drug design approach, we methodically explored the comparatively large binding pocket of the BACE1 enzyme and identified key interactions between the ligand and the protein that contributed to the affinity.  One of the more potent compds., (S)-II, displayed an IC50 value for BACE1 of 10 nM and exhibited comparable cellular activity (EC50 = 20 nM) in the ELISA assay.  Acute oral administration of (S)-II at 100 mg/kg resulted in a 69% redn. of plasma Aβ40 at 8 h in a Tg2576 mouse (p < 0.001).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovSHqfBBe70bVg90H21EOLACvtfcHk0li2PzX3oHDfFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN&md5=a27e4fbd64ed167ca7baae773c178fbc</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Fjm901414e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901414e%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520Synthesis%2520of%25205%252C5%25E2%2580%25B2-Disubstituted%2520Aminohydantoins%2520as%2520Potent%2520and%2520Selective%2520Human%2520%25CE%25B2-Secretase%2520%2528BACE1%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1146%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, O</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurlino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gool, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. T.</span><span> </span><span class="NLM_article-title">Rational design and synthesis of aminopiperazinones as β-secretase (BACE) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7255</span><span class="NLM_x">–</span> <span class="NLM_lpage">7260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=7255-7260&author=G.+Tresadernauthor=F.+Delgadoauthor=O+Delgadoauthor=H.+Gijsenauthor=G.+J.+Macdonaldauthor=D.+Moecharsauthor=F.+Romboutsauthor=R.+Alexanderauthor=J.+Spurlinoauthor=M.+V.+Goolauthor=J.+A.+Vegaauthor=A.+T.+Trabanco&title=Rational+design+and+synthesis+of+aminopiperazinones+as+%CE%B2-secretase+%28BACE%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DF.%26aulast%3DDelgado%26aufirst%3DO%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DGool%26aufirst%3DM.%2BV.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3DTrabanco%26aufirst%3DA.%2BT.%26atitle%3DRational%2520design%2520and%2520synthesis%2520of%2520aminopiperazinones%2520as%2520%25CE%25B2-secretase%2520%2528BACE%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D7255%26epage%3D7260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Boy, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guernon, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tebben, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muckelbauer, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camac, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. A.,  III.</span><span> </span><span class="NLM_article-title">Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of b-secretase (BACE)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6916</span><span class="NLM_x">–</span> <span class="NLM_lpage">6924</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6916-6924&author=K.+M.+Boyauthor=J.+M.+Guernonauthor=J.+Shiauthor=J.+H.+Toynauthor=J.+E.+Meredithauthor=D.+M.+Bartenauthor=C.+R.+Burtonauthor=C.+F.+Albrightauthor=J.+Marcinkevicieneauthor=A.+C.+Goodauthor=A.+J.+Tebbenauthor=J.+K.+Muckelbauerauthor=D.+M.+Camacauthor=K.+A.+Lentzauthor=J.+J.+Bronsonauthor=R.+E.+Olsonauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Monosubstituted+%CE%B3-lactam+and+conformationally+constrained+1%2C3-diaminopropan-2-ol+transition-state+isostere+inhibitors+of+b-secretase+%28BACE%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoy%26aufirst%3DK.%2BM.%26aulast%3DGuernon%26aufirst%3DJ.%2BM.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DMeredith%26aufirst%3DJ.%2BE.%26aulast%3DBarten%26aufirst%3DD.%2BM.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DTebben%26aufirst%3DA.%2BJ.%26aulast%3DMuckelbauer%26aufirst%3DJ.%2BK.%26aulast%3DCamac%26aufirst%3DD.%2BM.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DMonosubstituted%2520%25CE%25B3-lactam%2520and%2520conformationally%2520constrained%25201%252C3-diaminopropan-2-ol%2520transition-state%2520isostere%2520inhibitors%2520of%2520b-secretase%2520%2528BACE%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6916%26epage%3D6924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Swahn, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plobeck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehgelmeble, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as BACE-1 inhibitors: The challenge to achieve in vivo brain efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1854</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1854-1859&author=B.+M.+Swahnauthor=J.+Holenzauthor=J.+Kihlstr%C3%B6mauthor=K.+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=N.+Plobeckauthor=D.+Rotticciauthor=F.+Sehgelmebleauthor=M.+Sundstr%C3%B6mauthor=S.+von+Bergauthor=J.+F%C3%A4ltingauthor=B.+Georgievskaauthor=S.+Gustavssonauthor=J.+Neelissenauthor=M.+Ekauthor=L.+L.+Olssonauthor=S.+Berg&title=Aminoimidazoles+as+BACE-1+inhibitors%3A+The+challenge+to+achieve+in+vivo+brain+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.%2BM.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DPlobeck%26aufirst%3DN.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DEk%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DBerg%26aufirst%3DS.%26atitle%3DAminoimidazoles%2520as%2520BACE-1%2520inhibitors%253A%2520The%2520challenge%2520to%2520achieve%2520in%2520vivo%2520brain%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1854%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2444</span><span class="NLM_x">–</span> <span class="NLM_lpage">2449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1016%2Fj.bmcl.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=22390835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2444-2449&author=J.+N.+Cummingauthor=E.+M.+Smithauthor=L.+Wangauthor=J.+Misiaszekauthor=J.+Durkinauthor=J.+Panauthor=U.+Iserlohauthor=Y.+Wuauthor=Z.+Zhuauthor=C.+Stricklandauthor=J.+Voigtauthor=X.+Chenauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=M.+F.+Czarnieckiauthor=W.+J.+Greenleeauthor=B.+A.+McKittrickauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Structure+based+design+of+iminohydantoin+BACE1+inhibitors%3A+identification+of+an+orally+available%2C+centrally+active+BACE1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6fR"><div class="casContent"><span class="casTitleNuber">6f</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor</span></div><div class="casAuthors">Cumming, Jared N.; Smith, Elizabeth M.; Wang, Lingyan; Misiaszek, Jeffrey; Durkin, James; Pan, Jianping; Iserloh, Ulrich; Wu, Yusheng; Zhu, Zhaoning; Strickland, Corey; Voigt, Johannes; Chen, Xia; Kennedy, Matthew E.; Kuvelkar, Reshma; Hyde, Lynn A.; Cox, Kathleen; Favreau, Leonard; Czarniecki, Michael F.; Greenlee, William J.; McKittrick, Brian A.; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2444-2449</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">From an initial lead 2-imino-1-methyl-4,4-diphenyl-5-imidazolidinone, a structure-based design approach led to identification of the novel, high-affinity iminohydantoin BACE1 inhibitor I that lowers CNS-derived Aβ following oral administration to rats.  SAR development in the S3 and F' subsites of BACE1 for this series, the synthetic approaches employed in this effort, and in vivo data for I are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tWBE09QKNLVg90H21EOLACvtfcHk0lhxSfj9Nt0u3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D&md5=783b6cb9a6d9608ff5e9dc4f5d634397</span></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCzarniecki%26aufirst%3DM.%2BF.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure%2520based%2520design%2520of%2520iminohydantoin%2520BACE1%2520inhibitors%253A%2520identification%2520of%2520an%2520orally%2520available%252C%2520centrally%2520active%2520BACE1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2444%26epage%3D2449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Kaller, M. M.; Harried, S. S.; Albrecht, B.; Amarante, P.; Babu-Khan, S.; Bartberger, M. D.; Brown, J.; Chen, K.; Cheng, Y.; Citron, M.; Croghan, M. D.; Dunn, R.; Graceffa, R.; Hickman, D.; Judd, T.; Kreiman, C.; La, D.; Lopez, P.; Luo, Y.; Masse, C.; Monenschein, H.; Nguyen, T.; Pennington, L. D.; San Miguel, T.; Wahl, R. C.; Weiss, M. M.; Wen, P. H.; Williamson, T.; Wood, S.; Xue, M.; Yang, B.; Zhang, J.; Patel, V.; Zhong, W.; Hitchcock, S.</span><span> </span><span class="NLM_article-title">A potent and orally efficacious, hydroxyethylamine based inhibitor of beta-secretase</span>.  <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span><div class="note"><p class="first last">submitted for publication</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+M.+Kaller&author=S.+S.+Harried&author=B.+Albrecht&author=P.+Amarante&author=S.+Babu-Khan&author=M.+D.+Bartberger&author=J.+Brown&author=K.+Chen&author=Y.+Cheng&author=M.+Citron&author=M.+D.+Croghan&author=R.+Dunn&author=R.+Graceffa&author=D.+Hickman&author=T.+Judd&author=C.+Kreiman&author=D.+La&author=P.+Lopez&author=Y.+Luo&author=C.+Masse&author=H.+Monenschein&author=T.+Nguyen&author=L.+D.+Pennington&author=T.+San+Miguel&author=R.+C.+Wahl&author=M.+M.+Weiss&author=P.+H.+Wen&author=T.+Williamson&author=S.+Wood&author=M.+Xue&author=B.+Yang&author=J.+Zhang&author=V.+Patel&author=W.+Zhong&author=S.+Hitchcock&title=A+potent+and+orally+efficacious%2C+hydroxyethylamine+based+inhibitor+of+beta-secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaller%26aufirst%3DM.%2BM.%26atitle%3DA%2520potent%2520and%2520orally%2520efficacious%252C%2520hydroxyethylamine%2520based%2520inhibitor%2520of%2520beta-secretase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Harried, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reider, P. J.</span><span> </span><span class="NLM_article-title">Stereoselective synthesis of <i>anti</i>-N-protected 3-amino-1,2-epoxides by nucleophillic addition to <i>N</i>-<i>tert</i>-butanesulfinyl imine of a glyceraldehydes synthon</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">5975</span><span class="NLM_x">–</span> <span class="NLM_lpage">5982</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo900643b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=5975-5982&issue=16&author=S.+S.+Harriedauthor=M.+D.+Croghanauthor=M.+R.+Kallerauthor=P.+Lopezauthor=W.+Zhongauthor=R.+Hungateauthor=P.+J.+Reider&title=Stereoselective+synthesis+of+anti-N-protected+3-amino-1%2C2-epoxides+by+nucleophillic+addition+to+N-tert-butanesulfinyl+imine+of+a+glyceraldehydes+synthon"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjo900643b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo900643b%26sid%3Dliteratum%253Aachs%26aulast%3DHarried%26aufirst%3DS.%2BS.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DReider%26aufirst%3DP.%2BJ.%26atitle%3DStereoselective%2520synthesis%2520of%2520anti-N-protected%25203-amino-1%252C2-epoxides%2520by%2520nucleophillic%2520addition%2520to%2520N-tert-butanesulfinyl%2520imine%2520of%2520a%2520glyceraldehydes%2520synthon%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26issue%3D16%26spage%3D5975%26epage%3D5982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M.</span><span> </span><span class="NLM_article-title">Using the Golden Triangle to optimize clearance and oral absorption</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5560</span><span class="NLM_x">–</span> <span class="NLM_lpage">5564</span><div class="note"><p class="first last">and references therein</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1016%2Fj.bmcl.2009.08.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=19720530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5560-5564&author=T.+W.+Johnsonauthor=K.+R.+Dressauthor=M.+Edwards&title=Using+the+Golden+Triangle+to+optimize+clearance+and+oral+absorption"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Using the Golden Triangle to optimize clearance and oral absorption</span></div><div class="casAuthors">Johnson, Ted W.; Dress, Klaus R.; Edwards, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5560-5564</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Golden Triangle is a visualization tool developed from in vitro permeability, in vitro clearance and computational data designed to aid medicinal chemists in achieving metabolically stable, permeable and potent drug candidates.  Classifying compds. as permeable and stable and plotting mol. wt. (MW) vs. octanol:buffer (pH 7.4) distribution coeffs. (log D) or estd. octanol:buffer (pH 7.4) distribution coeffs. (elog D) reveals useful trends.  Anal. of at least 2 orthogonal trends, such as permeability and clearance, can be extremely effective in balancing and optimizing multiple properties.  In addn., mol. wt. and log D impact potency-efficiency calcns., allowing potency, clearance and permeability to be optimized simultaneously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjGjEaOp0237Vg90H21EOLACvtfcHk0ljvCw2krFLsmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE&md5=3cfed1288ec451eb4419f1db753ae4b4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.045%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DUsing%2520the%2520Golden%2520Triangle%2520to%2520optimize%2520clearance%2520and%2520oral%2520absorption%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5560%26epage%3D5564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="note"><p class="first last">Metabolite identification studies demonstrated that the primary sites of oxidative metabolism were in the neopentyl fragment.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Kumagai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuto, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, A. K.</span><span> </span><span class="NLM_article-title">Disposition of Methylenedioxyphenyl Compounds</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span><div class="note"><p class="first last">and references therein</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=254-261&author=Y.+Kumagaiauthor=J.+M.+Fukutoauthor=A.+K.+Cho&title=Disposition+of+Methylenedioxyphenyl+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumagai%26aufirst%3DY.%26aulast%3DFukuto%26aufirst%3DJ.%2BM.%26aulast%3DCho%26aufirst%3DA.%2BK.%26atitle%3DDisposition%2520of%2520Methylenedioxyphenyl%2520Compounds%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D1994%26volume%3D4%26spage%3D254%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Murray, M.</span><span> </span><span class="NLM_article-title">Methylenedioxyphenyl insecticide synergists as potential human health hazards</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.2174%2F1389200003339270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=11467081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlt1Whurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=67-84&author=M.+Murray&title=Methylenedioxyphenyl+insecticide+synergists+as+potential+human+health+hazards"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation</span></div><div class="casAuthors">Murray, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-84</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with 110 refs.  Cytochrome P 450 (CYP) enzymes catalyze the oxidative conversion of drugs and other lipophilic compds. to hydrophilic metabolites.  Thus, CYPs play a dominant role in the elimination of drugs from the body.  Inhibitory interactions occur when drugs compete for oxidn. by specific CYPs, whereas certain drugs increase the capacity for oxidative biotransformation by inducing the synthesis of new CYPs.  Methylenedioxyphenyl (MDP) compds. have been widely employed as com. important pesticide synergists and a no. of derivs. are found in oils and spices.  MDP compds. are of considerable toxicol. significance because of their capacity to inhibit and induce CYP enzymes in mammals; some derivs. produce neurotoxic and hepatotoxic effects.  Although there are relatively few therapeutic agents of present clin. importance that possess the MDP structural feature, the synthesis and preclin. evaluation of such agents appears to be increasing.  In the context of the existing literature surrounding MDP compds. it is noteworthy that these potential drugs also elicit significant modulatory effects on CYP activities in rat and human liver.  These developments indicate the importance of understanding the chem. mechanisms by which MDPs interact with CYPs.  Thus, the presence of the MDP structure may undermine the potential clin. value of new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYAjGf6nf5ZbVg90H21EOLACvtfcHk0ljvCw2krFLsmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlt1Whurs%253D&md5=dcafc824c8bcd0080d256d6dd8c50ae7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F1389200003339270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200003339270%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DM.%26atitle%3DMethylenedioxyphenyl%2520insecticide%2520synergists%2520as%2520potential%2520human%2520health%2520hazards%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2000%26volume%3D1%26spage%3D67%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Koudriakova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iatsimirskaia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utkin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vouros, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storozhuk, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orza, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, N.</span><span> </span><span class="NLM_article-title">Modulation of Drug Metabolism and Antiviral Therapies</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1998&pages=552-561&author=T.+Koudriakovaauthor=E.+Iatsimirskaiaauthor=I.+Utkinauthor=E.+Ganglauthor=P.+Vourosauthor=E.+Storozhukauthor=D.+Orzaauthor=J.+Marininaauthor=N.+Gerber&title=Modulation+of+Drug+Metabolism+and+Antiviral+Therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DIatsimirskaia%26aufirst%3DE.%26aulast%3DUtkin%26aufirst%3DI.%26aulast%3DGangl%26aufirst%3DE.%26aulast%3DVouros%26aufirst%3DP.%26aulast%3DStorozhuk%26aufirst%3DE.%26aulast%3DOrza%26aufirst%3DD.%26aulast%3DMarinina%26aufirst%3DJ.%26aulast%3DGerber%26aufirst%3DN.%26atitle%3DModulation%2520of%2520Drug%2520Metabolism%2520and%2520Antiviral%2520Therapies%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1998%26volume%3D26%26spage%3D552%26epage%3D561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Acosta, E. P.</span><span> </span><span class="NLM_article-title">Pharmacokinetic enhancement of protease inhibitors</span> <span class="citation_source-journal">JAIDS, J. Acquired Immune Defic. Syndr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">S11</span><span class="NLM_x">–</span> <span class="NLM_lpage">S18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2002&pages=S11-S18&author=E.+P.+Acosta&title=Pharmacokinetic+enhancement+of+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAcosta%26aufirst%3DE.%2BP.%26atitle%3DPharmacokinetic%2520enhancement%2520of%2520protease%2520inhibitors%26jtitle%3DJAIDS%252C%2520J.%2520Acquired%2520Immune%2520Defic.%2520Syndr.%26date%3D2002%26volume%3D29%26spage%3DS11%26epage%3DS18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rathbun, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, D. R.</span><span> </span><span class="NLM_article-title">Low-Dose Ritonavir for Protease Inhibitor Pharmacokinetic Enhancement</span> <span class="citation_source-journal">Ann. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=702-706&author=R.+C.+Rathbunauthor=D.+R.+Rossi&title=Low-Dose+Ritonavir+for+Protease+Inhibitor+Pharmacokinetic+Enhancement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRathbun%26aufirst%3DR.%2BC.%26aulast%3DRossi%26aufirst%3DD.%2BR.%26atitle%3DLow-Dose%2520Ritonavir%2520for%2520Protease%2520Inhibitor%2520Pharmacokinetic%2520Enhancement%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2002%26volume%3D36%26spage%3D702%26epage%3D706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kempf, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denissen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukulka, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granneman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroldi, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzuti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norbeck, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J. M.</span><span> </span><span class="NLM_article-title">Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">654</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1997&pages=654-660&author=D.+J.+Kempfauthor=K.+C.+Marshauthor=G.+Kumarauthor=A.+D.+Rodriguesauthor=J.+F.+Denissenauthor=E.+McDonaldauthor=M.+J.+Kukulkaauthor=A.+Hsuauthor=G.+R.+Grannemanauthor=P.+A.+Baroldiauthor=E.+Sunauthor=D.+Pizzutiauthor=J.+J.+Plattnerauthor=D.+W.+Norbeckauthor=J.+M.+Leonard&title=Pharmacokinetic+enhancement+of+inhibitors+of+the+human+immunodeficiency+virus+protease+by+coadministration+with+ritonavir"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DKumar%26aufirst%3DG.%26aulast%3DRodrigues%26aufirst%3DA.%2BD.%26aulast%3DDenissen%26aufirst%3DJ.%2BF.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DKukulka%26aufirst%3DM.%2BJ.%26aulast%3DHsu%26aufirst%3DA.%26aulast%3DGranneman%26aufirst%3DG.%2BR.%26aulast%3DBaroldi%26aufirst%3DP.%2BA.%26aulast%3DSun%26aufirst%3DE.%26aulast%3DPizzuti%26aufirst%3DD.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DNorbeck%26aufirst%3DD.%2BW.%26aulast%3DLeonard%26aufirst%3DJ.%2BM.%26atitle%3DPharmacokinetic%2520enhancement%2520of%2520inhibitors%2520of%2520the%2520human%2520immunodeficiency%2520virus%2520protease%2520by%2520coadministration%2520with%2520ritonavir%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1997%26volume%3D41%26spage%3D654%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="note"><p class="first last">HMG CoA reductase inhibitors are commonly used by the elderly population. Within this class of inhibitors, pravastatin and rosuvastatin represent two medications that are not metabolized by Cyp3A4.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Mahar Doan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wring, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shampine, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serabjit-Singh, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkinson, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span> </span><span class="NLM_article-title">Passive permeability and P-glycoprotein mediated efflux differentiate CNS and non-CNS marketed drugs</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1124%2Fjpet.102.039255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=12438524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A280%3ADC%252BD38nptVKmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=1029-1037&author=K.+M.+Mahar+Doanauthor=J.+E.+Humphreysauthor=L.+O.+Websterauthor=S.+A.+Wringauthor=L.+J.+Shampineauthor=C.+J.+Serabjit-Singhauthor=K.+K.+Adkinsonauthor=J.+W.+Polli&title=Passive+permeability+and+P-glycoprotein+mediated+efflux+differentiate+CNS+and+non-CNS+marketed+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs</span></div><div class="casAuthors">Mahar Doan Kelly M; Humphreys Joan E; Webster Lindsey O; Wring Stephen A; Shampine Larry J; Serabjit-Singh Cosette J; Adkison Kimberly K; Polli Joseph W</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1029-37</span>
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Membrane permeability and P-glycoprotein (Pgp) can be limiting factors for blood-brain barrier penetration.  The objectives of this study were to determine whether there are differences in the in vitro permeability, Pgp substrate profiles, and physicochemical properties of drugs for central nervous system (CNS) and non-CNS indications, and whether these differences are useful criteria in selecting compounds for drug development.  Apparent permeability (P(app)) and Pgp substrate profiles for 93 CNS (n = 48) and non-CNS (n = 45) drugs were determined by monolayer efflux.  Calcein-AM inhibition assays were used to supplement the efflux results.  The CNS set (2 of 48, 4.2%) had a 7-fold lower incidence of passive permeability values <150 nm/s compared with the non-CNS set (13 of 45, 28.9%).  The majority of drugs (72.0%, 67 of 93) were not Pgp substrates; however, 49.5% (46 of 93) were positive in the calcein-AM assay when tested at 100 microM.  The CNS drug set (n = 7 of 48, 14.6%) had a 3-fold lower incidence of Pgp-mediated efflux than the non-CNS drug set (n = 19 of 45, 42.2%).  Analysis of 18 physicochemical properties revealed that the CNS drug set had fewer hydrogen bond donors, fewer positive charges, greater lipophilicity, lower polar surface area, and reduced flexibility compared with the non-CNS group (p < 0.05), properties that enhance membrane permeability.  This study on a large, diverse set of marketed compounds clearly demonstrates that permeability, Pgp-mediated efflux, and certain physicochemical properties are factors that differentiate CNS and non-CNS drugs.  For CNS delivery, a drug should ideally have an in vitro passive permeability >150 nm/s and not be a good (B --> A/A --> B ratio <2.5) Pgp substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_HiV1Xqt18Vf1XRtfYM0dfW6udTcc2eZK2DU4H8Rilbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38nptVKmsw%253D%253D&md5=b841902aa8502de47c1e1603c80e09fb</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039255%26sid%3Dliteratum%253Aachs%26aulast%3DMahar%2BDoan%26aufirst%3DK.%2BM.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DWebster%26aufirst%3DL.%2BO.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DShampine%26aufirst%3DL.%2BJ.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BJ.%26aulast%3DAdkinson%26aufirst%3DK.%2BK.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26atitle%3DPassive%2520permeability%2520and%2520P-glycoprotein%2520mediated%2520efflux%2520differentiate%2520CNS%2520and%2520non-CNS%2520marketed%2520drugs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D1029%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Natta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worboys, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monshouwer, M.</span><span> </span><span class="NLM_article-title">Unbound Drug Concentration in Brain Homogenate and Cerebral Spinal Fluid at Steady State as a Surrogate for Unbound Concentration in Brain Interstitial Fluid</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1124%2Fdmd.108.024125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=19116265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=787-793&author=X.+Liuauthor=K.+Van+Nattaauthor=H.+Yeoauthor=O.+Vilenskiauthor=P.+E.+Wellerauthor=P.+D.+Worboysauthor=M.+Monshouwer&title=Unbound+Drug+Concentration+in+Brain+Homogenate+and+Cerebral+Spinal+Fluid+at+Steady+State+as+a+Surrogate+for+Unbound+Concentration+in+Brain+Interstitial+Fluid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span></div><div class="casAuthors">Liu, Xingrong; Van Natta, Kristine; Yeo, Helen; Vilenski, Olga; Weller, Paul E.; Worboys, Philip D.; Monshouwer, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">787-793</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The objective of the present study was to examine the accuracy of using unbound brain concn. detd. by a brain homogenate method (Cub), cerebral spinal fluid concn. (CCSF), and unbound plasma concn. (Cup) as a surrogate for brain interstitial fluid concn. detd. by brain microdialysis (Cm).  Nine compds.-carbamazepine, citalopram, ganciclovir, metoclopramide, N-desmethylclozapine, quinidine, risperidone, 9-hydroxyrisperidone, and thiopental-were selected, and each was administered as an i.v. bolus (up to 5 mg/kg) followed by a const. i.v. infusion (1-9 mg/kg/h) for 6 h in rats.  For eight of the nine compds., the Cubs were within 3-fold of their Cm; thiopental had a Cm 4-fold of its Cub.  The CCSFs of eight of the nine compds. were within 3-fold of their corresponding Cm; 9-hydroxyrisperidone showed a CCSF 5-fold of its Cm.  The Cups of five of the nine compds. were within 3-fold of their Cm; four compds. (ganciclovir, metoclopramide, quinidine, and 9-hydroxyrisperidone) had Cups 6- to 14-fold of their Cm.  In conclusion, the Cub and CCSF were within 3-fold of the Cm for the majority of the compds. tested.  The Cups were within 3-fold of Cm for lipophilic non-P-glycoprotein (-P-gp) substrates and greater than 3-fold of Cm for hydrophilic or P-gp substrates.  The present study indicates that the brain homogenate and cerebral spinal fluid methods may be used as surrogate methods to predict brain interstitial fluid concns. within 3-fold of error in drug discovery and development settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVK_I2XYWfrrVg90H21EOLACvtfcHk0ljloeN0hzia6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D&md5=feb6abdcfa4e2e007c5abd44066c0e19</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.024125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.024125%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVan%2BNatta%26aufirst%3DK.%26aulast%3DYeo%26aufirst%3DH.%26aulast%3DVilenski%26aufirst%3DO.%26aulast%3DWeller%26aufirst%3DP.%2BE.%26aulast%3DWorboys%26aufirst%3DP.%2BD.%26aulast%3DMonshouwer%26aufirst%3DM.%26atitle%3DUnbound%2520Drug%2520Concentration%2520in%2520Brain%2520Homogenate%2520and%2520Cerebral%2520Spinal%2520Fluid%2520at%2520Steady%2520State%2520as%2520a%2520Surrogate%2520for%2520Unbound%2520Concentration%2520in%2520Brain%2520Interstitial%2520Fluid%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D787%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–Brain Exposure Relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span><div class="note"><p class="first last">and references therein</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93Brain+Exposure+Relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593Brain%2520Exposure%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D26%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2601</span><span class="NLM_x">–</span> <span class="NLM_lpage">2611</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100087s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2601-2611&author=B.+Kuhnauthor=P.+Mohrauthor=M.+Stahl&title=Intramolecular+hydrogen+bonding+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span></div><div class="casAuthors">Kuhn, Bernd; Mohr, Peter; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2601-2611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The formation of intramol. hydrogen bonds has a very pronounced effect on mol. structure and properties.  We study both aspects in detail with the aim of enabling a more rational use of this class of interactions in medicinal chem.  On the basis of exhaustive searches in crystal structure databases, we derive propensities for intramol. hydrogen bond formation of five- to eight-membered ring systems of relevance in drug discovery.  A no. of motifs, several of which are clearly underutilized in drug discovery, are analyzed in more detail by comparing small mol. and protein-ligand X-ray structures.  To investigate effects on physicochem. properties, sets of closely related structures with and without the ability to form intramol. hydrogen bonds were designed, synthesized, and characterized with respect to membrane permeability, water soly., and lipophilicity.  We find that changes in these properties depend on a subtle balance between the strength of the hydrogen bond interaction, geometry of the newly formed ring system, and the relative energies of the open and closed conformations in polar and unpolar environments.  A no. of general guidelines for medicinal chemists emerge from this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaV7tFRU4k7Vg90H21EOLACvtfcHk0ljloeN0hzia6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D&md5=b9b6865dfcc9bdf7796d15218f6e8ff2</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm100087s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100087s%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2601%26epage%3D2611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="note"><p class="first last">Coordinates for the complex of BACE with inhibitor <b>21</b> have been deposited in the Protein Data Bank under PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DH6">4DH6</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Crystal structure of memapsin 2 (beta-secretase) in complex with an inhibitor OM00–3</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">10963</span><span class="NLM_x">–</span> <span class="NLM_lpage">10967</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi026232n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=10963-10967&author=L.+Hongauthor=R.+T.+Turnerauthor=G.+Koelschauthor=D.+Shinauthor=A.+K.+Ghoshauthor=J.+Tang&title=Crystal+structure+of+memapsin+2+%28beta-secretase%29+in+complex+with+an+inhibitor+OM00%E2%80%933"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fbi026232n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi026232n%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DL.%26aulast%3DTurner%26aufirst%3DR.%2BT.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DShin%26aufirst%3DD.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DCrystal%2520structure%2520of%2520memapsin%25202%2520%2528beta-secretase%2529%2520in%2520complex%2520with%2520an%2520inhibitor%2520OM00%25E2%2580%25933%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D10963%26epage%3D10967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Flap position of free memapsin 2 (beta-secretase), a model for flap opening in aspartic protease catalysis</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4689</span><span class="NLM_x">–</span> <span class="NLM_lpage">4695</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0498252" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=4689-4695&author=L.+Hongauthor=J.+Tang&title=Flap+position+of+free+memapsin+2+%28beta-secretase%29%2C+a+model+for+flap+opening+in+aspartic+protease+catalysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1021%2Fbi0498252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0498252%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DFlap%2520position%2520of%2520free%2520memapsin%25202%2520%2528beta-secretase%2529%252C%2520a%2520model%2520for%2520flap%2520opening%2520in%2520aspartic%2520protease%2520catalysis%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D4689%26epage%3D4695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="note"><p class="first last">Plasma protein binding values were interpolated using best-fit parameters generated from fitting a two-site binding model.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Turner, R. T.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanheira, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Subsite specificity of memapsin (β-secretase): implications for inhibitor design</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">10001</span><span class="NLM_x">–</span> <span class="NLM_lpage">10006</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi015546s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=10001-10006&author=R.+T.+Turnerauthor=G.+Koelschauthor=L.+Hongauthor=P.+Castanheiraauthor=A.+Ghoshauthor=J.+Tang&title=Subsite+specificity+of+memapsin+%28%CE%B2-secretase%29%3A+implications+for+inhibitor+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fbi015546s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi015546s%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DR.%2BT.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DCastanheira%26aufirst%3DP.%26aulast%3DGhosh%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DSubsite%2520specificity%2520of%2520memapsin%2520%2528%25CE%25B2-secretase%2529%253A%2520implications%2520for%2520inhibitor%2520design%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D10001%26epage%3D10006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Haniu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span> </span><span class="NLM_article-title">Characterization of Alzheimer’s beta-secretase protein BACE. A pepsin family member with unusual properties</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">21099</span><span class="NLM_x">–</span> <span class="NLM_lpage">21106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=21099-21106&author=M.+Haniuauthor=P.+Denisauthor=Y.+Youngauthor=E.+A.+Mendiazauthor=J.+Fullerauthor=J.+O.+Huiauthor=B.+D.+Bennettauthor=S.+Kahnauthor=S.+Rossauthor=T.+Burgess&title=Characterization+of+Alzheimer%E2%80%99s+beta-secretase+protein+BACE.+A+pepsin+family+member+with+unusual+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaniu%26aufirst%3DM.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DY.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DHui%26aufirst%3DJ.%2BO.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DBurgess%26aufirst%3DT.%26atitle%3DCharacterization%2520of%2520Alzheimer%25E2%2580%2599s%2520beta-secretase%2520protein%2520BACE.%2520A%2520pepsin%2520family%2520member%2520with%2520unusual%2520properties%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D21099%26epage%3D21106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Schinkel, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagenaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Deemter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mol, C. A. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borst, P.</span><span> </span><span class="NLM_article-title">Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">1698</span><span class="NLM_x">–</span> <span class="NLM_lpage">1705</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1995&pages=1698-1705&author=A.+H.+Schinkelauthor=E.+Wagenaarauthor=L.+van+Deemterauthor=C.+A.+A.+M.+Molauthor=P.+Borst&title=Absence+of+the+mdr1a+P-glycoprotein+in+mice+affects+tissue+distribution+and+pharmacokinetics+of+dexamethasone%2C+digoxin%2C+and+cyclosporin+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26aulast%3DWagenaar%26aufirst%3DE.%26aulast%3Dvan%2BDeemter%26aufirst%3DL.%26aulast%3DMol%26aufirst%3DC.%2BA.%2BA.%2BM.%26aulast%3DBorst%26aufirst%3DP.%26atitle%3DAbsence%2520of%2520the%2520mdr1a%2520P-glycoprotein%2520in%2520mice%2520affects%2520tissue%2520distribution%2520and%2520pharmacokinetics%2520of%2520dexamethasone%252C%2520digoxin%252C%2520and%2520cyclosporin%2520A%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1995%26volume%3D96%26spage%3D1698%26epage%3D1705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Booth-Genthe, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlini, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leake, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhandler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochman, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rushmore, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, M.</span><span> </span><span class="NLM_article-title">Development and characterization of LLC-PK1 cells containing Sprague–Dawley rat <i>Abcb</i>1a (<i>Mdr</i>1a): comparison of rat P-glycoprotein transport to human and mouse</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1016%2Fj.vascn.2005.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=16545584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFSkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=78-89&author=C.+L.+Booth-Gentheauthor=S.+W.+Louieauthor=E.+J.+Carliniauthor=B.+Liauthor=B.+F.+Leakeauthor=R.+Eisenhandlerauthor=J.+H.+Hochmanauthor=Q.+Meiauthor=R.+B.+Kimauthor=T.+H.+Rushmoreauthor=M.+Yamazaki&title=Development+and+characterization+of+LLC-PK1+cells+containing+Sprague%E2%80%93Dawley+rat+Abcb1a+%28Mdr1a%29%3A+comparison+of+rat+P-glycoprotein+transport+to+human+and+mouse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Development and characterization of LLC-PK1 cells containing Sprague-Dawley rat Abcb1a (Mdr1a): Comparison of rat P-glycoprotein transport to human and mouse</span></div><div class="casAuthors">Booth-Genthe, Catherine L.; Louie, Steven W.; Carlini, Edward J.; Li, Bing; Leake, Brenda F.; Eisenhandler, Roy; Hochman, Jerome H.; Mei, Qin; Kim, Richard B.; Rushmore, Thomas H.; Yamazaki, Masayo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-89</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">P-glycoprotein is localized in numerous tissues throughout the body and plays an important role in the disposition of many xenobiotics.  The contribution of P-glycoprotein-mediated drug transport is being evaluated in early drug discovery stages, particularly for compds. targeted to the central nervous system, using in vitro tools including cell lines expressing P-glycoprotein.  Previous work in our lab. suggests there are species differences in P-glycoprotein transport activity between humans and animals.  The rat Abcb1a form of P-glycoprotein (formerly known as Mdr1a), the predominate isoform in the brain, has not been described in a functional cell system.  Here, we describe the development and characterization of LLC-PK1 cells expressing rat Abcb1.  We cloned rat Abcb1a and generated a stable LLC-PK1 cell line.  Expression and function of the cells were evaluated by immunoblot anal., cytotoxicity anal., cellular accumulation assays, and transcellular transport of probe substrates.  The transport ratios of structurally diverse compds. obtained from parental cells or cells stably transfected with human ABCB1, mouse Abcb1a or rat Abcb1a were compared.  Two forms of rat Abcb1a were cloned from Sprague-Dawley cDNA that differ by six amino acids and a base pair deletion.  The intact form was stably transfected in LLC-PK1 cells.  Immunoblot anal. demonstrated expression of the protein.  The cells demonstrated P-glycoprotein-mediated function by directional transport of dexamethasone, ritonavir, and vinblastine in a transwell assay that was inhibited in the presence of cyclosporin A, verapamil, or quinidine.  Likewise, the cells showed reduced cellular accumulation of Rh123 by FACS anal. that was reversed in the presence of cyclosporin A.  These cells showed ≥ 350-fold resistance to colchicine, doxorubicin, vinblastine, and taxol and were sensitized in the presence of verapamil or cyclosporin A.  Of 179 chem. diverse compds. evaluated, ∼20% of the compds. evaluated were predicted to be substrates in one species but not in other species.  Taken together, these data suggest these cells will be useful for evaluation of rat Abcb1a-mediated transport and for evaluation of species-specific P-glycoprotein-mediated transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTnY-e_sTc7LVg90H21EOLACvtfcHk0lh3FxJbhEh3YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFSkuro%253D&md5=3390b072631084f62434e147269b6c13</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2005.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2005.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DBooth-Genthe%26aufirst%3DC.%2BL.%26aulast%3DLouie%26aufirst%3DS.%2BW.%26aulast%3DCarlini%26aufirst%3DE.%2BJ.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLeake%26aufirst%3DB.%2BF.%26aulast%3DEisenhandler%26aufirst%3DR.%26aulast%3DHochman%26aufirst%3DJ.%2BH.%26aulast%3DMei%26aufirst%3DQ.%26aulast%3DKim%26aufirst%3DR.%2BB.%26aulast%3DRushmore%26aufirst%3DT.%2BH.%26aulast%3DYamazaki%26aufirst%3DM.%26atitle%3DDevelopment%2520and%2520characterization%2520of%2520LLC-PK1%2520cells%2520containing%2520Sprague%25E2%2580%2593Dawley%2520rat%2520Abcb1a%2520%2528Mdr1a%2529%253A%2520comparison%2520of%2520rat%2520P-glycoprotein%2520transport%2520to%2520human%2520and%2520mouse%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2006%26volume%3D54%26spage%3D78%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuillard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yon, J.</span><span> </span><span class="NLM_article-title">Apo and inhibitor complex structures of BACE (beta-secretase)</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2004&pages=407-416&author=S.+Patelauthor=L.+Vuillardauthor=A.+Cleasbyauthor=C.+W.+Murrayauthor=J.+Yon&title=Apo+and+inhibitor+complex+structures+of+BACE+%28beta-secretase%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DVuillard%26aufirst%3DL.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DYon%26aufirst%3DJ.%26atitle%3DApo%2520and%2520inhibitor%2520complex%2520structures%2520of%2520BACE%2520%2528beta-secretase%2529%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D343%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray diffraction data collected in oscillation mode</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+of+X-ray+diffraction+data+collected+in+oscillation+mode"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0lhcf6frv6pF0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520X-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lhcf6frv6pF0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">D53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0lhcf6frv6pF0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3DD53%26spage%3D240%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">D60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lhcf6frv6pF0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3DD60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. T.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esmay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbeah-Ampiah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monenschein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Potent, Orally Efficacious Hydroxyethylamine Derived β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors</span> <span class="citation_source-journal">J. Med. Chem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1021/jm300118s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300118s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=T.+A.+Dineenauthor=M.+M.+Weissauthor=T.+Williamsonauthor=P.+Actonauthor=S.+Babu-Khanauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=Y.+Chengauthor=M.+Citronauthor=M.+D.+Croghanauthor=R.+T.+Dunnauthor=J.+Esmayauthor=R.+F.+Graceffaauthor=S.+S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=D.+B.+Horneauthor=H.+Huangauthor=R.+Imbeah-Ampiahauthor=T.+Juddauthor=M.+R.+Kallerauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=V.+Liauthor=P.+Lopezauthor=S.+Louieauthor=H.+Monenscheinauthor=T.+T.+Nguyenauthor=L.+D.+Penningtonauthor=T.+San+Miguelauthor=E.+A.+Sickmierauthor=H.+M.+Vargasauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=D.+A.+Whittingtonauthor=S.+Woodauthor=Q.+Xueauthor=B.+H.+Yangauthor=V.+F.+Patelauthor=W.+Zhong&title=Design+and+Synthesis+of+Potent%2C+Orally+Efficacious+Hydroxyethylamine+Derived+%CE%B2-Site+Amyloid+Precursor+Protein+Cleaving+Enzyme+%28BACE1%29+Inhibitors&doi=10.1021%2Fjm300118s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm300118s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300118s%26sid%3Dliteratum%253Aachs%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DActon%26aufirst%3DP.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DDunn%26aufirst%3DR.%2BT.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarried%26aufirst%3DS.%2BS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DHorne%26aufirst%3DD.%2BB.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DImbeah-Ampiah%26aufirst%3DR.%26aulast%3DJudd%26aufirst%3DT.%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DMonenschein%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DVargas%26aufirst%3DH.%2BM.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DB.%2BH.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DZhong%26aufirst%3DW.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Potent%252C%2520Orally%2520Efficacious%2520Hydroxyethylamine%2520Derived%2520%25CE%25B2-Site%2520Amyloid%2520Precursor%2520Protein%2520Cleaving%2520Enzyme%2520%2528BACE1%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem%26date%3D2012%26doi%3D10.1021%2Fjm300118s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d','cit1e','cit1f'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5a','cit5b','cit5c','cit5d'],'ref6':['cit6a','cit6b','cit6c','cit6d','cit6e','cit6f'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':[],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c'],'ref15':[],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':[],'ref21':['cit21a','cit21b'],'ref22':[],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 46 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Hangchen Hu, Zhaoqiang Chen, Xiang Xu, <span class="NLM_string-name hlFld-ContribAuthor">Yechun Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Survey of the Binding Modes of BACE1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (2)
                                     , 880-889. <a href="https://doi.org/10.1021/acschemneuro.8b00420" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00420</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00420%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DStructure-Based%252BSurvey%252Bof%252Bthe%252BBinding%252BModes%252Bof%252BBACE1%252BInhibitors%26aulast%3DHu%26aufirst%3DHangchen%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D18082018%26date%3D12122018%26date%3D27122018%26date%3D12122018%26volume%3D10%26issue%3D2%26spage%3D880%26epage%3D889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Nicholas A. Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (14)
                                     , 5822-5880. <a href="https://doi.org/10.1021/acs.jmedchem.7b01788" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01788%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFluorine%252Band%252BFluorinated%252BMotifs%252Bin%252Bthe%252BDesign%252Band%252BApplication%252Bof%252BBioisosteres%252Bfor%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D05122017%26date%3D05022018%26volume%3D61%26issue%3D14%26spage%3D5822%26epage%3D5880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana B.  Bueno</span>, <span class="hlFld-ContribAuthor ">Javier  Agejas</span>, <span class="hlFld-ContribAuthor ">Howard  Broughton</span>, <span class="hlFld-ContribAuthor ">Robert  Dally</span>, <span class="hlFld-ContribAuthor ">Timothy B.  Durham</span>, <span class="hlFld-ContribAuthor ">Juan Félix  Espinosa</span>, <span class="hlFld-ContribAuthor ">Rosario  González</span>, <span class="hlFld-ContribAuthor ">Patric J.  Hahn</span>, <span class="hlFld-ContribAuthor ">Alicia  Marcos</span>, <span class="hlFld-ContribAuthor ">Ramón  Rodríguez</span>, <span class="hlFld-ContribAuthor ">Gema  Sanz</span>, <span class="hlFld-ContribAuthor ">José F.  Soriano</span>, <span class="hlFld-ContribAuthor ">David  Timm</span>, <span class="hlFld-ContribAuthor ">Paloma  Vidal</span>, <span class="hlFld-ContribAuthor ">Hsiu-Chiung  Yang</span>, and <span class="hlFld-ContribAuthor ">James R.  McCarthy</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimization of Hydroxyethylamine Transition State Isosteres as Aspartic Protease Inhibitors by Exploiting Conformational Preferences. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (23)
                                     , 9807-9820. <a href="https://doi.org/10.1021/acs.jmedchem.7b01304" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01304%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BHydroxyethylamine%252BTransition%252BState%252BIsosteres%252Bas%252BAspartic%252BProtease%252BInhibitors%252Bby%252BExploiting%252BConformational%252BPreferences%26aulast%3DBueno%26aufirst%3DAna%2BB.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04092017%26date%3D28112017%26date%3D14122017%26date%3D31102017%26volume%3D60%26issue%3D23%26spage%3D9807%26epage%3D9820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mihirbaran  Mandal</span>, <span class="hlFld-ContribAuthor ">Yusheng  Wu</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Misiaszek</span>, <span class="hlFld-ContribAuthor ">Guoqing  Li</span>, <span class="hlFld-ContribAuthor ">Alexei  Buevich</span>, <span class="hlFld-ContribAuthor ">John P.  Caldwell</span>, <span class="hlFld-ContribAuthor ">Xiaoxiang  Liu</span>, <span class="hlFld-ContribAuthor ">Robert D.  Mazzola</span>, <span class="hlFld-ContribAuthor ">Peter  Orth</span>, <span class="hlFld-ContribAuthor ">Corey  Strickland</span>, <span class="hlFld-ContribAuthor ">Johannes  Voigt</span>, <span class="hlFld-ContribAuthor ">Hongwu  Wang</span>, <span class="hlFld-ContribAuthor ">Zhaoning  Zhu</span>, <span class="hlFld-ContribAuthor ">Xia  Chen</span>, <span class="hlFld-ContribAuthor ">Michael  Grzelak</span>, <span class="hlFld-ContribAuthor ">Lynn A.  Hyde</span>, <span class="hlFld-ContribAuthor ">Reshma  Kuvelkar</span>, <span class="hlFld-ContribAuthor ">Prescott T.  Leach</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Terracina</span>, <span class="hlFld-ContribAuthor ">Lili  Zhang</span>, <span class="hlFld-ContribAuthor ">Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Maria S.  Michener</span>, <span class="hlFld-ContribAuthor ">Brad  Smith</span>, <span class="hlFld-ContribAuthor ">Kathleen  Cox</span>, <span class="hlFld-ContribAuthor ">Diane  Grotz</span>, <span class="hlFld-ContribAuthor ">Leonard  Favreau</span>, <span class="hlFld-ContribAuthor ">Kaushik  Mitra</span>, <span class="hlFld-ContribAuthor ">Irina  Kazakevich</span>, <span class="hlFld-ContribAuthor ">Brian A.  McKittrick</span>, <span class="hlFld-ContribAuthor ">William  Greenlee</span>, <span class="hlFld-ContribAuthor ">Matthew E.  Kennedy</span>, <span class="hlFld-ContribAuthor ">Eric M.  Parker</span>, <span class="hlFld-ContribAuthor ">Jared N.  Cumming</span>, and <span class="hlFld-ContribAuthor ">Andrew W.  Stamford</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of an Iminoheterocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aβ in Nonhuman Primates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (7)
                                     , 3231-3248. <a href="https://doi.org/10.1021/acs.jmedchem.5b01995" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01995</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01995%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252Ban%252BIminoheterocyclic%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B%252528BACE%252529%252BInhibitor%252Bthat%252BLowers%252BCentral%252BA%2525CE%2525B2%252Bin%252BNonhuman%252BPrimates%26aulast%3DMandal%26aufirst%3DMihirbaran%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D23122015%26date%3D22032016%26date%3D14042016%26date%3D03032016%26volume%3D59%26issue%3D7%26spage%3D3231%26epage%3D3248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Jason S.    Tedrow </span><span class="hlFld-ContribAuthor "> Wenge    Zhong </span>. </span><span class="cited-content_cbyCitation_article-title">Design and Enabling Development of Hydroxyethylamine-Derived BACE1 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 137-170. <a href="https://doi.org/10.1021/bk-2016-1240.ch004" title="DOI URL">https://doi.org/10.1021/bk-2016-1240.ch004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2016-1240.ch004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2016-1240.ch004%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Band%252BEnabling%252BDevelopment%252Bof%252BHydroxyethylamine-Derived%252BBACE1%252BInhibitor%26aulast%3DTedrow%26aufirst%3DJason%2BS.%26date%3D2016%26date%3D2016%26spage%3D137%26epage%3D170%26atitle%3DComprehensive%252BAccounts%252Bof%252BPharmaceutical%252BResearch%252Band%252BDevelopment%25253A%252BFrom%252BDiscovery%252Bto%252BLate-Stage%252BProcess%252BDevelopment%252BVolume%252B2%26aulast%3DAbdel-Magid%26aufirst%3DAhmed%2BF.%26date%3D2016%26date%3D2016%26volume%3D1240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric P.  Gillis</span>, <span class="hlFld-ContribAuthor ">Kyle J.  Eastman</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Hill</span>, <span class="hlFld-ContribAuthor ">David J.  Donnelly</span>, and <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Applications of Fluorine in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (21)
                                     , 8315-8359. <a href="https://doi.org/10.1021/acs.jmedchem.5b00258" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplications%252Bof%252BFluorine%252Bin%252BMedicinal%252BChemistry%26aulast%3DGillis%26aufirst%3DEric%2BP.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D13022015%26date%3D22072015%26date%3D12112015%26volume%3D58%26issue%3D21%26spage%3D8315%26epage%3D8359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingbei  Zeng</span>, <span class="hlFld-ContribAuthor ">Jiabing  Wang</span>, <span class="hlFld-ContribAuthor ">Ziqiang  Cheng</span>, <span class="hlFld-ContribAuthor ">Kan  Chen</span>, <span class="hlFld-ContribAuthor ">Peter  Johnström</span>, <span class="hlFld-ContribAuthor ">Katarina  Varnäs</span>, <span class="hlFld-ContribAuthor ">David Yunzhi  Li</span>, <span class="hlFld-ContribAuthor ">Zhen Fan  Yang</span>, and <span class="hlFld-ContribAuthor ">Xiaolin  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Evaluation of Clinical Candidate AZD3759, a Potent, Oral Active, Central Nervous System-Penetrant, Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (20)
                                     , 8200-8215. <a href="https://doi.org/10.1021/acs.jmedchem.5b01073" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01073%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BEvaluation%252Bof%252BClinical%252BCandidate%252BAZD3759%25252C%252Ba%252BPotent%25252C%252BOral%252BActive%25252C%252BCentral%252BNervous%252BSystem-Penetrant%25252C%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BTyrosine%252BKinase%252BInhibitor%26aulast%3DZeng%26aufirst%3DQingbei%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D10072015%26date%3D09102015%26date%3D22102015%26date%3D27082015%26volume%3D58%26issue%3D20%26spage%3D8200%26epage%3D8215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zoran  Rankovic</span>  . </span><span class="cited-content_cbyCitation_article-title">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (6)
                                     , 2584-2608. <a href="https://doi.org/10.1021/jm501535r" title="DOI URL">https://doi.org/10.1021/jm501535r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501535r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501535r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCNS%252BDrug%252BDesign%25253A%252BBalancing%252BPhysicochemical%252BProperties%252Bfor%252BOptimal%252BBrain%252BExposure%26aulast%3DRankovic%26aufirst%3DZoran%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D05102014%26date%3D06012015%26date%3D26032015%26date%3D11122014%26volume%3D58%26issue%3D6%26spage%3D2584%26epage%3D2608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oleg  Epstein</span>, <span class="hlFld-ContribAuthor ">Marian C.  Bryan</span>, <span class="hlFld-ContribAuthor ">Alan C.  Cheng</span>, <span class="hlFld-ContribAuthor ">Katayoun  Derakhchan</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Dineen</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Zihao  Hua</span>, <span class="hlFld-ContribAuthor ">Jason B.  Human</span>, <span class="hlFld-ContribAuthor ">Charles  Kreiman</span>, <span class="hlFld-ContribAuthor ">Isaac E.  Marx</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Robert C.  Wahl</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Xiao Mei  Zheng</span>, <span class="hlFld-ContribAuthor ">Robert T.  Fremeau, Jr.</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, and <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>  . </span><span class="cited-content_cbyCitation_article-title">Lead Optimization and Modulation of hERG Activity in a Series of Aminooxazoline Xanthene β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 9796-9810. <a href="https://doi.org/10.1021/jm501266w" title="DOI URL">https://doi.org/10.1021/jm501266w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501266w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501266w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLead%252BOptimization%252Band%252BModulation%252Bof%252BhERG%252BActivity%252Bin%252Ba%252BSeries%252Bof%252BAminooxazoline%252BXanthene%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B%252528BACE1%252529%252BInhibitors%26aulast%3DEpstein%26aufirst%3DOleg%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18082014%26date%3D12112014%26date%3D11122014%26volume%3D57%26issue%3D23%26spage%3D9796%26epage%3D9810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Dineen</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Alan C.  Cheng</span>, <span class="hlFld-ContribAuthor ">Katayoun  Derakhchan</span>, <span class="hlFld-ContribAuthor ">Oleg  Epstein</span>, <span class="hlFld-ContribAuthor ">Joel  Esmay</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Chuck E.  Kreiman</span>, <span class="hlFld-ContribAuthor ">Isaac E.  Marx</span>, <span class="hlFld-ContribAuthor ">Robert C.  Wahl</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Robert T.  Fremeau, Jr.</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, and <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>  . </span><span class="cited-content_cbyCitation_article-title">Inhibitors of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1): Identification of (S)-7-(2-Fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5′H-spiro[chromeno[2,3-b]pyridine-5,4′-oxazol]-2′-amine (AMG-8718). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 9811-9831. <a href="https://doi.org/10.1021/jm5012676" title="DOI URL">https://doi.org/10.1021/jm5012676</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5012676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5012676%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibitors%252Bof%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B%252528BACE1%252529%25253A%252BIdentification%252Bof%252B%252528S%252529-7-%2525282-Fluoropyridin-3-yl%252529-3-%252528%2525283-methyloxetan-3-yl%252529ethynyl%252529-5%2525E2%252580%2525B2H-spiro%25255Bchromeno%25255B2%25252C3-b%25255Dpyridine-5%25252C4%2525E2%252580%2525B2-oxazol%25255D-2%2525E2%252580%2525B2-amine%252B%252528AMG-8718%252529%26aulast%3DDineen%26aufirst%3DThomas%2BA.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18082014%26date%3D14112014%26date%3D11122014%26date%3D01112014%26volume%3D57%26issue%3D23%26spage%3D9811%26epage%3D9831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Yuan</span>, <span class="hlFld-ContribAuthor ">Shankar  Venkatraman</span>, <span class="hlFld-ContribAuthor ">Yajun  Zheng</span>, <span class="hlFld-ContribAuthor ">Brian M.  McKeever</span>, <span class="hlFld-ContribAuthor ">Lawrence W.  Dillard</span>, and <span class="hlFld-ContribAuthor ">Suresh B.  Singh</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (11)
                                     , 4156-4180. <a href="https://doi.org/10.1021/jm301659n" title="DOI URL">https://doi.org/10.1021/jm301659n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301659n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301659n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252B%2525CE%2525B2-Site%252BAPP%252BCleaving%252BEnzyme%252B1%252B%252528BACE1%252529%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DYuan%26aufirst%3DJing%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D09112012%26date%3D05042013%26date%3D13062013%26date%3D19032013%26volume%3D56%26issue%3D11%26spage%3D4156%26epage%3D4180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Dineen</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Toni  Williamson</span>, <span class="hlFld-ContribAuthor ">Paul  Acton</span>, <span class="hlFld-ContribAuthor ">Safura  Babu-Khan</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">James  Brown</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Yuan  Cheng</span>, <span class="hlFld-ContribAuthor ">Martin  Citron</span>, <span class="hlFld-ContribAuthor ">Michael D.  Croghan</span>, <span class="hlFld-ContribAuthor ">Robert T.  Dunn, II</span>, <span class="hlFld-ContribAuthor ">Joel  Esmay</span>, <span class="hlFld-ContribAuthor ">Russell F.  Graceffa</span>, <span class="hlFld-ContribAuthor ">Scott S.  Harried</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Hitchcock</span>, <span class="hlFld-ContribAuthor ">Daniel B.  Horne</span>, <span class="hlFld-ContribAuthor ">Hongbing  Huang</span>, <span class="hlFld-ContribAuthor ">Ronke  Imbeah-Ampiah</span>, <span class="hlFld-ContribAuthor ">Ted  Judd</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Kaller</span>, <span class="hlFld-ContribAuthor ">Charles R.  Kreiman</span>, <span class="hlFld-ContribAuthor ">Daniel S.  La</span>, <span class="hlFld-ContribAuthor ">Vivian  Li</span>, <span class="hlFld-ContribAuthor ">Patricia  Lopez</span>, <span class="hlFld-ContribAuthor ">Steven  Louie</span>, <span class="hlFld-ContribAuthor ">Holger  Monenschein</span>, <span class="hlFld-ContribAuthor ">Thomas T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Lewis D.  Pennington</span>, <span class="hlFld-ContribAuthor ">Tisha  San Miguel</span>, <span class="hlFld-ContribAuthor ">E. Allen  Sickmier</span>, <span class="hlFld-ContribAuthor ">Hugo M.  Vargas</span>, <span class="hlFld-ContribAuthor ">Robert C.  Wahl</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Qiufen  Xue</span>, <span class="hlFld-ContribAuthor ">Bryant H.  Yang</span>, <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>, and <span class="hlFld-ContribAuthor ">Wenge  Zhong</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Potent, Orally Efficacious Hydroxyethylamine Derived β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (21)
                                     , 9025-9044. <a href="https://doi.org/10.1021/jm300118s" title="DOI URL">https://doi.org/10.1021/jm300118s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300118s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300118s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BPotent%25252C%252BOrally%252BEfficacious%252BHydroxyethylamine%252BDerived%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B%252528BACE1%252529%252BInhibitors%26aulast%3DDineen%26aufirst%3DThomas%2BA.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D27012012%26date%3D18042012%26date%3D08112012%26date%3D02042012%26volume%3D55%26issue%3D21%26spage%3D9025%26epage%3D9044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Britt-Marie  Swahn</span>, <span class="hlFld-ContribAuthor ">Karin  Kolmodin</span>, <span class="hlFld-ContribAuthor ">Sofia  Karlström</span>, <span class="hlFld-ContribAuthor ">Stefan  von Berg</span>, <span class="hlFld-ContribAuthor ">Peter  Söderman</span>, <span class="hlFld-ContribAuthor ">Jörg  Holenz</span>, <span class="hlFld-ContribAuthor ">Stefan  Berg</span>, <span class="hlFld-ContribAuthor ">Johan  Lindström</span>, <span class="hlFld-ContribAuthor ">Marie  Sundström</span>, <span class="hlFld-ContribAuthor ">Dominika  Turek</span>, <span class="hlFld-ContribAuthor ">Jacob  Kihlström</span>, <span class="hlFld-ContribAuthor ">Can  Slivo</span>, <span class="hlFld-ContribAuthor ">Lars  Andersson</span>, <span class="hlFld-ContribAuthor ">David  Pyring</span>, <span class="hlFld-ContribAuthor ">Didier  Rotticci</span>, <span class="hlFld-ContribAuthor ">Liselotte  Öhberg</span>, <span class="hlFld-ContribAuthor ">Annika  Kers</span>, <span class="hlFld-ContribAuthor ">Krisztian  Bogar</span>, <span class="hlFld-ContribAuthor ">Fredrik  von Kieseritzky</span>, <span class="hlFld-ContribAuthor ">Margareta  Bergh</span>, <span class="hlFld-ContribAuthor ">Lise-Lotte  Olsson</span>, <span class="hlFld-ContribAuthor ">Juliette  Janson</span>, <span class="hlFld-ContribAuthor ">Susanna  Eketjäll</span>, <span class="hlFld-ContribAuthor ">Biljana  Georgievska</span>, <span class="hlFld-ContribAuthor ">Fredrik  Jeppsson</span>, and <span class="hlFld-ContribAuthor ">Johanna  Fälting</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (21)
                                     , 9346-9361. <a href="https://doi.org/10.1021/jm3009025" title="DOI URL">https://doi.org/10.1021/jm3009025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3009025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3009025%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B%252528BACE1%252529%252BInhibitors%252Bwith%252Bin%252BVivo%252BBrain%252BReduction%252Bof%252B%2525CE%2525B2-Amyloid%252BPeptides%26aulast%3DSwahn%26aufirst%3DBritt-Marie%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D27062012%26date%3D17092012%26date%3D08112012%26date%3D27082012%26volume%3D55%26issue%3D21%26spage%3D9346%26epage%3D9361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ylva  Gravenfors</span>, <span class="hlFld-ContribAuthor ">Jenny  Viklund</span>, <span class="hlFld-ContribAuthor ">Jan  Blid</span>, <span class="hlFld-ContribAuthor ">Tobias  Ginman</span>, <span class="hlFld-ContribAuthor ">Sofia  Karlström</span>, <span class="hlFld-ContribAuthor ">Jacob  Kihlström</span>, <span class="hlFld-ContribAuthor ">Karin  Kolmodin</span>, <span class="hlFld-ContribAuthor ">Johan  Lindström</span>, <span class="hlFld-ContribAuthor ">Stefan  von Berg</span>, <span class="hlFld-ContribAuthor ">Fredrik  von Kieseritzky</span>, <span class="hlFld-ContribAuthor ">Can  Slivo</span>, <span class="hlFld-ContribAuthor ">Britt-Marie  Swahn</span>, <span class="hlFld-ContribAuthor ">Lise-Lotte  Olsson</span>, <span class="hlFld-ContribAuthor ">Patrik  Johansson</span>, <span class="hlFld-ContribAuthor ">Susanna  Eketjäll</span>, <span class="hlFld-ContribAuthor ">Johanna  Fälting</span>, <span class="hlFld-ContribAuthor ">Fredrik  Jeppsson</span>, <span class="hlFld-ContribAuthor ">Kia  Strömberg</span>, <span class="hlFld-ContribAuthor ">Juliette  Janson</span>, and <span class="hlFld-ContribAuthor ">Fredrik  Rahm</span>  . </span><span class="cited-content_cbyCitation_article-title">New Aminoimidazoles as β-Secretase (BACE-1) Inhibitors Showing Amyloid-β (Aβ) Lowering in Brain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (21)
                                     , 9297-9311. <a href="https://doi.org/10.1021/jm300991n" title="DOI URL">https://doi.org/10.1021/jm300991n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300991n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300991n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252BAminoimidazoles%252Bas%252B%2525CE%2525B2-Secretase%252B%252528BACE-1%252529%252BInhibitors%252BShowing%252BAmyloid-%2525CE%2525B2%252B%252528A%2525CE%2525B2%252529%252BLowering%252Bin%252BBrain%26aulast%3DGravenfors%26aufirst%3DYlva%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D09072012%26date%3D03102012%26date%3D08112012%26date%3D27092012%26volume%3D55%26issue%3D21%26spage%3D9297%26epage%3D9311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">The Design and Application of Bioisosteres in Drug Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-81. <a href="https://doi.org/10.1002/0471266949.bmc259" title="DOI URL">https://doi.org/10.1002/0471266949.bmc259</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc259%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDesign%252Band%252BApplication%252Bof%252BBioisosteres%252Bin%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D81%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thai-Son  Tran</span>, <span class="hlFld-ContribAuthor ">Minh-Tri  Le</span>, <span class="hlFld-ContribAuthor ">Thi-Cam-Vi  Nguyen</span>, <span class="hlFld-ContribAuthor ">The-Huan  Tran</span>, <span class="hlFld-ContribAuthor ">Thanh-Dao  Tran</span>, <span class="hlFld-ContribAuthor ">Khac-Minh  Thai</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, In Silico and In Vitro Evaluation for Acetylcholinesterase and BACE-1 Inhibitory Activity of Some N-Substituted-4-Phenothiazine-Chalcones. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (17)
                                     , 3916. <a href="https://doi.org/10.3390/molecules25173916" title="DOI URL">https://doi.org/10.3390/molecules25173916</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25173916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25173916%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%25252C%252BIn%252BSilico%252Band%252BIn%252BVitro%252BEvaluation%252Bfor%252BAcetylcholinesterase%252Band%252BBACE-1%252BInhibitory%252BActivity%252Bof%252BSome%252BN-Substituted-4-Phenothiazine-Chalcones%26aulast%3DTran%26aufirst%3DThai-Son%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D17%26spage%3D3916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thai-Son  Tran</span>, <span class="hlFld-ContribAuthor ">Minh-Tri  Le</span>, <span class="hlFld-ContribAuthor ">Thanh-Dao  Tran</span>, <span class="hlFld-ContribAuthor ">The-Huan  Tran</span>, <span class="hlFld-ContribAuthor ">Khac-Minh  Thai</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Curcumin and Flavonoid Derivatives with Acetylcholinesterase and Beta-Secretase Inhibitory Activities Using in Silico Approaches. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (16)
                                     , 3644. <a href="https://doi.org/10.3390/molecules25163644" title="DOI URL">https://doi.org/10.3390/molecules25163644</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25163644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25163644%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%252Bof%252BCurcumin%252Band%252BFlavonoid%252BDerivatives%252Bwith%252BAcetylcholinesterase%252Band%252BBeta-Secretase%252BInhibitory%252BActivities%252BUsing%252Bin%252BSilico%252BApproaches%26aulast%3DTran%26aufirst%3DThai-Son%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D16%26spage%3D3644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aida  Iraji</span>, <span class="hlFld-ContribAuthor ">Mahsima  Khoshneviszadeh</span>, <span class="hlFld-ContribAuthor ">Omidreza  Firuzi</span>, <span class="hlFld-ContribAuthor ">Mehdi  Khoshneviszadeh</span>, <span class="hlFld-ContribAuthor ">Najmeh  Edraki</span>. </span><span class="cited-content_cbyCitation_article-title">Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>97 </em>, 103649. <a href="https://doi.org/10.1016/j.bioorg.2020.103649" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103649%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252Bsmall%252Bmolecule%252Btherapeutic%252Bagents%252Bfor%252BAlzheimer%252Bdisease%25253A%252BFocusing%252Bon%252BBACE1%252Band%252Bmulti-target%252Bdirected%252Bligands%26aulast%3DIraji%26aufirst%3DAida%26date%3D2020%26volume%3D97%26spage%3D103649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaoyi  Sun</span>, <span class="hlFld-ContribAuthor ">Qi  Jia</span>, <span class="hlFld-ContribAuthor ">Zaihui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of amide isosteres in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (18)
                                     , 2535-2550. <a href="https://doi.org/10.1016/j.bmcl.2019.07.033" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.07.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.07.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DApplications%252Bof%252Bamide%252Bisosteres%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DSun%26aufirst%3DShaoyi%26date%3D2019%26volume%3D29%26issue%3D18%26spage%3D2535%26epage%3D2550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melissa A.  Herbage</span>, <span class="hlFld-ContribAuthor ">Jolaine  Savoie</span>, <span class="hlFld-ContribAuthor ">Joshua D.  Sieber</span>, <span class="hlFld-ContribAuthor ">Jean-Nicolas  Desrosiers</span>, <span class="hlFld-ContribAuthor ">Yongda  Zhang</span>, <span class="hlFld-ContribAuthor ">Maurice A.  Marsini</span>, <span class="hlFld-ContribAuthor ">Keith R.  Fandrick</span>, <span class="hlFld-ContribAuthor ">Daniel  Rivalti</span>, <span class="hlFld-ContribAuthor ">Chris H.  Senanayake</span>. </span><span class="cited-content_cbyCitation_article-title">Addition of Non-Stabilized Carbon-Based Nucleophilic Reagents to Chiral
              N
              -Sulfinyl Imines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 1-422. <a href="https://doi.org/10.1002/0471264180.or099.01" title="DOI URL">https://doi.org/10.1002/0471264180.or099.01</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471264180.or099.01&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471264180.or099.01%26sid%3Dliteratum%253Aachs%26atitle%3DAddition%252Bof%252BNon-Stabilized%252BCarbon-Based%252BNucleophilic%252BReagents%252Bto%252BChiral%252BN%252B-Sulfinyl%252BImines%26aulast%3DHerbage%26aufirst%3DMelissa%2BA.%26date%3D2019%26date%3D2019%26spage%3D1%26epage%3D422%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DOrganic%252BReactions%26date%3D2004%26date%3D2004%26volume%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rona R.  Ramsay</span>, <span class="hlFld-ContribAuthor ">Marija R.  Popovic‐Nikolic</span>, <span class="hlFld-ContribAuthor ">Katarina  Nikolic</span>, <span class="hlFld-ContribAuthor ">Elisa  Uliassi</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">A perspective on multi‐target drug discovery and design for complex diseases. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Translational Medicine</span><span> <strong>2018,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40169-017-0181-2" title="DOI URL">https://doi.org/10.1186/s40169-017-0181-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40169-017-0181-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40169-017-0181-2%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Translational%2520Medicine%26atitle%3DA%252Bperspective%252Bon%252Bmulti%2525E2%252580%252590target%252Bdrug%252Bdiscovery%252Band%252Bdesign%252Bfor%252Bcomplex%252Bdiseases%26aulast%3DRamsay%26aufirst%3DRona%2BR.%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Shen</span>, <span class="hlFld-ContribAuthor ">Haibo  Wang</span>, <span class="hlFld-ContribAuthor ">Qiying  Sun</span>, <span class="hlFld-ContribAuthor ">Hailan  Yao</span>, <span class="hlFld-ContribAuthor ">Andrew P.  Keegan</span>, <span class="hlFld-ContribAuthor ">Mike  Mullan</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Wilson</span>, <span class="hlFld-ContribAuthor ">Simone  Lista</span>, <span class="hlFld-ContribAuthor ">Thomas  Leyhe</span>, <span class="hlFld-ContribAuthor ">Christoph  Laske</span>, <span class="hlFld-ContribAuthor ">Dan  Rujescu</span>, <span class="hlFld-ContribAuthor ">Allan  Levey</span>, <span class="hlFld-ContribAuthor ">Anders  Wallin</span>, <span class="hlFld-ContribAuthor ">Kaj  Blennow</span>, <span class="hlFld-ContribAuthor ">Rena  Li</span>, <span class="hlFld-ContribAuthor ">Harald  Hampel</span>. </span><span class="cited-content_cbyCitation_article-title">Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer’s Disease Dementia in Individuals With Mild Cognitive Impairment. </span><span class="cited-content_cbyCitation_journal-name">Biological Psychiatry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (5)
                                     , 447-455. <a href="https://doi.org/10.1016/j.biopsych.2017.02.007" title="DOI URL">https://doi.org/10.1016/j.biopsych.2017.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopsych.2017.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopsych.2017.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520Psychiatry%26atitle%3DIncreased%252BPlasma%252BBeta-Secretase%252B1%252BMay%252BPredict%252BConversion%252Bto%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BDementia%252Bin%252BIndividuals%252BWith%252BMild%252BCognitive%252BImpairment%26aulast%3DShen%26aufirst%3DYong%26date%3D2018%26volume%3D83%26issue%3D5%26spage%3D447%26epage%3D455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ravichand  Palakurti</span>, <span class="hlFld-ContribAuthor ">Ramakrishna  Vadrevu</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore based 3D-QSAR modeling, virtual screening and docking for identification of potential inhibitors of β-secretase. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2017,</strong> <em>68 </em>, 107-117. <a href="https://doi.org/10.1016/j.compbiolchem.2017.03.001" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2017.03.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2017.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2017.03.001%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DPharmacophore%252Bbased%252B3D-QSAR%252Bmodeling%25252C%252Bvirtual%252Bscreening%252Band%252Bdocking%252Bfor%252Bidentification%252Bof%252Bpotential%252Binhibitors%252Bof%252B%2525CE%2525B2-secretase%26aulast%3DPalakurti%26aufirst%3DRavichand%26date%3D2017%26volume%3D68%26spage%3D107%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.M.  Tice</span>, <span class="hlFld-ContribAuthor ">Y.  Zheng</span>, <span class="hlFld-ContribAuthor ">S.B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 211-263. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12291-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12291-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12291-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12291-7%26sid%3Dliteratum%253Aachs%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BDrug%252BDiscovery%26aulast%3DTice%26aufirst%3DC.M.%26date%3D2017%26spage%3D211%26epage%3D263%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martín  Estrada</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">Elena  Soriano</span>, <span class="hlFld-ContribAuthor ">Erik  Laurini</span>, <span class="hlFld-ContribAuthor ">Maurizio  Romano</span>, <span class="hlFld-ContribAuthor ">Sabrina  Pricl</span>, <span class="hlFld-ContribAuthor ">José A  Morales-García</span>, <span class="hlFld-ContribAuthor ">Ana  Pérez-Castillo</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2016,</strong> <em>8 </em>
                                    (11)
                                     , 1191-1207. <a href="https://doi.org/10.4155/fmc-2016-0036" title="DOI URL">https://doi.org/10.4155/fmc-2016-0036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2016-0036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2016-0036%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bneurogenic%252Blipoic-based%252Bhybrids%252Bas%252Binnovative%252BAlzheimer%252527s%252Bdrugs%252Bwith%252B%2525CF%252583-1%252Bagonism%252Band%252B%2525CE%2525B2-secretase%252Binhibition%26aulast%3DEstrada%26aufirst%3DMart%25C3%25ADn%26date%3D2016%26volume%3D8%26issue%3D11%26spage%3D1191%26epage%3D1207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarina  Nikolic</span>, <span class="hlFld-ContribAuthor ">Lazaros  Mavridis</span>, <span class="hlFld-ContribAuthor ">Teodora  Djikic</span>, <span class="hlFld-ContribAuthor ">Jelica  Vucicevic</span>, <span class="hlFld-ContribAuthor ">Danica  Agbaba</span>, <span class="hlFld-ContribAuthor ">Kemal  Yelekci</span>, <span class="hlFld-ContribAuthor ">John B. O.  Mitchell</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2016,</strong> <em>10 </em><a href="https://doi.org/10.3389/fnins.2016.00265" title="DOI URL">https://doi.org/10.3389/fnins.2016.00265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2016.00265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2016.00265%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DDrug%252BDesign%252Bfor%252BCNS%252BDiseases%25253A%252BPolypharmacological%252BProfiling%252Bof%252BCompounds%252BUsing%252BCheminformatic%25252C%252B3D-QSAR%252Band%252BVirtual%252BScreening%252BMethodologies%26aulast%3DNikolic%26aufirst%3DKatarina%26date%3D2016%26date%3D2016%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carlos  Gueto-Tettay</span>, <span class="hlFld-ContribAuthor ">Roberto  Pestana-Nobles</span>, <span class="hlFld-ContribAuthor ">Juan Carlos  Drosos-Ramirez</span>. </span><span class="cited-content_cbyCitation_article-title">Determination of the protonation state for the catalytic dyad in β-secretase when bound to hydroxyethylamine transition state analogue inhibitors: A molecular dynamics simulation study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2016,</strong> <em>66 </em>, 155-167. <a href="https://doi.org/10.1016/j.jmgm.2016.04.003" title="DOI URL">https://doi.org/10.1016/j.jmgm.2016.04.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2016.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2016.04.003%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DDetermination%252Bof%252Bthe%252Bprotonation%252Bstate%252Bfor%252Bthe%252Bcatalytic%252Bdyad%252Bin%252B%2525CE%2525B2-secretase%252Bwhen%252Bbound%252Bto%252Bhydroxyethylamine%252Btransition%252Bstate%252Banalogue%252Binhibitors%25253A%252BA%252Bmolecular%252Bdynamics%252Bsimulation%252Bstudy%26aulast%3DGueto-Tettay%26aufirst%3DCarlos%26date%3D2016%26volume%3D66%26spage%3D155%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony J.  Burke</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in metal catalyzed intramolecular aryl additions—accessing bioactive molecules. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (11)
                                     , 1197-1204. <a href="https://doi.org/10.1016/j.tetlet.2016.02.023" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.02.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.02.023%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DRecent%252Badvances%252Bin%252Bmetal%252Bcatalyzed%252Bintramolecular%252Baryl%252Badditions%2525E2%252580%252594accessing%252Bbioactive%252Bmolecules%26aulast%3DBurke%26aufirst%3DAnthony%2BJ.%26date%3D2016%26volume%3D57%26issue%3D11%26spage%3D1197%26epage%3D1204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel F.  Wyss</span>, <span class="hlFld-ContribAuthor ">Jared N.  Cumming</span>, <span class="hlFld-ContribAuthor ">Corey O.  Strickland</span>, <span class="hlFld-ContribAuthor ">Andrew W.  Stamford</span>. </span><span class="cited-content_cbyCitation_article-title">BACE Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 327-354. <a href="https://doi.org/10.1002/9783527683604.ch14" title="DOI URL">https://doi.org/10.1002/9783527683604.ch14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527683604.ch14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527683604.ch14%26sid%3Dliteratum%253Aachs%26atitle%3DBACE%252BInhibitors%26aulast%3DWyss%26aufirst%3DDaniel%2BF.%26date%3D2016%26date%3D2016%26spage%3D327%26epage%3D354%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DFragment-based%252BDrug%252BDiscovery%252BLessons%252Band%252BOutlook%26aulast%3DErlanson%26aufirst%3DDaniel%2BA.%26date%3D2016%26volume%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esteban Gabriel  Vega-Hissi</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Tosso</span>, <span class="hlFld-ContribAuthor ">Ricardo Daniel  Enriz</span>, <span class="hlFld-ContribAuthor ">Lucas Joel  Gutierrez</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular insight into the interaction mechanisms of amino-2
              H
              -imidazole derivatives with BACE1 protease: A QM/MM and QTAIM study. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Quantum Chemistry</span><span> <strong>2015,</strong> <em>115 </em>
                                    (6)
                                     , 389-397. <a href="https://doi.org/10.1002/qua.24854" title="DOI URL">https://doi.org/10.1002/qua.24854</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/qua.24854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fqua.24854%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Quantum%2520Chemistry%26atitle%3DMolecular%252Binsight%252Binto%252Bthe%252Binteraction%252Bmechanisms%252Bof%252Bamino-2%252BH%252B-imidazole%252Bderivatives%252Bwith%252BBACE1%252Bprotease%25253A%252BA%252BQM%25252FMM%252Band%252BQTAIM%252Bstudy%26aulast%3DVega-Hissi%26aufirst%3DEsteban%2BGabriel%26date%3D2015%26date%3D2014%26volume%3D115%26issue%3D6%26spage%3D389%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin J.  Hodgetts</span>. </span><span class="cited-content_cbyCitation_article-title">Case Studies of CNS Drug Optimization-Medicinal Chemistry and CNS Biology Perspectives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 425-445. <a href="https://doi.org/10.1002/9781118788523.ch19" title="DOI URL">https://doi.org/10.1002/9781118788523.ch19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118788523.ch19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118788523.ch19%26sid%3Dliteratum%253Aachs%26atitle%3DCase%252BStudies%252Bof%252BCNS%252BDrug%252BOptimization-Medicinal%252BChemistry%252Band%252BCNS%252BBiology%252BPerspectives%26aulast%3DHodgetts%26aufirst%3DKevin%2BJ.%26date%3D2015%26date%3D2015%26spage%3D425%26epage%3D445%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DBlood-Brain%252BBarrier%252Bin%252BDrug%252BDiscovery%26aulast%3DDi%26aufirst%3DLi%26date%3D2015%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T. J.  Ritchie</span>, <span class="hlFld-ContribAuthor ">S. J. F.  Macdonald</span>, <span class="hlFld-ContribAuthor ">S. D.  Pickett</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into the impact of N- and O-methylation on aqueous solubility and lipophilicity using matched molecular pair analysis. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (10)
                                     , 1787-1797. <a href="https://doi.org/10.1039/C5MD00309A" title="DOI URL">https://doi.org/10.1039/C5MD00309A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00309A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00309A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DInsights%252Binto%252Bthe%252Bimpact%252Bof%252BN-%252Band%252BO-methylation%252Bon%252Baqueous%252Bsolubility%252Band%252Blipophilicity%252Busing%252Bmatched%252Bmolecular%252Bpair%252Banalysis%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D10%26spage%3D1787%26epage%3D1797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yajun  Zheng</span>, <span class="hlFld-ContribAuthor ">Colin M.  Tice</span>, <span class="hlFld-ContribAuthor ">Suresh B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">The use of spirocyclic scaffolds in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (16)
                                     , 3673-3682. <a href="https://doi.org/10.1016/j.bmcl.2014.06.081" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.06.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.06.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.06.081%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Buse%252Bof%252Bspirocyclic%252Bscaffolds%252Bin%252Bdrug%252Bdiscovery%26aulast%3DZheng%26aufirst%3DYajun%26date%3D2014%26volume%3D24%26issue%3D16%26spage%3D3673%26epage%3D3682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juliette  Janson</span>, <span class="hlFld-ContribAuthor ">Susanna  Eketjäll</span>, <span class="hlFld-ContribAuthor ">Karin  Tunblad</span>, <span class="hlFld-ContribAuthor ">Fredrik  Jeppsson</span>, <span class="hlFld-ContribAuthor ">Stefan  Von Berg</span>, <span class="hlFld-ContribAuthor ">Camilla  Niva</span>, <span class="hlFld-ContribAuthor ">Ann-Cathrin  Radesäter</span>, <span class="hlFld-ContribAuthor ">Johanna  Fälting</span>, <span class="hlFld-ContribAuthor ">Sandra A. G.  Visser</span>. </span><span class="cited-content_cbyCitation_article-title">Population PKPD Modeling of BACE1 Inhibitor-Induced Reduction in Aβ Levels In Vivo and Correlation to In Vitro Potency in Primary Cortical Neurons from Mouse and Guinea Pig. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Research</span><span> <strong>2014,</strong> <em>31 </em>
                                    (3)
                                     , 670-683. <a href="https://doi.org/10.1007/s11095-013-1189-y" title="DOI URL">https://doi.org/10.1007/s11095-013-1189-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11095-013-1189-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11095-013-1189-y%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Research%26atitle%3DPopulation%252BPKPD%252BModeling%252Bof%252BBACE1%252BInhibitor-Induced%252BReduction%252Bin%252BA%2525CE%2525B2%252BLevels%252BIn%252BVivo%252Band%252BCorrelation%252Bto%252BIn%252BVitro%252BPotency%252Bin%252BPrimary%252BCortical%252BNeurons%252Bfrom%252BMouse%252Band%252BGuinea%252BPig%26aulast%3DJanson%26aufirst%3DJuliette%26date%3D2014%26date%3D2013%26volume%3D31%26issue%3D3%26spage%3D670%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Omar  Aziz</span>, <span class="hlFld-ContribAuthor ">Roland W.  Bürli</span>, <span class="hlFld-ContribAuthor ">David F.  Fischer</span>, <span class="hlFld-ContribAuthor ">Julie  Frearson</span>, <span class="hlFld-ContribAuthor ">Michael D.  Wall</span>. </span><span class="cited-content_cbyCitation_article-title">Towards Small Molecules as Therapies for Alzheimer’s Disease and Other Neurodegenerative Disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 199-290. <a href="https://doi.org/10.1016/B978-0-12-803959-5.50004-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-803959-5.50004-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803959-5.50004-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803959-5.50004-0%26sid%3Dliteratum%253Aachs%26atitle%3DTowards%252BSmall%252BMolecules%252Bas%252BTherapies%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Band%252BOther%252BNeurodegenerative%252BDisorders%26aulast%3DAziz%26aufirst%3DOmar%26date%3D2014%26spage%3D199%26epage%3D290%26pub%3DElsevier%26atitle%3DDrug%252BDesign%252Band%252BDiscovery%252Bin%252BAlzheimer%252527s%252BDisease%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaspreet Kaur  Dhanjal</span>, <span class="hlFld-ContribAuthor ">Sukriti  Goyal</span>, <span class="hlFld-ContribAuthor ">Sudhanshu  Sharma</span>, <span class="hlFld-ContribAuthor ">Rabia  Hamid</span>, <span class="hlFld-ContribAuthor ">Abhinav  Grover</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic insights into mode of action of potent natural antagonists of BACE-1 for checking Alzheimer’s plaque pathology. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2014,</strong> <em>443 </em>
                                    (3)
                                     , 1054-1059. <a href="https://doi.org/10.1016/j.bbrc.2013.12.088" title="DOI URL">https://doi.org/10.1016/j.bbrc.2013.12.088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2013.12.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2013.12.088%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DMechanistic%252Binsights%252Binto%252Bmode%252Bof%252Baction%252Bof%252Bpotent%252Bnatural%252Bantagonists%252Bof%252BBACE-1%252Bfor%252Bchecking%252BAlzheimer%2525E2%252580%252599s%252Bplaque%252Bpathology%26aulast%3DDhanjal%26aufirst%3DJaspreet%2BKaur%26date%3D2014%26volume%3D443%26issue%3D3%26spage%3D1054%26epage%3D1059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arun K.  Ghosh</span>, <span class="hlFld-ContribAuthor ">Heather L.  Osswald</span>. </span><span class="cited-content_cbyCitation_article-title">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Chem. Soc. Rev.</span><span> <strong>2014,</strong> <em>43 </em>
                                    (19)
                                     , 6765-6813. <a href="https://doi.org/10.1039/C3CS60460H" title="DOI URL">https://doi.org/10.1039/C3CS60460H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C3CS60460H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC3CS60460H%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Soc.%2520Rev.%26atitle%3DBACE1%252B%252528%2525CE%2525B2-secretase%252529%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DGhosh%26aufirst%3DArun%2BK.%26date%3D2014%26date%3D2014%26volume%3D43%26issue%3D19%26spage%3D6765%26epage%3D6813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Genevieve  Evin</span>, <span class="hlFld-ContribAuthor ">Christopher  Hince</span>. </span><span class="cited-content_cbyCitation_article-title">BACE1 as a Therapeutic Target in Alzheimer’s Disease: Rationale and Current Status. </span><span class="cited-content_cbyCitation_journal-name">Drugs & Aging</span><span> <strong>2013,</strong> <em>30 </em>
                                    (10)
                                     , 755-764. <a href="https://doi.org/10.1007/s40266-013-0099-3" title="DOI URL">https://doi.org/10.1007/s40266-013-0099-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40266-013-0099-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40266-013-0099-3%26sid%3Dliteratum%253Aachs%26jtitle%3DDrugs%2520%2526%2520Aging%26atitle%3DBACE1%252Bas%252Ba%252BTherapeutic%252BTarget%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BRationale%252Band%252BCurrent%252BStatus%26aulast%3DEvin%26aufirst%3DGenevieve%26date%3D2013%26date%3D2013%26volume%3D30%26issue%3D10%26spage%3D755%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshio  Hamada</span>, <span class="hlFld-ContribAuthor ">Yoshiaki  Kiso</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the identification of β-secretase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2013,</strong> <em>8 </em>
                                    (6)
                                     , 709-731. <a href="https://doi.org/10.1517/17460441.2013.784267" title="DOI URL">https://doi.org/10.1517/17460441.2013.784267</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2013.784267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2013.784267%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DAdvances%252Bin%252Bthe%252Bidentification%252Bof%252B%2525CE%2525B2-secretase%252Binhibitors%26aulast%3DHamada%26aufirst%3DYoshio%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D6%26spage%3D709%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lewis D.  Pennington</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Steven R.  Jordan</span>, <span class="hlFld-ContribAuthor ">Holger  Monenschein</span>, <span class="hlFld-ContribAuthor ">Thomas T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Bryant H.  Yang</span>, <span class="hlFld-ContribAuthor ">Qiufen M.  Xue</span>, <span class="hlFld-ContribAuthor ">Filisaty  Vounatsos</span>, <span class="hlFld-ContribAuthor ">Robert C.  Wahl</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Martin  Citron</span>, <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Hitchcock</span>, <span class="hlFld-ContribAuthor ">Wenge  Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">Hydroxyethylamine-based inhibitors of BACE1: P1–P3 macrocyclization can improve potency, selectivity, and cell activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (15)
                                     , 4459-4464. <a href="https://doi.org/10.1016/j.bmcl.2013.05.028" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.05.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.05.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.05.028%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHydroxyethylamine-based%252Binhibitors%252Bof%252BBACE1%25253A%252BP1%2525E2%252580%252593P3%252Bmacrocyclization%252Bcan%252Bimprove%252Bpotency%25252C%252Bselectivity%25252C%252Band%252Bcell%252Bactivity%26aulast%3DPennington%26aufirst%3DLewis%2BD.%26date%3D2013%26volume%3D23%26issue%3D15%26spage%3D4459%26epage%3D4464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raymond A.  Ng</span>, <span class="hlFld-ContribAuthor ">Minghua  Sun</span>, <span class="hlFld-ContribAuthor ">Simeon  Bowers</span>, <span class="hlFld-ContribAuthor ">Roy K.  Hom</span>, <span class="hlFld-ContribAuthor ">Gary D.  Probst</span>, <span class="hlFld-ContribAuthor ">Varghese  John</span>, <span class="hlFld-ContribAuthor ">Lawrence Y.  Fang</span>, <span class="hlFld-ContribAuthor ">Michel  Maillard</span>, <span class="hlFld-ContribAuthor ">Andrea  Gailunas</span>, <span class="hlFld-ContribAuthor ">Louis  Brogley</span>, <span class="hlFld-ContribAuthor ">R. Jeffrey  Neitz</span>, <span class="hlFld-ContribAuthor ">Jay S.  Tung</span>, <span class="hlFld-ContribAuthor ">Michael A.  Pleiss</span>, <span class="hlFld-ContribAuthor ">Andrei W.  Konradi</span>, <span class="hlFld-ContribAuthor ">Hing L.  Sham</span>, <span class="hlFld-ContribAuthor ">Michael S.  Dappen</span>, <span class="hlFld-ContribAuthor ">Marc  Adler</span>, <span class="hlFld-ContribAuthor ">Nanhua  Yao</span>, <span class="hlFld-ContribAuthor ">Wes  Zmolek</span>, <span class="hlFld-ContribAuthor ">David  Nakamura</span>, <span class="hlFld-ContribAuthor ">Kevin P.  Quinn</span>, <span class="hlFld-ContribAuthor ">John-Michael  Sauer</span>, <span class="hlFld-ContribAuthor ">Michael P.  Bova</span>, <span class="hlFld-ContribAuthor ">Lany  Ruslim</span>, <span class="hlFld-ContribAuthor ">Dean R.  Artis</span>, <span class="hlFld-ContribAuthor ">Ted A.  Yednock</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: Prime side chromane-containing inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (16)
                                     , 4674-4679. <a href="https://doi.org/10.1016/j.bmcl.2013.06.006" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.06.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.06.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bhydroxyethylamine%252B%252528HEA%252529%252BBACE-1%252Binhibitors%25253A%252BPrime%252Bside%252Bchromane-containing%252Binhibitors%26aulast%3DNg%26aufirst%3DRaymond%2BA.%26date%3D2013%26volume%3D23%26issue%3D16%26spage%3D4674%26epage%3D4679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Harvey  Wong</span>, <span class="hlFld-ContribAuthor ">Kimberly  Scearce-Levie</span>, <span class="hlFld-ContribAuthor ">Ryan J.  Watts</span>, <span class="hlFld-ContribAuthor ">Melis  Coraggio</span>, <span class="hlFld-ContribAuthor ">Young G.  Shin</span>, <span class="hlFld-ContribAuthor ">Kun  Peng</span>, <span class="hlFld-ContribAuthor ">Kristin R.  Wildsmith</span>, <span class="hlFld-ContribAuthor ">Jasvinder K.  Atwal</span>, <span class="hlFld-ContribAuthor ">Jason  Mango</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Schauer</span>, <span class="hlFld-ContribAuthor ">Kelly  Regal</span>, <span class="hlFld-ContribAuthor ">Kevin W.  Hunt</span>, <span class="hlFld-ContribAuthor ">Allen A.  Thomas</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>, <span class="hlFld-ContribAuthor ">Joseph  Lyssikatos</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Cornelis E. C. A.  Hop</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic Pharmacokinetic-Pharmacodynamic Modeling of BACE1 Inhibition in Monkeys: Development of a Predictive Model for Amyloid Precursor Protein Processing. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2013,</strong> <em>41 </em>
                                    (7)
                                     , 1319-1328. <a href="https://doi.org/10.1124/dmd.112.050864" title="DOI URL">https://doi.org/10.1124/dmd.112.050864</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.112.050864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.112.050864%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DMechanistic%252BPharmacokinetic-Pharmacodynamic%252BModeling%252Bof%252BBACE1%252BInhibition%252Bin%252BMonkeys%25253A%252BDevelopment%252Bof%252Ba%252BPredictive%252BModel%252Bfor%252BAmyloid%252BPrecursor%252BProtein%252BProcessing%26aulast%3DLiu%26aufirst%3DXingrong%26date%3D2013%26date%3D2013%26volume%3D41%26issue%3D7%26spage%3D1319%26epage%3D1328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-zi  Xu</span>, <span class="hlFld-ContribAuthor ">Shendong  Yuan</span>, <span class="hlFld-ContribAuthor ">Simeon  Bowers</span>, <span class="hlFld-ContribAuthor ">Roy K.  Hom</span>, <span class="hlFld-ContribAuthor ">Wayman  Chan</span>, <span class="hlFld-ContribAuthor ">Hing L.  Sham</span>, <span class="hlFld-ContribAuthor ">Yong L.  Zhu</span>, <span class="hlFld-ContribAuthor ">Paul  Beroza</span>, <span class="hlFld-ContribAuthor ">Hu  Pan</span>, <span class="hlFld-ContribAuthor ">Eric  Brecht</span>, <span class="hlFld-ContribAuthor ">Nanhua  Yao</span>, <span class="hlFld-ContribAuthor ">Julie  Lougheed</span>, <span class="hlFld-ContribAuthor ">Jiangli  Yan</span>, <span class="hlFld-ContribAuthor ">Danny  Tam</span>, <span class="hlFld-ContribAuthor ">Zhao  Ren</span>, <span class="hlFld-ContribAuthor ">Lany  Ruslim</span>, <span class="hlFld-ContribAuthor ">Michael P.  Bova</span>, <span class="hlFld-ContribAuthor ">Dean R.  Artis</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (10)
                                     , 3075-3080. <a href="https://doi.org/10.1016/j.bmcl.2013.03.009" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.03.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.03.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bthiophene%252Bdihydroisoquinolines%252Bas%252Bnovel%252BBACE1%252Binhibitors%26aulast%3DXu%26aufirst%3DYing-zi%26date%3D2013%26volume%3D23%26issue%3D10%26spage%3D3075%26epage%3D3080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anders  Lindgren</span>, <span class="hlFld-ContribAuthor ">Göran  Eklund</span>, <span class="hlFld-ContribAuthor ">Dominika  Turek</span>, <span class="hlFld-ContribAuthor ">Jonas  Malmquist</span>, <span class="hlFld-ContribAuthor ">Britt-Marie  Swahn</span>, <span class="hlFld-ContribAuthor ">Jörg  Holenz</span>, <span class="hlFld-ContribAuthor ">Stefan  von Berg</span>, <span class="hlFld-ContribAuthor ">Sofia  Karlström</span>, <span class="hlFld-ContribAuthor ">Tjerk  Bueters</span>. </span><span class="cited-content_cbyCitation_article-title">Biotransformation of Two
              β
              -Secretase Inhibitors Including Ring Opening and Contraction of a Pyrimidine Ring. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2013,</strong> <em>41 </em>
                                    (5)
                                     , 1134-1147. <a href="https://doi.org/10.1124/dmd.112.050351" title="DOI URL">https://doi.org/10.1124/dmd.112.050351</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.112.050351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.112.050351%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DBiotransformation%252Bof%252BTwo%252B%2525CE%2525B2%252B-Secretase%252BInhibitors%252BIncluding%252BRing%252BOpening%252Band%252BContraction%252Bof%252Ba%252BPyrimidine%252BRing%26aulast%3DLindgren%26aufirst%3DAnders%26date%3D2013%26date%3D2013%26volume%3D41%26issue%3D5%26spage%3D1134%26epage%3D1147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">The Influence of Bioisosteres in Drug Design: Tactical Applications to Address Developability Problems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 283-381. <a href="https://doi.org/10.1007/7355_2013_29" title="DOI URL">https://doi.org/10.1007/7355_2013_29</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2013_29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2013_29%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BInfluence%252Bof%252BBioisosteres%252Bin%252BDrug%252BDesign%25253A%252BTactical%252BApplications%252Bto%252BAddress%252BDevelopability%252BProblems%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2013%26date%3D2014%26spage%3D283%26epage%3D381%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DTactics%252Bin%252BContemporary%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2015%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Jianhua  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Zhu</span>, <span class="hlFld-ContribAuthor ">Yi  Luo</span>, <span class="hlFld-ContribAuthor ">Safura  Babu-Khan</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Roger  Pham</span>, <span class="hlFld-ContribAuthor ">Joel  Esmay</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Dineen</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Kaller</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Hitchcock</span>, <span class="hlFld-ContribAuthor ">Martin  Citron</span>, <span class="hlFld-ContribAuthor ">Wenge  Zhong</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Toni  Williamson</span>. </span><span class="cited-content_cbyCitation_article-title">Establishing the Relationship between In Vitro Potency, Pharmacokinetic, and Pharmacodynamic Parameters in a Series of Orally Available, Hydroxyethylamine-Derived β-Secretase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2012,</strong> <em>343 </em>
                                    (2)
                                     , 460-467. <a href="https://doi.org/10.1124/jpet.112.197954" title="DOI URL">https://doi.org/10.1124/jpet.112.197954</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.112.197954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.112.197954%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DEstablishing%252Bthe%252BRelationship%252Bbetween%252BIn%252BVitro%252BPotency%25252C%252BPharmacokinetic%25252C%252Band%252BPharmacodynamic%252BParameters%252Bin%252Ba%252BSeries%252Bof%252BOrally%252BAvailable%25252C%252BHydroxyethylamine-Derived%252B%2525CE%2525B2-Secretase%252BInhibitors%26aulast%3DWood%26aufirst%3DStephen%26date%3D2012%26date%3D2012%26volume%3D343%26issue%3D2%26spage%3D460%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/medium/jm-2012-00119p_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300119p&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/medium/jm-2012-00119p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Previously reported BACE1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300119p&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/medium/jm-2012-00119p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300119p&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) THF, −65 °C, 42–76%; (b) HCl, ethanol 15 °C then Boc<sub>2</sub>O, TEA, 73–78%; (c) Dess–Martin periodinane, NaHCO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 72–91%; (d) methyl 2-(<i>tert</i>-butoxycarbonylamino)-2-(dimethoxyphosphoryl)acetate, DBU, DCM, 65–94%; (e) (1<i>R</i>,1<i>R</i>′,2<i>S</i>,2<i>S</i>′)-(COD)Rh(DuanPhos)BF<sub>4</sub>, CH<sub>3</sub>OH, H<sub>2</sub>, 50 psi, 94–96%, >95% ee; (f) LiOH, THF, H<sub>2</sub>O, 100%; (g) isobutyl chloroformate, TEA, CH<sub>2</sub>N<sub>2</sub>, THF;HBr, AcOH, THF; K<sub>2</sub>CO<sub>3</sub>, NaOAc, DMF, 42–99%; (h) LiH(OtBu)<sub>3</sub>, THF, −78 °C, 82–98%; (i) dimethoxypropane, CSA, DMF, 95–96%; (j) K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>OH, 50–74%; (k) Dess–Martin periodinane, NaHCO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 84–93%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/medium/jm-2012-00119p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300119p&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <b>12</b>, (CH<sub>3</sub>O)<sub>3</sub>CH, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (b) HCl, dioxane, CH<sub>3</sub>OH, 97–100%, 2 steps; (c) <i>N</i>-acetylimidazole, DIPEA, DMF, 39–72%, or carbonyldiimidazole, DIPEA, Y-CO<sub>2</sub>H, CH<sub>2</sub>Cl<sub>2</sub>, 77–91%, or HATU, Y-CO<sub>2</sub>H, DIPEA, DMF, 35–53%.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/medium/jm-2012-00119p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cocrystal structure of BACE1 complexed with <b>21</b>; the flap is depicted in blue. (left) Interactions in S1′ and S2′ as well as the hydrogen bonding between <b>21</b> and the catalytic aspartates. (right) Hydrogen bonding contacts between Gly230 and Thr72 residues and the amide of <b>21</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300119p&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/medium/jm-2012-00119p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0011.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vivo Aβ<sub>40</sub> reduction in naïve rats with <b>21</b> (10, 30, and 100 mg/kg, po). *** <i>P</i> ≤ 0.0001; ** <i>P</i> ≤ 0.005.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm300119p/production/images/large/jm-2012-00119p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300119p&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62440" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62440" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Alzheimer’s Association</span><span class="NLM_x">. </span><span> </span><span class="NLM_article-title">Alzheimer’s disease facts and figures</span>.  <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=20298981" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=158-194&issue=6&author=Alzheimer%E2%80%99s+Association&title=Alzheimer%E2%80%99s+disease+facts+and+figures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520facts%2520and%2520figures%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2010%26issue%3D6%26spage%3D158%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Translating cell biology into therapeutic advances in Alzheimer’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">399</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 6738</span><span class="NLM_x">) </span> <span class="NLM_fpage">A23</span><span class="NLM_x">–</span> <span class="NLM_lpage">A31</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=1999&pages=A23-A31&issue=Suppl.+6738&author=D.+J.+Selkoe&title=Translating+cell+biology+into+therapeutic+advances+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DTranslating%2520cell%2520biology%2520into%2520therapeutic%2520advances%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D1999%26volume%3D399%26issue%3DSuppl.%25206738%26spage%3DA23%26epage%3DA31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cummings, J. L.</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1056%2FNEJMra040223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=15229308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltlOjsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2004&pages=56-67&author=J.+L.+Cummings&title=Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Cummings, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-67</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review on Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE6JT2vPzAVrVg90H21EOLACvtfcHk0lhSjkhQS1v3Zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltlOjsb8%253D&md5=ec3a7d85cdfbeb7ea5cfaeeefc3a94ad</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1056%2FNEJMra040223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra040223%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D351%26spage%3D56%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Querfurth, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1056%2FNEJMra0909142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=20107219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=329-344&author=H.+W.+Querfurthauthor=F.+M.+LaFerla&title=Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Querfurth, Henry W.; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-344</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The role of β-amyloid peptide in spontaneous self-aggregation in brain in Alzheimer's disease is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPeniV_Jn6orVg90H21EOLACvtfcHk0lizwEXlqXlxBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D&md5=c116f6a6b8fed9af9f5282cc4b755c70</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0909142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0909142%26sid%3Dliteratum%253Aachs%26aulast%3DQuerfurth%26aufirst%3DH.%2BW.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D329%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Leon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2006&pages=387-403&author=K.+Blennowauthor=M.+J.+de+Leonauthor=H.+Zetterberg&title=Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3Dde%2BLeon%26aufirst%3DM.%2BJ.%26aulast%3DZetterberg%26aufirst%3DH.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2006%26volume%3D368%26spage%3D387%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Williams, M.</span><span> </span><span class="NLM_article-title">Progress in Alzheimer’s disease drug discovery: an update</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=23-34&author=M.+Williams&title=Progress+in+Alzheimer%E2%80%99s+disease+drug+discovery%3A+an+update"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3DProgress%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520drug%2520discovery%253A%2520an%2520update%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D23%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Goedert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillantini, M. G.</span><span> </span><span class="NLM_article-title">A century of Alzheimer’s Disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=777-781&author=M.+Goedertauthor=M.+G.+Spillantini&title=A+century+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26atitle%3DA%2520century%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D777%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+Amyloid+Hypothesis+of+Alzheimer%E2%80%99s+Disease%3A+Progress+and+Problems+on+the+Road+to+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lizwEXlqXlxBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Amyloid%2520Hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Progress%2520and%2520Problems%2520on%2520the%2520Road%2520to%2520Therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Prasher, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessling, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, E. M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barber, S. P. C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, A. C.</span><span> </span><span class="NLM_article-title">Molecular Mapping of Iiv Alzheimer-Type Dementia in Down’s Syndrome</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1002%2Fana.410430316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=9506555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADyaK1cXitFart7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1998&pages=380-383&author=V.+P.+Prasherauthor=M.+J.+Farrerauthor=A.+M.+Kesslingauthor=E.+M.+C.+Fisherauthor=R.+J.+Westauthor=S.+P.+C+Barberauthor=A.+C.+Butler&title=Molecular+Mapping+of+Iiv+Alzheimer-Type+Dementia+in+Down%E2%80%99s+Syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mapping of Alzheimer-type dementia in Down's syndrome</span></div><div class="casAuthors">Prasher, V. P.; Farrer, Matthew J.; Kessling, Anna M.; Fisher, Elizabeth M. C.; West, R. J.; Barber, P. C.; Butler, A. C.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">380-383</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">Previous research has hypothesized an assocn. between Alzheimer's disease and the amyloid precursor protein (APP) gene found on chromosome 21.  The case of a 78-yr-old woman with Down's syndrome with partial trisomy 21 [46,XX,rec(21)dup q, inv(21) (p12q22.1)] is reported.  No evidence of Alzheimer's disease was found on neuropsychol., magnetic resonance imaging, and neuropathol. assessment.  The gene sequence for APP was present in only two copies.  This case further supports the hypothesis that Alzheimer's disease is assocd. with trisomy for proximal chromosome 21q, including the APP gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWqCnda6vForVg90H21EOLACvtfcHk0lizwEXlqXlxBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitFart7g%253D&md5=0a2aa8d05adbcd573235f12d2ab4f8da</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1002%2Fana.410430316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410430316%26sid%3Dliteratum%253Aachs%26aulast%3DPrasher%26aufirst%3DV.%2BP.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26aulast%3DKessling%26aufirst%3DA.%2BM.%26aulast%3DFisher%26aufirst%3DE.%2BM.%2BC.%26aulast%3DWest%26aufirst%3DR.%2BJ.%26aulast%3DBarber%26aufirst%3DS.%2BP.%2BC%26aulast%3DButler%26aufirst%3DA.%2BC.%26atitle%3DMolecular%2520Mapping%2520of%2520Iiv%2520Alzheimer-Type%2520Dementia%2520in%2520Down%25E2%2580%2599s%2520Syndrome%26jtitle%3DAnn.%2520Neurol.%26date%3D1998%26volume%3D43%26spage%3D380%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">BACE1: The β-Secretase Enzyme in Alzheimer’s Disease</span> <span class="citation_source-journal">J. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">1–2</span><span class="NLM_x">) </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1385%2FJMN%3A23%3A1-2%3A105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=15126696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks12jtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=105-114&issue=1%E2%80%932&author=R.+Vassar&title=BACE1%3A+The+%CE%B2-Secretase+Enzyme+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1. The β-secretase enzyme in Alzheimer's disease</span></div><div class="casAuthors">Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">105-113</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Data that have accumulated for well over a decade have implicated the β-amyloid (Aβ) peptide as a central player in the pathogenesis of Alzheimer's disease (AD).  Amyloid plaques, composed primarily of Aβ progressively form in the brains of AD patients, and mutations in three genes (amyloid precursor protein [APP] and presenilin 1 and 2 [PS1 and PS2]) cause early-onset familial AD (FAD) by directly increasing prodn. of the toxic, plaque-promoting Aβ42 peptide.  Given the strong assocn. between Aβ and AD, it is likely that therapeutic strategies to lower the levels of Aβ in the brain should prove beneficial for the treatment of AD.  One such strategy could involve inhibiting the enzymes that generate Aβ.  Aβ is a product of catabolism of the large type-I membrane protein APP.  Two proteases, called β- and γ-secretase, endoproteolyzed APP to liberate the Aβ peptide.  Recently, the mols. responsible for these proteolytic activities have been identified.  Several lines of evidence suggest that the PS1 and PS2 proteins are γ-secretase, and the identity of β-secretase has been shown to be the novel transmembrane aspartic protease, β-site APP-cleaving enzyme 1 (BACE1; also called Asp2 and memapsin 2).  BACE2, a protease homologous to BACE1, was also identified, and together the two enzymes define a new family of transmembrane aspartic proteases.  BACE1 exhibits all the functional properties of β-secretase, and as the key enzyme that initiates the formation of Aβ, BACE1 is an attractive drug target for AD.  This review discusses the identification and initial characterization of BACE1 and BACE2, and summarizes recent studies of BACE1 knockout mice that have validated BACE1 as the authentic β-secretase in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzcKcTBX0jSLVg90H21EOLACvtfcHk0lgG7NrUpswiTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks12jtr4%253D&md5=374a70b4cb76ebda767218550a6601a2</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1385%2FJMN%3A23%3A1-2%3A105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FJMN%253A23%253A1-2%253A105%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DBACE1%253A%2520The%2520%25CE%25B2-Secretase%2520Enzyme%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2004%26volume%3D23%26issue%3D1%25E2%2580%25932%26spage%3D105%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberburg, I.</span><span> </span><span class="NLM_article-title">Cellular mechanisms of β-amyloid production and secretion</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">11049</span><span class="NLM_x">–</span> <span class="NLM_lpage">11053</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1073%2Fpnas.96.20.11049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=10500121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADyaK1MXmvVCntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=11049-11053&author=S.+Sinhaauthor=I.+Lieberburg&title=Cellular+mechanisms+of+%CE%B2-amyloid+production+and+secretion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular mechanisms of β-amyloid production and secretion</span></div><div class="casAuthors">Sinha, Sukanto; Lieberburg, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11049-11053</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review with 46 refs.  The major constituent of senile plaques in Alzheimer's disease is a 42-aa peptide, referred to as β-amyloid (Aβ).  Aβ is generated from a family of differentially spliced, type-1 transmembrane domain (TM)-contg. proteins, called APP, by endoproteolytic processing.  The major, relatively ubiquitous pathway of APP metab. in cell culture involves cleavage by α-secretase, which cleaves within the Aβ sequence, thus precluding Aβ formation and deposition.  An alternate secretory pathway, enriched in neurons and brain, leads to cleavage of APP at the N terminus of the Aβ peptide by β-secretase, thus generating a cell-assocd. β-C-terminal fragment (β-CTF).  A pathogenic mutation at codons 670/671 in APP (APP "Swedish") leads to enhanced cleavage at the β-secretase scissile bond and increased Aβ formation.  An inhibitor of vacuolar ATPase, bafilomycin, selectively inhibits the action of β-secretase in cell culture, suggesting a requirement for an acidic intracellular compartment for effective β-secretase cleavage of APP.  β-CTF is cleaved in the TM domain by γ-secretase(s), generating both Aβ 1-40 (90%) and Aβ 1-42 (10%).  Pathogenic mutations in APP at codon 717 (APP "London") lead to an increased proportion of Aβ 1-42 being produced and secreted.  Missense mutations in PS-1, localized to chromosome 14, are pathogenic in the majority of familial Alzheimer's pedigrees.  These mutations also lead to increased prodn. of Aβ 1-42 over Aβ 1-40.  Knockout of PS-1 in transgenic animals leads to significant inhibition of prodn. of both Aβ 1-40 and Aβ 1-42 in primary cultures, indicating that PS-1 expression is important for γ-secretase cleavages.  Peptide aldehyde inhibitors that block Aβ prodn. by inhibiting γ-secretase cleavage of β-CTF have been discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy2KZEsg4xkrVg90H21EOLACvtfcHk0lgG7NrUpswiTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvVCntLc%253D&md5=7a48271061bce0b2aee1a60fd305662d</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.20.11049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.20.11049%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DLieberburg%26aufirst%3DI.%26atitle%3DCellular%2520mechanisms%2520of%2520%25CE%25B2-amyloid%2520production%2520and%2520secretion%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D11049%26epage%3D11053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">beta-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease bace</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=beta-Secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+bace"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0lgG7NrUpswiTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3Dbeta-Secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520bace%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintzer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, J. L.</span><span> </span><span class="NLM_article-title">Disease-modifying therapies in Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1016%2Fj.jalz.2007.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=18631951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlSmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=65-79&author=S.+Sallowayauthor=J.+Mintzerauthor=M.+F.+Weinerauthor=J.+L.+Cummings&title=Disease-modifying+therapies+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Disease-modifying therapies in Alzheimer's disease</span></div><div class="casAuthors">Salloway, Stephen; Mintzer, Jacobo; Weiner, Myron F.; Cummings, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & Dementia</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">65-79</span>CODEN:
                <span class="NLM_cas:coden">ADLEBN</span>;
        ISSN:<span class="NLM_cas:issn">1552-5260</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a chronic, progressive, neurodegenerative disorder that places a substantial burden on patients, their families, and society.  The disease affects approx. 5 million individuals in the United States, with an annual cost of care greater than $100 billion.  During the past dozen years, several agents have been approved that enhance cognition and global function of AD patients, and recent advances in understanding AD pathogenesis has led to the development of numerous compds. that might modify the disease process.  A wide array of antiamyloid and neuroprotective therapeutic approaches are under investigation on the basis of the hypothesis that amyloid beta (Aβ) protein plays a pivotal role in disease onset and progression and that secondary consequences of Aβ generation and deposition, including tau hyperphosphorylation and neurofibrillary tangle formation, oxidn., inflammation, and excitotoxicity, contribute to the disease process.  Interventions in these processes with agents that reduce amyloid prodn., limit aggregation, or increase removal might block the cascade of events comprising AD pathogenesis.  Reducing tau hyperphosphorylation, limiting oxidn. and excitotoxicity, and controlling inflammation might be beneficial disease-modifying strategies.  Potentially neuroprotective and restorative treatments such as neurotrophins, neurotrophic factor enhancers, and stem cell-related approaches are also under investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDVz15jwhEbrVg90H21EOLACvtfcHk0lgtO-llXYcaxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlSmtb0%253D&md5=626e36a2b80a383e57173f52e7722a86</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2007.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2007.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DMintzer%26aufirst%3DJ.%26aulast%3DWeiner%26aufirst%3DM.%2BF.%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26atitle%3DDisease-modifying%2520therapies%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2008%26volume%3D4%26spage%3D65%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: strategies for disease modification</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=387-398&author=M.+Citron&title=Alzheimer%E2%80%99s+disease%3A+strategies+for+disease+modification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520strategies%2520for%2520disease%2520modification%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D387%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T.</span><span> </span><span class="NLM_article-title">The secretases: enzymes with therapeutic potential in Alzheimer disease</span> <span class="citation_source-journal">Nature Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1038%2Fnrneurol.2009.218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=20139999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=99-107&author=B.+De+Strooperauthor=R.+Vassarauthor=T.+Golde&title=The+secretases%3A+enzymes+with+therapeutic+potential+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">The secretases: enzymes with therapeutic potential in Alzheimer disease</span></div><div class="casAuthors">De Strooper, Bart; Vassar, Robert; Golde, Todd</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-107</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The three secretases that process amyloid precursor protein are central to the generation of amyloid-β, and the accumulation of this peptide in extracellular plaques is one of the hallmarks of Alzheimer disease.  In this Review, De Strooper et al. discuss the evidence that suggests that these enzymes are potential therapeutic targets for Alzheimer disease drug treatments.  The amyloid hypothesis has yielded a series of well-validated candidate drug targets with potential for the treatment of Alzheimer disease (AD).  Three proteases that are involved in the processing of amyloid precursor protein-α-secretase, β-secretase and γ-secretase-are of particular interest as they are central to the generation and modulation of amyloid-β peptide and can be targeted by small compds. in vitro and in vivo.  Given that these proteases also fulfill other important biol. roles, inhibiting their activity will clearly be inherently assocd. with mechanism-based toxicity.  Carefully detg. a suitable therapeutic window and optimizing the selectivity of the drug treatments towards amyloid precursor protein processing might be ways of overcoming this potential complication.  Secretase inhibitors are likely to be the first small-mol. therapies aimed at AD modification that will be fully tested in the clinic.  Success or failure of these first-generation AD therapies will have enormous consequences for further drug development efforts for AD and possibly other neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQBldqS_TKy7Vg90H21EOLACvtfcHk0lgtO-llXYcaxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Ogt70%253D&md5=40135a0a59da6b70e4856a81ddfa6088</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2009.218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2009.218%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DGolde%26aufirst%3DT.%26atitle%3DThe%2520secretases%253A%2520enzymes%2520with%2520therapeutic%2520potential%2520in%2520Alzheimer%2520disease%26jtitle%3DNature%2520Rev.%2520Neurol.%26date%3D2010%26volume%3D6%26spage%3D99%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">beta-Secretase inhibition for the treatment of Alzheimer’s disease—promise and challenge</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=92-97&author=M.+Citron&title=beta-Secretase+inhibition+for+the+treatment+of+Alzheimer%E2%80%99s+disease%E2%80%94promise+and+challenge"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3Dbeta-Secretase%2520inhibition%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%25E2%2580%2594promise%2520and%2520challenge%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2004%26volume%3D25%26spage%3D92%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="note"><p class="first last">For recent reviews and work in this area, please see the following:</p></div><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=560-574&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D560%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Design and Synthesis of 5,5′-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901414e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1146-1158&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=S.+Jacobsenauthor=R.+L.+Magoldaauthor=M.+Pangalosauthor=A.+J.+Robichaud&title=Design+and+Synthesis+of+5%2C5%E2%80%B2-Disubstituted+Aminohydantoins+as+Potent+and+Selective+Human+%CE%B2-Secretase+%28BACE1%29+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 5,5'-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Erdei, Jim; Gunawan, Iwan; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Jacobsen, Steve; Magolda, Ronald L.; Pangalos, Menelas; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1146-1158</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit low nanomolar potency for BACE1, show comparable activity in a cell-based (ELISA) assay, and demonstrate > 100 × selectivity for the other structurally related aspartyl proteases BACE2, cathepsinD, renin, and pepsin.  On the basis of the cocrystal structure of the HTS-hit I in the BACE1 active site and by use of a structure-based drug design approach, we methodically explored the comparatively large binding pocket of the BACE1 enzyme and identified key interactions between the ligand and the protein that contributed to the affinity.  One of the more potent compds., (S)-II, displayed an IC50 value for BACE1 of 10 nM and exhibited comparable cellular activity (EC50 = 20 nM) in the ELISA assay.  Acute oral administration of (S)-II at 100 mg/kg resulted in a 69% redn. of plasma Aβ40 at 8 h in a Tg2576 mouse (p < 0.001).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovSHqfBBe70bVg90H21EOLACvtfcHk0lhzovIUlKDyKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN&md5=a27e4fbd64ed167ca7baae773c178fbc</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Fjm901414e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901414e%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520Synthesis%2520of%25205%252C5%25E2%2580%25B2-Disubstituted%2520Aminohydantoins%2520as%2520Potent%2520and%2520Selective%2520Human%2520%25CE%25B2-Secretase%2520%2528BACE1%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1146%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, O</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurlino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gool, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. T.</span><span> </span><span class="NLM_article-title">Rational design and synthesis of aminopiperazinones as β-secretase (BACE) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7255</span><span class="NLM_x">–</span> <span class="NLM_lpage">7260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=7255-7260&author=G.+Tresadernauthor=F.+Delgadoauthor=O+Delgadoauthor=H.+Gijsenauthor=G.+J.+Macdonaldauthor=D.+Moecharsauthor=F.+Romboutsauthor=R.+Alexanderauthor=J.+Spurlinoauthor=M.+V.+Goolauthor=J.+A.+Vegaauthor=A.+T.+Trabanco&title=Rational+design+and+synthesis+of+aminopiperazinones+as+%CE%B2-secretase+%28BACE%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DF.%26aulast%3DDelgado%26aufirst%3DO%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DGool%26aufirst%3DM.%2BV.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3DTrabanco%26aufirst%3DA.%2BT.%26atitle%3DRational%2520design%2520and%2520synthesis%2520of%2520aminopiperazinones%2520as%2520%25CE%25B2-secretase%2520%2528BACE%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D7255%26epage%3D7260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Boy, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guernon, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barten, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albright, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tebben, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muckelbauer, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camac, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. A.,  III.</span><span> </span><span class="NLM_article-title">Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of b-secretase (BACE)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6916</span><span class="NLM_x">–</span> <span class="NLM_lpage">6924</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6916-6924&author=K.+M.+Boyauthor=J.+M.+Guernonauthor=J.+Shiauthor=J.+H.+Toynauthor=J.+E.+Meredithauthor=D.+M.+Bartenauthor=C.+R.+Burtonauthor=C.+F.+Albrightauthor=J.+Marcinkevicieneauthor=A.+C.+Goodauthor=A.+J.+Tebbenauthor=J.+K.+Muckelbauerauthor=D.+M.+Camacauthor=K.+A.+Lentzauthor=J.+J.+Bronsonauthor=R.+E.+Olsonauthor=J.+E.+Macorauthor=L.+A.+Thompson&title=Monosubstituted+%CE%B3-lactam+and+conformationally+constrained+1%2C3-diaminopropan-2-ol+transition-state+isostere+inhibitors+of+b-secretase+%28BACE%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoy%26aufirst%3DK.%2BM.%26aulast%3DGuernon%26aufirst%3DJ.%2BM.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DToyn%26aufirst%3DJ.%2BH.%26aulast%3DMeredith%26aufirst%3DJ.%2BE.%26aulast%3DBarten%26aufirst%3DD.%2BM.%26aulast%3DBurton%26aufirst%3DC.%2BR.%26aulast%3DAlbright%26aufirst%3DC.%2BF.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DTebben%26aufirst%3DA.%2BJ.%26aulast%3DMuckelbauer%26aufirst%3DJ.%2BK.%26aulast%3DCamac%26aufirst%3DD.%2BM.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26atitle%3DMonosubstituted%2520%25CE%25B3-lactam%2520and%2520conformationally%2520constrained%25201%252C3-diaminopropan-2-ol%2520transition-state%2520isostere%2520inhibitors%2520of%2520b-secretase%2520%2528BACE%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6916%26epage%3D6924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Swahn, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plobeck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehgelmeble, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as BACE-1 inhibitors: The challenge to achieve in vivo brain efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1854</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1854-1859&author=B.+M.+Swahnauthor=J.+Holenzauthor=J.+Kihlstr%C3%B6mauthor=K.+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=N.+Plobeckauthor=D.+Rotticciauthor=F.+Sehgelmebleauthor=M.+Sundstr%C3%B6mauthor=S.+von+Bergauthor=J.+F%C3%A4ltingauthor=B.+Georgievskaauthor=S.+Gustavssonauthor=J.+Neelissenauthor=M.+Ekauthor=L.+L.+Olssonauthor=S.+Berg&title=Aminoimidazoles+as+BACE-1+inhibitors%3A+The+challenge+to+achieve+in+vivo+brain+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.%2BM.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DPlobeck%26aufirst%3DN.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DEk%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.%2BL.%26aulast%3DBerg%26aufirst%3DS.%26atitle%3DAminoimidazoles%2520as%2520BACE-1%2520inhibitors%253A%2520The%2520challenge%2520to%2520achieve%2520in%2520vivo%2520brain%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1854%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2444</span><span class="NLM_x">–</span> <span class="NLM_lpage">2449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1016%2Fj.bmcl.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=22390835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2444-2449&author=J.+N.+Cummingauthor=E.+M.+Smithauthor=L.+Wangauthor=J.+Misiaszekauthor=J.+Durkinauthor=J.+Panauthor=U.+Iserlohauthor=Y.+Wuauthor=Z.+Zhuauthor=C.+Stricklandauthor=J.+Voigtauthor=X.+Chenauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=M.+F.+Czarnieckiauthor=W.+J.+Greenleeauthor=B.+A.+McKittrickauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Structure+based+design+of+iminohydantoin+BACE1+inhibitors%3A+identification+of+an+orally+available%2C+centrally+active+BACE1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6fR"><div class="casContent"><span class="casTitleNuber">6f</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor</span></div><div class="casAuthors">Cumming, Jared N.; Smith, Elizabeth M.; Wang, Lingyan; Misiaszek, Jeffrey; Durkin, James; Pan, Jianping; Iserloh, Ulrich; Wu, Yusheng; Zhu, Zhaoning; Strickland, Corey; Voigt, Johannes; Chen, Xia; Kennedy, Matthew E.; Kuvelkar, Reshma; Hyde, Lynn A.; Cox, Kathleen; Favreau, Leonard; Czarniecki, Michael F.; Greenlee, William J.; McKittrick, Brian A.; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2444-2449</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">From an initial lead 2-imino-1-methyl-4,4-diphenyl-5-imidazolidinone, a structure-based design approach led to identification of the novel, high-affinity iminohydantoin BACE1 inhibitor I that lowers CNS-derived Aβ following oral administration to rats.  SAR development in the S3 and F' subsites of BACE1 for this series, the synthetic approaches employed in this effort, and in vivo data for I are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tWBE09QKNLVg90H21EOLACvtfcHk0lhzovIUlKDyKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D&md5=783b6cb9a6d9608ff5e9dc4f5d634397</span></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCzarniecki%26aufirst%3DM.%2BF.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure%2520based%2520design%2520of%2520iminohydantoin%2520BACE1%2520inhibitors%253A%2520identification%2520of%2520an%2520orally%2520available%252C%2520centrally%2520active%2520BACE1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2444%26epage%3D2449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Kaller, M. M.; Harried, S. S.; Albrecht, B.; Amarante, P.; Babu-Khan, S.; Bartberger, M. D.; Brown, J.; Chen, K.; Cheng, Y.; Citron, M.; Croghan, M. D.; Dunn, R.; Graceffa, R.; Hickman, D.; Judd, T.; Kreiman, C.; La, D.; Lopez, P.; Luo, Y.; Masse, C.; Monenschein, H.; Nguyen, T.; Pennington, L. D.; San Miguel, T.; Wahl, R. C.; Weiss, M. M.; Wen, P. H.; Williamson, T.; Wood, S.; Xue, M.; Yang, B.; Zhang, J.; Patel, V.; Zhong, W.; Hitchcock, S.</span><span> </span><span class="NLM_article-title">A potent and orally efficacious, hydroxyethylamine based inhibitor of beta-secretase</span>.  <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span><div class="note"><p class="first last">submitted for publication</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+M.+Kaller&author=S.+S.+Harried&author=B.+Albrecht&author=P.+Amarante&author=S.+Babu-Khan&author=M.+D.+Bartberger&author=J.+Brown&author=K.+Chen&author=Y.+Cheng&author=M.+Citron&author=M.+D.+Croghan&author=R.+Dunn&author=R.+Graceffa&author=D.+Hickman&author=T.+Judd&author=C.+Kreiman&author=D.+La&author=P.+Lopez&author=Y.+Luo&author=C.+Masse&author=H.+Monenschein&author=T.+Nguyen&author=L.+D.+Pennington&author=T.+San+Miguel&author=R.+C.+Wahl&author=M.+M.+Weiss&author=P.+H.+Wen&author=T.+Williamson&author=S.+Wood&author=M.+Xue&author=B.+Yang&author=J.+Zhang&author=V.+Patel&author=W.+Zhong&author=S.+Hitchcock&title=A+potent+and+orally+efficacious%2C+hydroxyethylamine+based+inhibitor+of+beta-secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaller%26aufirst%3DM.%2BM.%26atitle%3DA%2520potent%2520and%2520orally%2520efficacious%252C%2520hydroxyethylamine%2520based%2520inhibitor%2520of%2520beta-secretase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Harried, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reider, P. J.</span><span> </span><span class="NLM_article-title">Stereoselective synthesis of <i>anti</i>-N-protected 3-amino-1,2-epoxides by nucleophillic addition to <i>N</i>-<i>tert</i>-butanesulfinyl imine of a glyceraldehydes synthon</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">5975</span><span class="NLM_x">–</span> <span class="NLM_lpage">5982</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo900643b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=5975-5982&issue=16&author=S.+S.+Harriedauthor=M.+D.+Croghanauthor=M.+R.+Kallerauthor=P.+Lopezauthor=W.+Zhongauthor=R.+Hungateauthor=P.+J.+Reider&title=Stereoselective+synthesis+of+anti-N-protected+3-amino-1%2C2-epoxides+by+nucleophillic+addition+to+N-tert-butanesulfinyl+imine+of+a+glyceraldehydes+synthon"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjo900643b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo900643b%26sid%3Dliteratum%253Aachs%26aulast%3DHarried%26aufirst%3DS.%2BS.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DReider%26aufirst%3DP.%2BJ.%26atitle%3DStereoselective%2520synthesis%2520of%2520anti-N-protected%25203-amino-1%252C2-epoxides%2520by%2520nucleophillic%2520addition%2520to%2520N-tert-butanesulfinyl%2520imine%2520of%2520a%2520glyceraldehydes%2520synthon%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26issue%3D16%26spage%3D5975%26epage%3D5982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M.</span><span> </span><span class="NLM_article-title">Using the Golden Triangle to optimize clearance and oral absorption</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5560</span><span class="NLM_x">–</span> <span class="NLM_lpage">5564</span><div class="note"><p class="first last">and references therein</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1016%2Fj.bmcl.2009.08.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=19720530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5560-5564&author=T.+W.+Johnsonauthor=K.+R.+Dressauthor=M.+Edwards&title=Using+the+Golden+Triangle+to+optimize+clearance+and+oral+absorption"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Using the Golden Triangle to optimize clearance and oral absorption</span></div><div class="casAuthors">Johnson, Ted W.; Dress, Klaus R.; Edwards, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5560-5564</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Golden Triangle is a visualization tool developed from in vitro permeability, in vitro clearance and computational data designed to aid medicinal chemists in achieving metabolically stable, permeable and potent drug candidates.  Classifying compds. as permeable and stable and plotting mol. wt. (MW) vs. octanol:buffer (pH 7.4) distribution coeffs. (log D) or estd. octanol:buffer (pH 7.4) distribution coeffs. (elog D) reveals useful trends.  Anal. of at least 2 orthogonal trends, such as permeability and clearance, can be extremely effective in balancing and optimizing multiple properties.  In addn., mol. wt. and log D impact potency-efficiency calcns., allowing potency, clearance and permeability to be optimized simultaneously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjGjEaOp0237Vg90H21EOLACvtfcHk0ljeYOQq9CSbyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE&md5=3cfed1288ec451eb4419f1db753ae4b4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.045%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DUsing%2520the%2520Golden%2520Triangle%2520to%2520optimize%2520clearance%2520and%2520oral%2520absorption%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5560%26epage%3D5564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="note"><p class="first last">Metabolite identification studies demonstrated that the primary sites of oxidative metabolism were in the neopentyl fragment.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Kumagai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuto, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, A. K.</span><span> </span><span class="NLM_article-title">Disposition of Methylenedioxyphenyl Compounds</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span><div class="note"><p class="first last">and references therein</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=254-261&author=Y.+Kumagaiauthor=J.+M.+Fukutoauthor=A.+K.+Cho&title=Disposition+of+Methylenedioxyphenyl+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumagai%26aufirst%3DY.%26aulast%3DFukuto%26aufirst%3DJ.%2BM.%26aulast%3DCho%26aufirst%3DA.%2BK.%26atitle%3DDisposition%2520of%2520Methylenedioxyphenyl%2520Compounds%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D1994%26volume%3D4%26spage%3D254%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Murray, M.</span><span> </span><span class="NLM_article-title">Methylenedioxyphenyl insecticide synergists as potential human health hazards</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.2174%2F1389200003339270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=11467081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlt1Whurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=67-84&author=M.+Murray&title=Methylenedioxyphenyl+insecticide+synergists+as+potential+human+health+hazards"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation</span></div><div class="casAuthors">Murray, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-84</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with 110 refs.  Cytochrome P 450 (CYP) enzymes catalyze the oxidative conversion of drugs and other lipophilic compds. to hydrophilic metabolites.  Thus, CYPs play a dominant role in the elimination of drugs from the body.  Inhibitory interactions occur when drugs compete for oxidn. by specific CYPs, whereas certain drugs increase the capacity for oxidative biotransformation by inducing the synthesis of new CYPs.  Methylenedioxyphenyl (MDP) compds. have been widely employed as com. important pesticide synergists and a no. of derivs. are found in oils and spices.  MDP compds. are of considerable toxicol. significance because of their capacity to inhibit and induce CYP enzymes in mammals; some derivs. produce neurotoxic and hepatotoxic effects.  Although there are relatively few therapeutic agents of present clin. importance that possess the MDP structural feature, the synthesis and preclin. evaluation of such agents appears to be increasing.  In the context of the existing literature surrounding MDP compds. it is noteworthy that these potential drugs also elicit significant modulatory effects on CYP activities in rat and human liver.  These developments indicate the importance of understanding the chem. mechanisms by which MDPs interact with CYPs.  Thus, the presence of the MDP structure may undermine the potential clin. value of new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYAjGf6nf5ZbVg90H21EOLACvtfcHk0lg_eVv7NfxTvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlt1Whurs%253D&md5=dcafc824c8bcd0080d256d6dd8c50ae7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F1389200003339270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200003339270%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DM.%26atitle%3DMethylenedioxyphenyl%2520insecticide%2520synergists%2520as%2520potential%2520human%2520health%2520hazards%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2000%26volume%3D1%26spage%3D67%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Koudriakova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iatsimirskaia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utkin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vouros, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storozhuk, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orza, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, N.</span><span> </span><span class="NLM_article-title">Modulation of Drug Metabolism and Antiviral Therapies</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1998&pages=552-561&author=T.+Koudriakovaauthor=E.+Iatsimirskaiaauthor=I.+Utkinauthor=E.+Ganglauthor=P.+Vourosauthor=E.+Storozhukauthor=D.+Orzaauthor=J.+Marininaauthor=N.+Gerber&title=Modulation+of+Drug+Metabolism+and+Antiviral+Therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DIatsimirskaia%26aufirst%3DE.%26aulast%3DUtkin%26aufirst%3DI.%26aulast%3DGangl%26aufirst%3DE.%26aulast%3DVouros%26aufirst%3DP.%26aulast%3DStorozhuk%26aufirst%3DE.%26aulast%3DOrza%26aufirst%3DD.%26aulast%3DMarinina%26aufirst%3DJ.%26aulast%3DGerber%26aufirst%3DN.%26atitle%3DModulation%2520of%2520Drug%2520Metabolism%2520and%2520Antiviral%2520Therapies%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D1998%26volume%3D26%26spage%3D552%26epage%3D561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Acosta, E. P.</span><span> </span><span class="NLM_article-title">Pharmacokinetic enhancement of protease inhibitors</span> <span class="citation_source-journal">JAIDS, J. Acquired Immune Defic. Syndr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">S11</span><span class="NLM_x">–</span> <span class="NLM_lpage">S18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2002&pages=S11-S18&author=E.+P.+Acosta&title=Pharmacokinetic+enhancement+of+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAcosta%26aufirst%3DE.%2BP.%26atitle%3DPharmacokinetic%2520enhancement%2520of%2520protease%2520inhibitors%26jtitle%3DJAIDS%252C%2520J.%2520Acquired%2520Immune%2520Defic.%2520Syndr.%26date%3D2002%26volume%3D29%26spage%3DS11%26epage%3DS18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rathbun, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, D. R.</span><span> </span><span class="NLM_article-title">Low-Dose Ritonavir for Protease Inhibitor Pharmacokinetic Enhancement</span> <span class="citation_source-journal">Ann. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">702</span><span class="NLM_x">–</span> <span class="NLM_lpage">706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=702-706&author=R.+C.+Rathbunauthor=D.+R.+Rossi&title=Low-Dose+Ritonavir+for+Protease+Inhibitor+Pharmacokinetic+Enhancement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRathbun%26aufirst%3DR.%2BC.%26aulast%3DRossi%26aufirst%3DD.%2BR.%26atitle%3DLow-Dose%2520Ritonavir%2520for%2520Protease%2520Inhibitor%2520Pharmacokinetic%2520Enhancement%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2002%26volume%3D36%26spage%3D702%26epage%3D706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kempf, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denissen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukulka, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granneman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroldi, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzuti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norbeck, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J. M.</span><span> </span><span class="NLM_article-title">Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">654</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1997&pages=654-660&author=D.+J.+Kempfauthor=K.+C.+Marshauthor=G.+Kumarauthor=A.+D.+Rodriguesauthor=J.+F.+Denissenauthor=E.+McDonaldauthor=M.+J.+Kukulkaauthor=A.+Hsuauthor=G.+R.+Grannemanauthor=P.+A.+Baroldiauthor=E.+Sunauthor=D.+Pizzutiauthor=J.+J.+Plattnerauthor=D.+W.+Norbeckauthor=J.+M.+Leonard&title=Pharmacokinetic+enhancement+of+inhibitors+of+the+human+immunodeficiency+virus+protease+by+coadministration+with+ritonavir"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DKumar%26aufirst%3DG.%26aulast%3DRodrigues%26aufirst%3DA.%2BD.%26aulast%3DDenissen%26aufirst%3DJ.%2BF.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DKukulka%26aufirst%3DM.%2BJ.%26aulast%3DHsu%26aufirst%3DA.%26aulast%3DGranneman%26aufirst%3DG.%2BR.%26aulast%3DBaroldi%26aufirst%3DP.%2BA.%26aulast%3DSun%26aufirst%3DE.%26aulast%3DPizzuti%26aufirst%3DD.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DNorbeck%26aufirst%3DD.%2BW.%26aulast%3DLeonard%26aufirst%3DJ.%2BM.%26atitle%3DPharmacokinetic%2520enhancement%2520of%2520inhibitors%2520of%2520the%2520human%2520immunodeficiency%2520virus%2520protease%2520by%2520coadministration%2520with%2520ritonavir%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1997%26volume%3D41%26spage%3D654%26epage%3D660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="note"><p class="first last">HMG CoA reductase inhibitors are commonly used by the elderly population. Within this class of inhibitors, pravastatin and rosuvastatin represent two medications that are not metabolized by Cyp3A4.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Mahar Doan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wring, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shampine, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serabjit-Singh, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkinson, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span> </span><span class="NLM_article-title">Passive permeability and P-glycoprotein mediated efflux differentiate CNS and non-CNS marketed drugs</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1124%2Fjpet.102.039255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=12438524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A280%3ADC%252BD38nptVKmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=1029-1037&author=K.+M.+Mahar+Doanauthor=J.+E.+Humphreysauthor=L.+O.+Websterauthor=S.+A.+Wringauthor=L.+J.+Shampineauthor=C.+J.+Serabjit-Singhauthor=K.+K.+Adkinsonauthor=J.+W.+Polli&title=Passive+permeability+and+P-glycoprotein+mediated+efflux+differentiate+CNS+and+non-CNS+marketed+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs</span></div><div class="casAuthors">Mahar Doan Kelly M; Humphreys Joan E; Webster Lindsey O; Wring Stephen A; Shampine Larry J; Serabjit-Singh Cosette J; Adkison Kimberly K; Polli Joseph W</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1029-37</span>
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Membrane permeability and P-glycoprotein (Pgp) can be limiting factors for blood-brain barrier penetration.  The objectives of this study were to determine whether there are differences in the in vitro permeability, Pgp substrate profiles, and physicochemical properties of drugs for central nervous system (CNS) and non-CNS indications, and whether these differences are useful criteria in selecting compounds for drug development.  Apparent permeability (P(app)) and Pgp substrate profiles for 93 CNS (n = 48) and non-CNS (n = 45) drugs were determined by monolayer efflux.  Calcein-AM inhibition assays were used to supplement the efflux results.  The CNS set (2 of 48, 4.2%) had a 7-fold lower incidence of passive permeability values <150 nm/s compared with the non-CNS set (13 of 45, 28.9%).  The majority of drugs (72.0%, 67 of 93) were not Pgp substrates; however, 49.5% (46 of 93) were positive in the calcein-AM assay when tested at 100 microM.  The CNS drug set (n = 7 of 48, 14.6%) had a 3-fold lower incidence of Pgp-mediated efflux than the non-CNS drug set (n = 19 of 45, 42.2%).  Analysis of 18 physicochemical properties revealed that the CNS drug set had fewer hydrogen bond donors, fewer positive charges, greater lipophilicity, lower polar surface area, and reduced flexibility compared with the non-CNS group (p < 0.05), properties that enhance membrane permeability.  This study on a large, diverse set of marketed compounds clearly demonstrates that permeability, Pgp-mediated efflux, and certain physicochemical properties are factors that differentiate CNS and non-CNS drugs.  For CNS delivery, a drug should ideally have an in vitro passive permeability >150 nm/s and not be a good (B --> A/A --> B ratio <2.5) Pgp substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_HiV1Xqt18Vf1XRtfYM0dfW6udTcc2eazR9sUZUYlibntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38nptVKmsw%253D%253D&md5=b841902aa8502de47c1e1603c80e09fb</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039255%26sid%3Dliteratum%253Aachs%26aulast%3DMahar%2BDoan%26aufirst%3DK.%2BM.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DWebster%26aufirst%3DL.%2BO.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DShampine%26aufirst%3DL.%2BJ.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BJ.%26aulast%3DAdkinson%26aufirst%3DK.%2BK.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26atitle%3DPassive%2520permeability%2520and%2520P-glycoprotein%2520mediated%2520efflux%2520differentiate%2520CNS%2520and%2520non-CNS%2520marketed%2520drugs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D1029%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Natta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worboys, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monshouwer, M.</span><span> </span><span class="NLM_article-title">Unbound Drug Concentration in Brain Homogenate and Cerebral Spinal Fluid at Steady State as a Surrogate for Unbound Concentration in Brain Interstitial Fluid</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1124%2Fdmd.108.024125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=19116265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=787-793&author=X.+Liuauthor=K.+Van+Nattaauthor=H.+Yeoauthor=O.+Vilenskiauthor=P.+E.+Wellerauthor=P.+D.+Worboysauthor=M.+Monshouwer&title=Unbound+Drug+Concentration+in+Brain+Homogenate+and+Cerebral+Spinal+Fluid+at+Steady+State+as+a+Surrogate+for+Unbound+Concentration+in+Brain+Interstitial+Fluid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span></div><div class="casAuthors">Liu, Xingrong; Van Natta, Kristine; Yeo, Helen; Vilenski, Olga; Weller, Paul E.; Worboys, Philip D.; Monshouwer, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">787-793</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The objective of the present study was to examine the accuracy of using unbound brain concn. detd. by a brain homogenate method (Cub), cerebral spinal fluid concn. (CCSF), and unbound plasma concn. (Cup) as a surrogate for brain interstitial fluid concn. detd. by brain microdialysis (Cm).  Nine compds.-carbamazepine, citalopram, ganciclovir, metoclopramide, N-desmethylclozapine, quinidine, risperidone, 9-hydroxyrisperidone, and thiopental-were selected, and each was administered as an i.v. bolus (up to 5 mg/kg) followed by a const. i.v. infusion (1-9 mg/kg/h) for 6 h in rats.  For eight of the nine compds., the Cubs were within 3-fold of their Cm; thiopental had a Cm 4-fold of its Cub.  The CCSFs of eight of the nine compds. were within 3-fold of their corresponding Cm; 9-hydroxyrisperidone showed a CCSF 5-fold of its Cm.  The Cups of five of the nine compds. were within 3-fold of their Cm; four compds. (ganciclovir, metoclopramide, quinidine, and 9-hydroxyrisperidone) had Cups 6- to 14-fold of their Cm.  In conclusion, the Cub and CCSF were within 3-fold of the Cm for the majority of the compds. tested.  The Cups were within 3-fold of Cm for lipophilic non-P-glycoprotein (-P-gp) substrates and greater than 3-fold of Cm for hydrophilic or P-gp substrates.  The present study indicates that the brain homogenate and cerebral spinal fluid methods may be used as surrogate methods to predict brain interstitial fluid concns. within 3-fold of error in drug discovery and development settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVK_I2XYWfrrVg90H21EOLACvtfcHk0lh55_5Dz8NtJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D&md5=feb6abdcfa4e2e007c5abd44066c0e19</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.024125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.024125%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVan%2BNatta%26aufirst%3DK.%26aulast%3DYeo%26aufirst%3DH.%26aulast%3DVilenski%26aufirst%3DO.%26aulast%3DWeller%26aufirst%3DP.%2BE.%26aulast%3DWorboys%26aufirst%3DP.%2BD.%26aulast%3DMonshouwer%26aufirst%3DM.%26atitle%3DUnbound%2520Drug%2520Concentration%2520in%2520Brain%2520Homogenate%2520and%2520Cerebral%2520Spinal%2520Fluid%2520at%2520Steady%2520State%2520as%2520a%2520Surrogate%2520for%2520Unbound%2520Concentration%2520in%2520Brain%2520Interstitial%2520Fluid%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D787%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–Brain Exposure Relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span><div class="note"><p class="first last">and references therein</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93Brain+Exposure+Relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593Brain%2520Exposure%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D26%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2601</span><span class="NLM_x">–</span> <span class="NLM_lpage">2611</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100087s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2601-2611&author=B.+Kuhnauthor=P.+Mohrauthor=M.+Stahl&title=Intramolecular+hydrogen+bonding+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span></div><div class="casAuthors">Kuhn, Bernd; Mohr, Peter; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2601-2611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The formation of intramol. hydrogen bonds has a very pronounced effect on mol. structure and properties.  We study both aspects in detail with the aim of enabling a more rational use of this class of interactions in medicinal chem.  On the basis of exhaustive searches in crystal structure databases, we derive propensities for intramol. hydrogen bond formation of five- to eight-membered ring systems of relevance in drug discovery.  A no. of motifs, several of which are clearly underutilized in drug discovery, are analyzed in more detail by comparing small mol. and protein-ligand X-ray structures.  To investigate effects on physicochem. properties, sets of closely related structures with and without the ability to form intramol. hydrogen bonds were designed, synthesized, and characterized with respect to membrane permeability, water soly., and lipophilicity.  We find that changes in these properties depend on a subtle balance between the strength of the hydrogen bond interaction, geometry of the newly formed ring system, and the relative energies of the open and closed conformations in polar and unpolar environments.  A no. of general guidelines for medicinal chemists emerge from this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaV7tFRU4k7Vg90H21EOLACvtfcHk0lh55_5Dz8NtJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D&md5=b9b6865dfcc9bdf7796d15218f6e8ff2</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm100087s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100087s%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2601%26epage%3D2611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="note"><p class="first last">Coordinates for the complex of BACE with inhibitor <b>21</b> have been deposited in the Protein Data Bank under PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DH6">4DH6</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Crystal structure of memapsin 2 (beta-secretase) in complex with an inhibitor OM00–3</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">10963</span><span class="NLM_x">–</span> <span class="NLM_lpage">10967</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi026232n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=10963-10967&author=L.+Hongauthor=R.+T.+Turnerauthor=G.+Koelschauthor=D.+Shinauthor=A.+K.+Ghoshauthor=J.+Tang&title=Crystal+structure+of+memapsin+2+%28beta-secretase%29+in+complex+with+an+inhibitor+OM00%E2%80%933"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1021%2Fbi026232n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi026232n%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DL.%26aulast%3DTurner%26aufirst%3DR.%2BT.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DShin%26aufirst%3DD.%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DCrystal%2520structure%2520of%2520memapsin%25202%2520%2528beta-secretase%2529%2520in%2520complex%2520with%2520an%2520inhibitor%2520OM00%25E2%2580%25933%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D10963%26epage%3D10967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Flap position of free memapsin 2 (beta-secretase), a model for flap opening in aspartic protease catalysis</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4689</span><span class="NLM_x">–</span> <span class="NLM_lpage">4695</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0498252" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=4689-4695&author=L.+Hongauthor=J.+Tang&title=Flap+position+of+free+memapsin+2+%28beta-secretase%29%2C+a+model+for+flap+opening+in+aspartic+protease+catalysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1021%2Fbi0498252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0498252%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DFlap%2520position%2520of%2520free%2520memapsin%25202%2520%2528beta-secretase%2529%252C%2520a%2520model%2520for%2520flap%2520opening%2520in%2520aspartic%2520protease%2520catalysis%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D4689%26epage%3D4695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="note"><p class="first last">Plasma protein binding values were interpolated using best-fit parameters generated from fitting a two-site binding model.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Turner, R. T.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanheira, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Subsite specificity of memapsin (β-secretase): implications for inhibitor design</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">10001</span><span class="NLM_x">–</span> <span class="NLM_lpage">10006</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi015546s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=10001-10006&author=R.+T.+Turnerauthor=G.+Koelschauthor=L.+Hongauthor=P.+Castanheiraauthor=A.+Ghoshauthor=J.+Tang&title=Subsite+specificity+of+memapsin+%28%CE%B2-secretase%29%3A+implications+for+inhibitor+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fbi015546s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi015546s%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DR.%2BT.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DCastanheira%26aufirst%3DP.%26aulast%3DGhosh%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DSubsite%2520specificity%2520of%2520memapsin%2520%2528%25CE%25B2-secretase%2529%253A%2520implications%2520for%2520inhibitor%2520design%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D10001%26epage%3D10006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Haniu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span> </span><span class="NLM_article-title">Characterization of Alzheimer’s beta-secretase protein BACE. A pepsin family member with unusual properties</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">21099</span><span class="NLM_x">–</span> <span class="NLM_lpage">21106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=21099-21106&author=M.+Haniuauthor=P.+Denisauthor=Y.+Youngauthor=E.+A.+Mendiazauthor=J.+Fullerauthor=J.+O.+Huiauthor=B.+D.+Bennettauthor=S.+Kahnauthor=S.+Rossauthor=T.+Burgess&title=Characterization+of+Alzheimer%E2%80%99s+beta-secretase+protein+BACE.+A+pepsin+family+member+with+unusual+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaniu%26aufirst%3DM.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DY.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DHui%26aufirst%3DJ.%2BO.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DBurgess%26aufirst%3DT.%26atitle%3DCharacterization%2520of%2520Alzheimer%25E2%2580%2599s%2520beta-secretase%2520protein%2520BACE.%2520A%2520pepsin%2520family%2520member%2520with%2520unusual%2520properties%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D21099%26epage%3D21106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Schinkel, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagenaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Deemter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mol, C. A. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borst, P.</span><span> </span><span class="NLM_article-title">Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">1698</span><span class="NLM_x">–</span> <span class="NLM_lpage">1705</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1995&pages=1698-1705&author=A.+H.+Schinkelauthor=E.+Wagenaarauthor=L.+van+Deemterauthor=C.+A.+A.+M.+Molauthor=P.+Borst&title=Absence+of+the+mdr1a+P-glycoprotein+in+mice+affects+tissue+distribution+and+pharmacokinetics+of+dexamethasone%2C+digoxin%2C+and+cyclosporin+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26aulast%3DWagenaar%26aufirst%3DE.%26aulast%3Dvan%2BDeemter%26aufirst%3DL.%26aulast%3DMol%26aufirst%3DC.%2BA.%2BA.%2BM.%26aulast%3DBorst%26aufirst%3DP.%26atitle%3DAbsence%2520of%2520the%2520mdr1a%2520P-glycoprotein%2520in%2520mice%2520affects%2520tissue%2520distribution%2520and%2520pharmacokinetics%2520of%2520dexamethasone%252C%2520digoxin%252C%2520and%2520cyclosporin%2520A%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1995%26volume%3D96%26spage%3D1698%26epage%3D1705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Booth-Genthe, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlini, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leake, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhandler, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochman, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rushmore, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, M.</span><span> </span><span class="NLM_article-title">Development and characterization of LLC-PK1 cells containing Sprague–Dawley rat <i>Abcb</i>1a (<i>Mdr</i>1a): comparison of rat P-glycoprotein transport to human and mouse</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1016%2Fj.vascn.2005.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=16545584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFSkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=78-89&author=C.+L.+Booth-Gentheauthor=S.+W.+Louieauthor=E.+J.+Carliniauthor=B.+Liauthor=B.+F.+Leakeauthor=R.+Eisenhandlerauthor=J.+H.+Hochmanauthor=Q.+Meiauthor=R.+B.+Kimauthor=T.+H.+Rushmoreauthor=M.+Yamazaki&title=Development+and+characterization+of+LLC-PK1+cells+containing+Sprague%E2%80%93Dawley+rat+Abcb1a+%28Mdr1a%29%3A+comparison+of+rat+P-glycoprotein+transport+to+human+and+mouse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Development and characterization of LLC-PK1 cells containing Sprague-Dawley rat Abcb1a (Mdr1a): Comparison of rat P-glycoprotein transport to human and mouse</span></div><div class="casAuthors">Booth-Genthe, Catherine L.; Louie, Steven W.; Carlini, Edward J.; Li, Bing; Leake, Brenda F.; Eisenhandler, Roy; Hochman, Jerome H.; Mei, Qin; Kim, Richard B.; Rushmore, Thomas H.; Yamazaki, Masayo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-89</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">P-glycoprotein is localized in numerous tissues throughout the body and plays an important role in the disposition of many xenobiotics.  The contribution of P-glycoprotein-mediated drug transport is being evaluated in early drug discovery stages, particularly for compds. targeted to the central nervous system, using in vitro tools including cell lines expressing P-glycoprotein.  Previous work in our lab. suggests there are species differences in P-glycoprotein transport activity between humans and animals.  The rat Abcb1a form of P-glycoprotein (formerly known as Mdr1a), the predominate isoform in the brain, has not been described in a functional cell system.  Here, we describe the development and characterization of LLC-PK1 cells expressing rat Abcb1.  We cloned rat Abcb1a and generated a stable LLC-PK1 cell line.  Expression and function of the cells were evaluated by immunoblot anal., cytotoxicity anal., cellular accumulation assays, and transcellular transport of probe substrates.  The transport ratios of structurally diverse compds. obtained from parental cells or cells stably transfected with human ABCB1, mouse Abcb1a or rat Abcb1a were compared.  Two forms of rat Abcb1a were cloned from Sprague-Dawley cDNA that differ by six amino acids and a base pair deletion.  The intact form was stably transfected in LLC-PK1 cells.  Immunoblot anal. demonstrated expression of the protein.  The cells demonstrated P-glycoprotein-mediated function by directional transport of dexamethasone, ritonavir, and vinblastine in a transwell assay that was inhibited in the presence of cyclosporin A, verapamil, or quinidine.  Likewise, the cells showed reduced cellular accumulation of Rh123 by FACS anal. that was reversed in the presence of cyclosporin A.  These cells showed ≥ 350-fold resistance to colchicine, doxorubicin, vinblastine, and taxol and were sensitized in the presence of verapamil or cyclosporin A.  Of 179 chem. diverse compds. evaluated, ∼20% of the compds. evaluated were predicted to be substrates in one species but not in other species.  Taken together, these data suggest these cells will be useful for evaluation of rat Abcb1a-mediated transport and for evaluation of species-specific P-glycoprotein-mediated transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTnY-e_sTc7LVg90H21EOLACvtfcHk0ljHBfF_JsVwBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFSkuro%253D&md5=3390b072631084f62434e147269b6c13</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2005.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2005.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DBooth-Genthe%26aufirst%3DC.%2BL.%26aulast%3DLouie%26aufirst%3DS.%2BW.%26aulast%3DCarlini%26aufirst%3DE.%2BJ.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLeake%26aufirst%3DB.%2BF.%26aulast%3DEisenhandler%26aufirst%3DR.%26aulast%3DHochman%26aufirst%3DJ.%2BH.%26aulast%3DMei%26aufirst%3DQ.%26aulast%3DKim%26aufirst%3DR.%2BB.%26aulast%3DRushmore%26aufirst%3DT.%2BH.%26aulast%3DYamazaki%26aufirst%3DM.%26atitle%3DDevelopment%2520and%2520characterization%2520of%2520LLC-PK1%2520cells%2520containing%2520Sprague%25E2%2580%2593Dawley%2520rat%2520Abcb1a%2520%2528Mdr1a%2529%253A%2520comparison%2520of%2520rat%2520P-glycoprotein%2520transport%2520to%2520human%2520and%2520mouse%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2006%26volume%3D54%26spage%3D78%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuillard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yon, J.</span><span> </span><span class="NLM_article-title">Apo and inhibitor complex structures of BACE (beta-secretase)</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2004&pages=407-416&author=S.+Patelauthor=L.+Vuillardauthor=A.+Cleasbyauthor=C.+W.+Murrayauthor=J.+Yon&title=Apo+and+inhibitor+complex+structures+of+BACE+%28beta-secretase%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DVuillard%26aufirst%3DL.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DYon%26aufirst%3DJ.%26atitle%3DApo%2520and%2520inhibitor%2520complex%2520structures%2520of%2520BACE%2520%2528beta-secretase%2529%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D343%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray diffraction data collected in oscillation mode</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+of+X-ray+diffraction+data+collected+in+oscillation+mode"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0ljHBfF_JsVwBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520X-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm300119p&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lh0unjQI5RjIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">D53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0lh0unjQI5RjIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3DD53%26spage%3D240%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">D60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm300119p&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm300119p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lh0unjQI5RjIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3DD60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. T.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esmay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbeah-Ampiah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monenschein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Potent, Orally Efficacious Hydroxyethylamine Derived β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors</span> <span class="citation_source-journal">J. Med. Chem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1021/jm300118s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300118s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=T.+A.+Dineenauthor=M.+M.+Weissauthor=T.+Williamsonauthor=P.+Actonauthor=S.+Babu-Khanauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=Y.+Chengauthor=M.+Citronauthor=M.+D.+Croghanauthor=R.+T.+Dunnauthor=J.+Esmayauthor=R.+F.+Graceffaauthor=S.+S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=D.+B.+Horneauthor=H.+Huangauthor=R.+Imbeah-Ampiahauthor=T.+Juddauthor=M.+R.+Kallerauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=V.+Liauthor=P.+Lopezauthor=S.+Louieauthor=H.+Monenscheinauthor=T.+T.+Nguyenauthor=L.+D.+Penningtonauthor=T.+San+Miguelauthor=E.+A.+Sickmierauthor=H.+M.+Vargasauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=D.+A.+Whittingtonauthor=S.+Woodauthor=Q.+Xueauthor=B.+H.+Yangauthor=V.+F.+Patelauthor=W.+Zhong&title=Design+and+Synthesis+of+Potent%2C+Orally+Efficacious+Hydroxyethylamine+Derived+%CE%B2-Site+Amyloid+Precursor+Protein+Cleaving+Enzyme+%28BACE1%29+Inhibitors&doi=10.1021%2Fjm300118s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm300118s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300118s%26sid%3Dliteratum%253Aachs%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DActon%26aufirst%3DP.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DDunn%26aufirst%3DR.%2BT.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarried%26aufirst%3DS.%2BS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DHorne%26aufirst%3DD.%2BB.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DImbeah-Ampiah%26aufirst%3DR.%26aulast%3DJudd%26aufirst%3DT.%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DMonenschein%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DVargas%26aufirst%3DH.%2BM.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DB.%2BH.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DZhong%26aufirst%3DW.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Potent%252C%2520Orally%2520Efficacious%2520Hydroxyethylamine%2520Derived%2520%25CE%25B2-Site%2520Amyloid%2520Precursor%2520Protein%2520Cleaving%2520Enzyme%2520%2528BACE1%2529%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem%26date%3D2012%26doi%3D10.1021%2Fjm300118s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DH6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4DH6','PDB','4DH6'); return false;">PDB: 4DH6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w50" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1w50','PDB','1w50'); return false;">PDB: 1w50</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i72"><a href="/doi/suppl/10.1021/jm300119p">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_61131"></div></div></div></div></div><hr /></hr><p class="last">Experimental section; coordinates for co-crystal of BACE1 + compound <b>21</b>.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300119p/suppl_file/jm300119p_si_001.pdf">jm300119p_si_001.pdf (95.88 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300119p&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-21%3Barticle%3Aarticle%3A10.1021%2Fjm300119p%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300119p" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990b54fee53d06","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
